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ABSTRACT 
This dissertation describes the development of 2-guanidinobenzimidazole (GBI) 
containing ruthenium based organometallic hydrogen bond donors and their applications 
in second coordination sphere promoted catalysis (SCSPC).  
The synperiplanar triad arrangement of the NH donor (D) sites in GBI and 
derivatives are studied to establish that chelation preorganizes GBI in a DDD motif that 
is not an energy minimum with the free ligand.  
Laterhe importance of preorganization is explored in reactions catalyzed by GBI 
and derivatives. Protonated or methylated BArf (B(3,5-C6H3(CF3)2)4) salts of GBI, 1
+
BArf
– (84%) and 2+ BArf
– (58%), are prepared along with the protonated salts of
guanidine and 2-aminobenzimidazole, 3+ BArf
– (70% ) and 4+ BArf
– (75%),
respectively. Refluxing GBI and (5-C5H5)Ru(PPh3)2(Cl) in toluene forms the chelated
complex [(5-C5H5)Ru(PPh3)(GBI)]
+ Cl (8+ Cl; 96%), which upon addition of CO
forms [(5-C5H5)Ru(CO)(GBI)]
+ Cl (9+ Cl; 91%). Subsequent anion metathesis of 8+
and 9+ Cl– gives the respective PF6
– and BArf
– salts (83-92%). 9+ PF6
– can also be
prepared from [(5-C5H5)Ru(CO)(NCCH3)2]
+ PF6
– (81%). GBI and 9+ Cl– (10 mol%,
rt) are ineffective (48 h) for the condensations of 1-methylindole and trans-ß-
nitrostyrene (6). In contrast, salts 1-4+ BArf
– (25-95%, 1 h) and 8-9+ X– (PF6
– and
BArf
–) are active catalysts (30-97%) under similar conditions.
Furthermore, GBI derivatives with a NHR group (GBI-R; R = 16a, CH2Ph; 16b, 
(SC)-CH(CH3)Ph; 16c, (RCRC)-CH-(CH2)4-CH-NMe2; 16d, (RCRC)-CH-(CH2)4-CH-
NCH2(CH2)3CH2) are prepared. Reactions with [(η
5-C5H5)Ru(CO)(NCCH3)2]
+ PF6
–
afford the chiral-at-metal chelates [(η5-C5H5)Ru(CO)(GBI-R)]
+ PF6
– (18a-d+ PF6
–, 39-
77%). The Ru,C configurational diastereomers of 18c+ PF6
– separate upon alumina
iii 
chromatography (RRuRCRC, >99:01 diastereomer ratio (dr); SRuRCRC, <2:98 dr). 
Configurations are assigned by CD spectra, DFT calculations, and a crystal structure. 
Both (SRuRCRC)-18c
+ PF6
– and (RRuRCRC)-18c
+ PF6
– (1-10 mol%) catalyze Michael
addition reactions between 1,3-dicarbonyl equivalents and 6 in high yields and 
enantioselectivities (90-99% ee). The free GBI-R ligand exhibits only modest activity. 
The chiral ruthenium center has little influence over the product configuration.  
Finally, ruthenium GBI complexes bearing a bulky electron withdrawing 
pentaphenylcyclopentadienyl ligand are accessed by treating a CH3CN suspension of 
(η5-C5Ph5)Ru(CO)2(Br) with Me3NO2H2O, GBI, and Ag
+ PF6
–. Silica gel
chromatography workups lead to [(η5-C5Ph5)Ru(CO)(GBI)]
+ PF6
– (48+ PF6
–; 70%),
whereas with alumina [(η5-C5Ph5)Ru(CO)(GBI)]
+ BArf
– (48+ BArf
–; 69%) is obtained
after anion metathesis. The neutral compound (η5-C5Ph5)Ru(CO)(GBI–H) (49; 72%)
bearing a deprotonated GBI ligand (GBI–H) is obtained from 48
+ PF6
– with K+ t-BuO–.
These are characterized by NMR, other spectroscopic methods, and X-ray 
crystallography. Protonation of 49 with the axially chiral enantiopure phosphoric acid, 
(P)-Phos-H (HOP(=O)(o-C10H6O)2)), leads to (RRu/SRu)-48
+ (P)-Phos– (92%) as a
mixture of Ru,Axial configurational diastereomers. The diastereomer (SRu)-48
+ (P)-
Phos– (35%) can be isolated with >98:02 dr from cold toluene/hexane. Subsequent anion 
metathesis provides (SRu)-48
+ BArf
– (80%). The absolute configuration is assigned by
CD spectroscopy. (SRu)-48
+ BArf
– (10 mol%) is an efficient catalyst for Friedel-Crafts
alkylations and Michael addition reactions even under aerobic conditions. The addition 
of thiophenol to trans-3-cinnamoyloxazolidin-2-one is highly enantioselective (>99%). 
The neutral complex 49 is even capable of acting as a multifunctional catalyst and 
promotes Michael addition reaction of diethyl malonate and 6 in the absence of an 
external base.  
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NOMENCLATURE 
δ chemical shift in ppm 
ε molar extinction coefficient 
ν stretching mode (IR) 
µ micro (  10–6)
° degree (angle) 
° degree (temperature) 
[θ] molar ellipticity 
Δε molar circular dichroism 
β beta position 
Δ Delta (right-handed, absolute stereo configuration of octahedral complex) 
Λ Lambda (left-handed, absolute stereo configuration of octahedral 
complex) 
ηn eta (hapticity), describes a ligand that coordinates through n contiguous 
atoms 
{
1
H} proton decoupled 
Å Angstrom 
Anal. analysis 
Ar aryl 
BAMOL 1,1'-biaryl-2,2'-dimenthol 
BINOL 1,1'-bi-2-naphthol 
vii 
br broad 
Bu butyl 
Calcd calculated 
CD circular dichroism 
CH2Cl2 dichloromethane 
CH3CN acetonitrile 
C6H14 hexane 
C5H12 pentane 
CH3COCH3 acetone 
CH3C6H5 toluene 
CH
3
COOH glacial acetic acid 
Cp
*
pentamethylcyclopentadienyl 
d doublet (NMR) 
d days 
dec decomposition 
dr diastereomer ratio 
DMSO dimethylsulfoxide 
ee enantiomeric excess 
en ethylenediamine 
Et ethyl 
Et3N triethylamine 
EtOAc ethyl acetate 
viii 
EtOH ethanol 
equiv equivalent 
g gram 
h hour 
HPLC high pressure liquid chromatography 
Hz hertz 
i ipso or iso 
i
Jjk scalar coupling constant for coupling of nucleus j with nucleus k through 
i bonds 
IR infrared 
kcal kilocalorie 
M mol/Liter 
M metal 
m multiplet (NMR), medium (IR) 
m meta 
Me methyl 
MeOH methanol 
min minutes 
mmol millimole 
mp melting point 
NMR nuclear magnetic resonance 
o ortho 
ix 
p para 
PF6
–
hexafluorophosphate 
Ph phenyl 
ppm parts per million 
Pr propyl 
q quartet 
R organic group 
rt room temperature 
s singlet (NMR), strong (IR) 
sep septet (NMR) 
t triplet (NMR) 
t tertiary 
TADDOL α,α,α,α-tetraaryl-1,3-dioxolane-4,5-dimethanol 
temp temperature 
TLC thin layer chromatography xxviii 
UV ultraviolet 
v/v volume/volume 
vis visible 
vs very strong 
w weak 
x 
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1. INTRODUCTION: SECOND COORDINATION SPHERE
PROMOTED CATALYSIS 
1.1 Hydrogen bonding and its applications 
Non-covalent interactions such as hydrogen bonding1 play a crucial role in our 
existence. Two prominent examples out of many include the double helical structure of 
DNA2 and the unique colligative properties of H2O.
1a The strengths of hydrogen bonds
span more than two orders of magnitude (0.2-40 kcal mol–1)1b and nature has 
ubiquitously exploited them for molecular recognition and tuning reactivity.3 The first 
mention of hydrogen bonding as some unexplained interaction dates back to 1913 when 
Moore and Winmill studied the ionization of aqueous solutions of primary, secondary, 
and tertiary amines and quaternary ammonium salts.4 Since then the understanding of 
hydrogen bonding has inspired chemists to apply these interactions for diverse 
purposes.5-9 
1.1.1 Hydrogen bonding in Organocatalysis 
From an application standpoint, hydrogen bonding has been explored as an 
architectural unit for supramolecular assembly and host-guest interactions.5-9 
Macromolecules that mimic enzyme binding sites have shown the capability to catalyze 
numerous organic transformations aided by hydrogen bonding from peptidic NH or OH  
linkages.3 Later, Etter with her pioneering work on hydrogen bonding motifs of ureas in 
the solid state (Figure 1.1)10 and Curran with his solution studies with thioureas 
(Scheme 1.1)11 laid the foundation for small molecule hydrogen bonding promoted 
2 
catalysis. These molecules are often termed as "organocatalysts".12 
Soon, this new field of catalysis exploded with chiral molecules capable of 
hydrogen bond donation. A plethora of enantioselective and/or diastereoselective 
transformations were shown to take place with this new kind of catalytic activation. 
Though thiourea and urea derivatives (thiourea, III, urea, II)13 were the first to be 
developed, many other backbones like guanidine (IV), TADDOL (V), BAMOL (VI), 
BINOL (VII), amidinium ions (VIII), squaramide (IX), and silanediols (X) emerged 
soon thereafter.13-20 Some representative catalysts are shown in Figure 1.2 (left). They 
can have one or more hydrogen bond donor sites. The systems shown in Figure 1.2 are 
the most typical. Achiral analogs can participate in a dual hydrogen bonding motif as 
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illustrated for ketones in XIa (Figure 1.2, right). These activate the carbonyl carbon 
towards nucleophilic attack. With a chiral catalyst and an unsymmetrical ketone, the host 
guest interaction creates two diastereotopic C=O faces as illustrated in XIb (Figure 1.2, 
right). Subsequent reactions with nucleophiles can lead to enantioenriched products. 
 
 
 
 
 
 
 
Enantiopure catalysts with auxiliary functionality have subsequently been 
developed. These new multifunctional hydrogen bond donors, XII-XIV21-23 (Figure 1.3, 
top), expanded the range of successfully catalyzed organic transformations. The Michael 
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addition reaction has seen particular emphasis. Plausible transition state assemblies for 
the XII-catalyzed addition of dialkyl malonates to trans--nitrostyrene have been shown 
in Figure 1.3 (bottom). The reason for the enantioenrichment was originally explained 
based on the model XVa (Figure 1.3, bottom box).21b Computationally, XVb was 
subsequently proposed as a transition state assembly for a similar reaction.21c This kind 
of system was first explored explicitly by Takemoto.8g,21 Subsequently, other types of 
NH containing bifunctional hydrogen bond donors were developed (selected examples 
include XIII-XIV, basic moiety N). All of these systems were extended to other types of 
asymmetric organic transformations.8g,13-19  
 
 
 
 
 
 
 
1.1.2 Hydrogen bonding in the "Second Coordination Sphere" 
 
Examples of hydrogen bonding in inorganic molecules include H2O and NH3. 
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Because H2O is a liquid, periodic trends predict that H2S should be a liquid. Similarly, 
periodic trends predict that PH3 should have a higher boiling point than NH3. In reality, 
H2S is a gas and NH3 has a higher boiling point than PH3. Only hydrogen bonding 
interactions can explain these anomalies. These interactions are not present in H2S and 
PH3.  
Hydrogen atoms directly linked to metals (M-H) can participate in hydrogen 
bonding. The M-H moiety usually acts as a hydrogen bond donor, as shown in XVI 
(Figure 1.4, left (top)).24 Also the metal itself sometimes can act as a hydrogen bond 
acceptor as illustrated in XVII (Figure 1.4 left (bottom)).25 
 
 
 
 
 
 
 
Similarly, hydrogen atoms not directly attached to the metal center (remote) can 
also participate in hydrogen bonding, either intermolecularly or intramolecularly. 
Numerous examples of such hydrogen bonding are evident in the crystal structures of 
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inorganic complexes. A simple and readily available cobalt trication,26 [Co(en)3]
3+ with 
three 1,2-ethylenediamine ligands, XVIII (Figure 1.4, right), can be found in 115 crystal 
structures in the Cambridge Crystallographic Data Centre (survey on February 2015).27 
The trication is "chiral-at-metal" and can be separated into enantiomers using the tartrate 
anion. Hydrogen bonding plays an important role in the resolution.28  
In these systems, the hydrogen atoms attached to nitrogen atoms are a part of the 
second coordination sphere. These hydrogen atoms act as donors and bind to suitable 
heteroatoms either intermolecularly or intramolecularly. These bonding interactions also 
involve anions or solvent molecules, which are evident in their crystal structures.27b 
Indeed, such interactions have been utilized in inorganic crystal engineering.29 A variety 
of metal-ammonia complexes [LyMNH3]
z+ (z = 0, 1) have been found to afford stable 
adducts with crown ethers, both in solution and the solid state.30,31 One example is 
shown as XIX (Figure 1.4, right).31  
Breit and Reek separately have shown (Scheme 1.2) that self-assembly of a 
monodentate ligand (XX) to a bidentate ligand can be achieved in situ with the aid of 
hydrogen bonding.32,33 This self assembled adduct behaves similarly to a chelating 
ligand and forms complexes of the type XXI. Similar covalently linked structures are 
difficult to obtain. Thus, the self-assembly approach simplifies ligand syntheses. An 
added benefit is the possibility of generating combinatorial libraries of bidentate ligands 
through the simple mixing of suitably functionalized monodentate precursors.32f,g  
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Reactions involving atoms directly connected to the metal center represent first 
coordination sphere interactions. Participating atoms remote from the metal center 
constitute second coordination sphere interactions. A classic example in which both first 
and second coordination sphere interactions are involved features Noyori’s ketone 
hydrogenation catalyst (transition state assembly XXII, Figure 1.5, left).34 Here, the 
ruthenium hydride moiety (Ru-H) is interacting with the carbonyl carbon in the first 
coordination sphere (Figure 1.5, right (blue)). A remote NH is interacting via hydrogen 
bonding to the carbonyl oxygen in the second coordination sphere (Figure 1.5, right 
(red)). 
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1.2 2-Guanidinobenzmidazole: an overlooked hydrogen bond donor 
 
1.2.1 Why 2-Guanidinobenzmidazole? 
 
An inexpensive and readily available nitrogen heterocycle, 2-
guanidinobenzimidazole (GBI), has been extensively studied.35 GBI has five N-H 
bonds (Scheme 1.3, blue) capable of hydrogen bonding as evident from the crystal 
structures of GBI, GBI/crown ether adducts, and GBI/aza crown ether adducts.36,37 Its 
structure has been thoroughly characterized both in solution35 and in the solid state.36-38 
As depicted in Scheme 1.3, it consists of guanidine (red) and benzimidazole (green) 
fragments. Like the constituent fragments, it also exhibits some biological activity.35c 
Similar to GBI, various derivatives have also been studied both in solution and the solid 
state.35a,39  
The GBI molecule can in theory exist as a number of different tautomeric 
structures stabilized by intramolecular and intermolecular hydrogen bonding.35a,c The 
tautomers XXIIIa-f are depicted in Scheme 1.3. The atom numbering system commonly 
employed is also illustrated. In most tautomers, N5, N2, and N4 feature N-H bonds. 
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Many planar nitrogen heterocycles with functionality arrays that can participate 
in hydrogen bond donor/acceptor host-guest interactions are known. It is common to 
indicate synperiplanar acceptor (A) and donor (D) sites of the heterocycle by a linear 
sequence of letters (e.g. DDADA). Complementary partners for host-guest interactions 
would have the opposite sequence of letters.  
Some molecules can be self-complementary whereas others interact with 
complementary partners. The D and A sites in GBI are shown in Scheme 1.3. Having 
both donor and acceptor sites within the same molecule makes GBI interesting for 
solution and solid state studies. Furthermore, due to the five atom array N1=C1-N2-
C2=N3, GBI can serve as a chelating ligand akin to acetylacetonate (acac). Many metal 
or main group element chelated complexes of GBI featuring six membered rings have 
been prepared and studied.35,39c,40  
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One would expect the five NH protons on GBI to exhibit comparable acidities, 
and several tautomers would be possible for the conjugate base GBI–H.
26 Two such 
anions are depicted in Scheme 1.4, together with chelate complexes derived from a 
cationic metal fragment LyM
+ (XXIVa/b). 
 
 
 
 
 
 
1.2.2 GBI in solution and the solid state 
 
GBI can exhibit different tautomeric forms stabilized by intramolecular and 
intermolecular hydrogen bonding.35a,c Consider the tautomer XXIIId from Scheme 1.3, 
which is believed to dominate in solution.35c It is redrawn in Scheme 1.5 together with 
the degenerate structure XXIIId'. These are interconvertable by a proton transfer from 
N5 to N3 and a subsequent 180° C2-N2 bond rotation. There are other C2-N2 rotamers, 
but those in Scheme 1.5 are distinguished by intramolecular hydrogen bonding. In these 
two structures GBI attains a DAD triad sequence. 
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GBI and its derivative, N-1H-benzimidazol-2-yl-N',N''-bis(isopropyl)guanidine, 
XXV (Figure 1.5, left), exhibit a N1-H1N3 hydrogen bond (Figure 1.6, left (bottom)). 
Even when the symmetry between N1 and N4 is removed, as in the constitutional isomer 
N'-1H-benzimidazole-2-yl-N,N-bis(isopropyl)guanidine), XXVI (Figure 1.6, right), a 
similar N1-H1N3 linkage is observed (Figure 1.6, right (bottom)).39b In both the 
examples in Figure 1.6, the heterocycle presents a DA dyad sequence.39b The hydrogen 
atom or lone pair on N4 does not exhibit a synperiplanar relationship to N2 lone pair, 
precluding a triad. 
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Crystal structures of GBI/crown ether adducts37a (Figure 1.7, left) and aza crown 
ether adducts37b demonstrate that GBI molecules form both intramolecular and 
intermolecular hydrogen bonds. In the GBI 18-crown-6 ether complex (XXVII), GBI is 
perpendicular to the ether plane and the N4 NH2 group points towards the cavity of the 
crown ether. Here, two of the NH units are hydrogen bonded to three oxygen atoms of 
the ether (cyan). The shortest hydrogen bond was seen in the case of the intramolecular 
interaction between N3 and H1 (red, < 2 Å). GBI exhibits a DAD triad.  
In cases of GBI-phthalimide38 and GBI (derivative)-phthalimide39c complexes, 
two kinds of structures were obtained. A GBI derivative, N'-(5,6-dimethyl-1H-
benzimidazol-2-yl)guanidine (dimethylGBI; XXVIII), afforded the 1:1 adduct XXIX 
whereas GBI yielded XXX (Figure 1.7, middle and right).39c Both of these structures 
are essentially planar with intramolecular hydrogen bonding between H1 and N3 of 
GBI. The only difference is in the intermolecular hydrogen bonding between N2 and the 
NH unit of phthalimide. The dimethylGBI triad in XXIX exhibits a DAD motif, whereas 
phthalimide possesses a complementary ADA motif. In contrast, the GBI phthalimide 
adduct (XXX) exhibits a linear DDD-AAA arrangement, indicating the transfer of the 
phthalimide proton to GBI, forming a zwitterion. This also reflects the ability of GBI to 
act as a base. The hydrogen bonding distances in XXX are shorter than those in XXIX.  
 
 
 
 13 
 
 
 
 
 
1.2.3 Hydrogen bonding in the second coordination sphere of metal GBI complexes 
 
The structures of metal GBI complexes have been investigated in solution by 
NMR and in the solid state by IR spectroscopy and X-ray crystallography.35,40a,d 
Chelation can be clearly identified by the changes in the IR spectra.40a Some 
representative neutral and cationic metal complexes of GBI are discussed below.  
The neutral tetrahedral zinc complex, Zn(GBI)Cl2 (XXXI), is seen to participate 
in intermolecular hydrogen bonding (Figure 1.8, top left).40d The chloride ligand 
interacts with the H2 and H5 protons of the GBI ligand of an adjacent molecule. 
Similarly, in a hydrated copper salt Cu(GBI)2+ 2ClO4
–H2O (XXXII), the dication 
shows hydrogen bonding interactions with H2O and one perchlorate anion (top right).
41  
In all of the examples above, the GBI ligand features a DDD triad, which is rare 
in studies of the free ligand. Thus, the metal can significantly alter the properties of the 
free ligand. The DDD arrangement can be compared to the DD motif seen in thioureas 
that have been used as hydrogen bond donor catalysts.13b Similarly, metal GBI 
complexes can potentially act as hydrogen bond donor catalysts. 
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Interestingly, the crystal structure of a nickel complex (XXXIII) derived from 
deprotonated dimethylGBI (dimethylGBI–H)
26 revealed two independent structures 
within the unit cell.39c One is derived from the loss of H5 forming a ADD triad while the 
other from the loss of H2 forming a DAD triad. The important feature is that two of the 
molecules with the ADD triad subsequently self assembled via hydrogen bonding as 
illustrated in Figure 1.8 (bottom). To complement each other, the molecules assemble 
head to tail leaving the N4 donor NH unbound. 
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For both GBI and GBI–H adducts, several tautomers are always possible, any 
one of which – or as in XXXIII, any group of which – can crystallize. The most obvious 
possibilities for GBI complex tautomers are summarized in Scheme 1.6. The central 
structure, XXXIV, represents the motif found most often in the subsequent chapters. 
 
 
 
 
 
 
 
1.3 Preorganization and hydrogen bonding 
 
1.3.1 Importance of preorganization and some applications 
 
Preorganization is both an important concept and phenomenon in chemistry.42 
The beneficial effect of preorganization with respect to binding affinities has been 
demonstrated by Cram for complexes of crown ethers and spherands with cations, as 
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illustrated for Li+ in Scheme 1.7.43 For both types of hosts, enhanced nucleophilicities 
are often observed for the counter anions associated with the cations. This reflects the 
diminished electrostatic and other interactions and represents one of the many 
applications of preorganization. 
 
 
 
 
 
 
 
In syntheses, in situ preorganization has been studied and exploited. It has been 
used to realize synthetically demanding structures or enhanced selectivities. These are 
often called template-directed syntheses.44 Stoddart has utilized π-π interactions to 
template the formation of various macrocycles of specific shape and sizes.44a,b,45 The 
reactants are otherwise prone to polymerize (by products) under the reaction conditions. 
Scheme 1.8 depicts one of many examples in which a pyrene molecule has been used as 
a template, in this case affording the box-like tetracationic salt XXXVII.45 Increased 
yield as compared to the non-template reaction (42% vs. 19%) clearly demonstrates the 
utility of template-directed syntheses. 
 17 
 
 
 
 
 
The Gladysz group had also explored the metal template synthesis of molecular 
gyroscopes, in which three fold intramolecular ring closing metatheses of alkenes is the 
key step.46 In particular, trigonal planar metal fragments preorganize the alkenes in a 
favorable conformation for metathesis leading to the desired product over others. 
Recently, Fujita has shown how TiO2 nanoparticles with a narrow polydispersity index 
(PDI = 1.02) can be realized with the aid of a macrocyclic cage he called a spherical 
coordination template.47 He also prepared hollow silica nanoparticles of precise size 
utilizing a core as a template.48 Gladysz, Leigh, and others have shown a metal template 
approach for synthesizing interlocked molecules better known as rotaxanes and 
catenanes.49 These are designed in such a way that the substrates are forced to react 
through one another forming the non-covalently interlocked molecule. Scheme 1.9 
shows a reaction developed by the Gladysz group in which they couple the axle 
(XXXVIII) through the macrocycle (IXL) to form the interlocked molecule, XL. 
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1.3.2 Preorganization in hydrogen bonding 
 
Both hydrogen bonding and preorganization have been utilized to mutual benefit. 
Hydrogen bonding has been used to preorganize a compound for a specific 
purpose5b,15,42c,50 while preorganization of a molecule enhances its hydrogen bonding 
capabilities.3a,g,6,51,52 For binding anions, detailed studies have shown that with 
preorganization, even carbon-hydrogen linkages can efficiently hydrogen bond to 
anions.50e,52  
The Meggers group has made important contributions to the area of preorganized 
metal containing hydrogen bond donor catalysts, as exemplified by XLI in Figure 1.9 
(left).53 This chiral-at-metal octahedral iridium(III) cation has been used to chelate a 
ligand containing a NH(C=CHR)NH moiety (Figure 1.9, middle). The metal has been 
used to install two additional chelate ligands with hydrogen bond donors in an 
appropriate orientation to promote the catalytic transformations. One of the chelated 
ligands acts as the hydrogen bond donor for one of the substrates (Figure 1.9, middle). 
The other is designed to achieve a compact transition state by bringing the other 
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substrate in close proximity via hydrogen bonding (Figure 1.9, right). This represents a 
bifunctional hydrogen bond donor. 
 
 
 
 
 
 
 
1.4 Purpose of second coordination sphere promoted catalysis with GBI 
 
Based on the above evidence, GBI can be a potent hydrogen bond donor and 
should be exploitable as a catalyst for simple organic transformations. Towards this end, 
several questions can be put forward: 
(1) Is GBI itself a good hydrogen bond donor catalyst or does one need to 
preorganize (modify) it (Scheme 1.10, top)?  
(2) Is GBI a better catalyst with chelation and second coordination sphere 
interactions (Scheme 1.10, top)?  
(3) Can one achieve a chiral hydrogen bond donor derived from GBI for 
enantioselective catalysis (Scheme 1.10, bottom)?  
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Each of these questions is systematically answered in the following chapters. The 
results include the syntheses of organometallic and non-metallic GBI derivatives and 
probes of their hydrogen bonding capabilities with organic acceptors. This will be 
followed by an investigation of their potential as hydrogen bond donor catalysts. 
Furthermore, enantiopure GBI derivatives will be targeted and used as catalysts for 
highly enantioselective organic transformations. Finally, the concept of second 
coordination sphere promoted catalysis will be established. 
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2. MODIFICATION AND APPLICATION OF 2-
GUANIDINOBENZIMIDAZOLE FOR SECOND COORDINATION 
SPHERE PROMOTED CATALYSIS* 
 
2.1 Introduction 
 
2.1.1 Inspiration 
 
The pioneering solid state studies on urea by Etter (see Figure 1.1, chapter 1, and 
below)10 laid the foundation for the thiourea based hydrogen bond donor 
organocatalysis.13,54 Similarly, numerous hydrogen bonding interactions of 2-
guanidinobenzimidazole (GBI) and its derivatives in the solid state (see section 1.2.2, 
chapter 1)35-40 inspired me to explore GBI as a similar catalyst for hydrogen bond 
mediated organic transformations.  
In this chapter, the capability of GBI as a hydrogen bond donor catalyst was 
initially investigated. Later, problems associated with the system were identified and 
solutions to the problems were sought. Towards this end, GBI was modified. Then, 
evidence was provided for second coordination sphere hydrogen bonding interactions 
between organic molecules and the modified compounds. Afterwards, these new 
compounds were successfully employed as catalysts for hydrogen bond mediated orga- 
 
 
* Reproduced in part with permission from Scherer, A.; Mukherjee, T.; Hampel, F.; 
Gladysz, J. A. Organometallics 2014, 33, 6709-6722. Copyright 2014 American 
Chemical Society. 
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nic transformations. The chapter concludes by establishing that these complexes promote 
organic transformations by second coordination sphere promoted catalysis (SCSPC). 
 
2.1.2 Preorganization and NH acidities 
 
Solid state studies by Etter involving numerous hydrogen bonded 1:1 urea 
(derivatives) and carbonyl/nitro compound adducts show some interesting features.10 
For example, in the 1:1 urea (derivative)-carbonyl adduct XLII (Figure 2.1), the NH 
protons from urea and the carbonyl oxygen atom are hydrogen bonded to each other. 
Hydrogen bonding is an interaction between two complementary partners, where one is a 
donor (D) while the other is an acceptor (A). Here, the NH protons act as hydrogen bond 
donors (D) and the carbonyl oxygen atom as the acceptor (A). In most of the adducts 
studied by Etter, two of the NH donor (D) sites in urea attain a synperiplanar DD dyad 
sequence.10  
 
 
 
 
 
 
 
A similar synperiplanar DD dyad sequence is also present in thioureas, and is 
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responsible for their success as hydrogen bond donor catalysts.8e,13a A modest amount 
of energy (ca. 7 kcal mol1) is associated in hydrogen bonding adduct formation 
between thioureas and carbonyl compounds.55,56 On this basis Schreiner predicted that 
entropic effects could dominate the association constants over the binding enthalpies.57 
Later, he showed that the strength of this hydrogen bonding interaction depends upon the 
rigidity of the donor molecule. Finally, he supported the hypothesis by demonstrating 
that enhanced rigidity increases the efficacy of the catalyst in hydrogen bond donor 
catalyzed Diels-Alder reaction (Scheme 2.1).57  
The effect of SH attractive/SR repulsive interactions, XLIIIa and XLIIIb 
(Scheme 2.1), is evident in the relative rates of IIIa and IIIb. The two interactions 
influence the rotations of the aryl groups and thereby catalytic activity. The rigid 
structure obtainable in IIIb accounts for the lesser entropic loss in the process of binding 
to the acceptor. Similar rate trends with IIIc,d,e and IIIf support the model mentioned 
above. In IIIf, the two CF3 group generate the most positively polarized ortho H atoms 
of the series. This leads to the most rigid structure and provides the fastest rate.57 At the 
other extreme, IIIa fails to attain a rigid structure and corresponds to the slowest rate. A 
similar beneficial effect of preorganization with respect to hydrogen bonding to anions is 
a well-known phenomenon and is well studied (see section 1.3, chapter 1).6,51,52  
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As explained in the previous chapter, GBI is a flexible molecule that is 
composed of two rigid units, guanidine and 2-aminobenzimidazole, as shown in Scheme 
2.2 (top). These are each capable of achieving a synperiplanar DD dyad sequence. When 
combined into GBI, in principle, a DDD triad should be obtained.  
On the contrary, GBI has numerous tautomeric structures as shown in Scheme 
2.2 (top). Structures XXIIIa,b and XXIIIf achieve this DDD triad while the others 
achieve ADD (XXIIIc), DAD (XXIIId), and DDA (XXIIIe) sequences. The tautomer 
XXIIId (DAD) and its degenerate structure XXIIId' (DAD), as shown in scheme 2.2 
(bottom), is believed to be dominant in solution.35c Even crystal structures of 
GBI/crown ether adducts37a (Figure 1.7, left, chapter 1) and aza crown ether adducts37b 
demonstrate a DAD triad.  
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In order to efficiently hydrogen bond to complementary acceptors, GBI needs to 
be preorganized into a DDD, ADD, DDA or DAD triad sequence. The first three 
sequences contain two donor sites (D) next to each other, similar to thioureas. In 
contrast, the DAD triad contains an acceptor (A) next to each donor (D).  
Similar to thioureas, preorganization would reduce the conformational degrees of 
freedom and thereby increase the hydrogen bonding capabilities of GBI. As mentioned 
before, the beneficial effect of preorganization is well known.6,42,43,51,52 Upon 
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preorganization of GBI, there would presumably be analogous effects on its reaction 
rates and catalytic activities. 
Furthermore, the NH acidities in the GBI molecule can also contribute to its 
catalytic activity. As reported by the Schreiner group, in the vinylogous aldol addition of 
γ-butenolide to benzaldehyde, the catalytic activity can be correlated with the pKa value 
of the thiourea catalyst employed (Scheme 2.3).58 However, the same series of catalysts 
fails to correlate to the pKa values in another reaction.
58 Although the preorganization of 
GBI is important for enhancing its hydrogen bonding capabilities, the tuning of NH 
acidities cannot be ignored.  
 
 
 
 
 
 
 
To understand the benefits of preorganization and increased NH acidities, GBI 
and its two constituent fragments (Scheme 2.2) were modified to cationic salts with 
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BArf
 26 as the anion. In each case, BArf
– was chosen because it is a weakly 
coordinating anion59 and also cannot participate in hydrogen bonding with the cation.60 
Finally, the catalytic activities of these salts were compared. These results are presented 
below. Based on these conclusions, ruthenium-GBI complexes were subsequently 
targeted.  
 
2.1.3 Preorganization of GBI by ruthenium 
 
Chelated complexes of GBI with boron and tin Lewis acid fragments have been 
described in the literature.40b,c Solid state studies of transition metal adducts show 
hydrogen bonding interactions in the second coordination sphere with anions and 
solvents.35b,40a Inspired by these facts, the Gladysz group has already shown that neutral 
tin complexes can be active catalysts for hydrogen bond promoted organic 
transformations (Scheme 2.4).61 The substrates were activated by hydrogen bonding in 
the second coordination sphere. Additionally, some of the chelated compounds with an 
enantiopure ligand attached to tin provided moderate enantioselectivities in the addition 
of nitrocyclohexane to 2-cyclohexen-1-one (XLVa-e, Scheme 2.4).61  
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Like tin, any chelate susceptible metal should also preorganize GBI, as shown in 
Figure 2.2 (top). Additionally, based on the nature and oxidation state of the metal, the 
N-H acidities can be further tuned. For example, more electron rich metal fragments will 
generally decrease X-H bond acidities, and more electron withdrawing metal fragments 
will generally increase X-H bond acidities. Moreover, an appropriate ligand arrangement 
around the metal would yield a chiral-at-metal complex as shown in Figure 2.2 (middle). 
Thus, the metal will serve three functions: (i) preoganization of GBI, (ii) tuning N-H 
acidities, and (iii) transforming achiral GBI to a chiral molecule. Furthermore, the 
solubility of ionic compounds can be optimized for various media by modifying the 
counter ion. Lastly, successful resolutions of the enantiomers lead to a catalyst that could 
be applied to enantioselective second coordination sphere promoted catalysis (SCSPC). 
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Here, ruthenium was chosen as an initial contender for this purpose. Ruthenium 
based piano stool complexes are well studied.62 These complexes are formally 
octahedral and with suitable ligand sets are chiral-at-metal.62-64 Half-sandwich 
ruthenium complexes similar to [(η5-C5R5)RuL1L2L3] (R = H or Me) have seen 
numerous application in catalysis.62  
Upon attaching GBI to a [(η5-C5R5)RuL] fragment, the ruthenium would attain a 
formally octahedral arrangement with the C5R5 ligand occupying three sites. This would 
be a racemic, chiral-at-metal complex. A cyclopentadienyl (η5-C5H5) variant was chosen 
because enantiopure chiral-at-metal (η5-C5H5)RuL1L2L3 cationic systems have been 
prepared before.62,63d,f,g,64d Further, the modular catalyst system shown in Figure 2.2 
(bottom) can be tuned in terms of electronics, solubilities, and sterics. Each parameter 
serves different purposes.  
 
2.2 Results 
 
2.2.1 Syntheses of cationic 2-guanidinobenzimidazolium, 2-aminobenzimidazolium, 
and guanidinium salts  
 
Two cationic species were prepared from GBI according to Scheme 2.5 (top). In 
one, GBI was protonated with HCl to form the salt 1+ Cl– according to literature.35a 
Subsequent anion metathesis with Na+ BArf
– 26,65 led to the new salt 1+ BArf
– as pale 
brown solid in 84% yield. Following a literature method, the methylated GBI salt 2+ Cl– 
was prepared.35a Similarly, anion exchange with Na+ BArf
– led to the new salt 2+ BArf
– 
as a dirty white solid in 58% yield.  
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Two other types of salts were also targeted as shown in Scheme 2.5 (bottom). 
First, the known guanidinium chloride 3+ Cl– underwent anion exchange when treated 
with Na+ BArf
– under biphasic conditions (CH2Cl2/H2O) to give the new salt 3
+ BArf
– 
in 77% yield. Second, 2-aminobenzimidazolium was protonated with HCl to give the 
salt 4+ Cl– in 50% crude yield. However, the crude sample was directly treated with Na+ 
BArf
– to give the new salt 4+ BArf
– as a white powder in 75% overall yield. All of the 
above BArf
– salts were characterized by NMR (1H and 13C) and IR spectroscopy, and 
microanalysis, as summarized in the experimental section. They exhibited good 
 31 
 
solubilities in CH2Cl2, CHCl3, MeOH, and DMSO. 
Due to the application of biphasic CH2Cl2/H2O conditions for the preparation of 
salt 1+ BArf
 and 3+ BArf
 by anion exchange, they were isolated as a hydrates (2.0-0.2 
H2O). Crystals of 3
+ BArf
– and 4+ BArf
– were obtained (see below). In another 
sequence, crystals of a dicationic bromide salt derived from GBI were accidentally 
obtained (below and experimental section). All of them showed hydrogen bonding to 
H2O and are discussed below. 
 
2.2.2 Crystallographic characterization  
 
Crystal structures of guanidinium salts are common, and a search in Cambridge 
Crystallographic Data Centre (surveyed on March 2015) for "guanidinium" resulted in 
1153 crystal structures.66 However, none with a BArf
 counter anion has ever been 
published. During the course of the above syntheses, single crystals of 3+ BArf
H2O 
were obtained from a CH2Cl2 solution. X-ray data were collected and refined as 
described in Table 2.1 and the experimental section. The resulting structure is shown in 
Figure 2.3 (top). Key metrical parameters are summarized in Table 2.2. Several of the 
CF3 groups and the C(NH2)3 groups were disordered, and modeled as described in the 
experimental section.  
The C-N bond lengths were similar to each other (1.33(3), 1.32(3), and 1.32(2) 
Å). The cation was hydrogen bonded to a H2O molecule by two NH units in a dual 
hydrogen bonding fashion common to urea and thiourea systems (chapter 1, Figure 
1.1).8e,13a From the H-N-N-H torsion angles (0.08°, 0.36°, 2.82°) it was evident that the 
cation contains three pairs of synperiplanar NH protons (DD dyad). The NHO and 
NO distances, which are summarized in Table 2.2, were in typical ranges for hydrogen  
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Table 2.1 Summary of crystallographic data.a 
 3+ BArf
H2O 
4+ BArf
 
H2O(CH2Cl2)0.5 
[1-H]2+ 2BrH2O 
Molecular formula C33H20BF24N3O C39.5H23BClF24N3O2 C8H13Br2N5O 
Formula weight 941.33 1057.87 355.05 
Crystal system Tetragonal Triclinic Monoclinic 
Space group P41 P-1 P21/c 
Diffractometer Bruker GADDS Bruker GADDS Bruker GADDS 
Wavelength [Å] 1.54178 1.54178 1.54178 
Unit cell dimensions:    
a [Å] 16.6073(5) 12.9532(6) 8.5710(4) 
b [Å] 16.6073(5) 17.0601(8) 11.8259(5) 
c [Å] 13.5055(6) 19.5110(9) 12.6300(6) 
α [°] 90 97.766(3) 90 
β [°] 90 101.549(3) 93.913(3) 
γ [°] 90 92.339(3) 90 
V [Å3] 3724.8(3) 4175.4(3) 127.19(10) 
Z 4 4 (Z' = 2) 4 
calc [Mgm
3] 1.679 1.683 1.846 
 [mm1] 1.696 2.167 7.985 
F (000) 1872 2108 696 
Crystal size [mm3] 0.05 0.03 0.01 0.12 0.08 0.06 0.07 0.04 0.03 
 range [°] 2.66 to 50.99 2.34 to 60.80 5.13 to 60.92 
Index ranges (h,k,l) 15,16;16,16;13,
13 
14,14;19,19;21,21 9,9;13,13;14,1
4 
Reflections collected 38897 100574 28147 
Independent reflections 3971 12367 1936 
Completeness to   59.6% (67.68) 81.8% (67.68) 83.5 (67.68) 
Data/restraints/parameter 3971/206/566 12367/0/1259 1936/0/149 
Goodness-of-fit on F2 1.043 1.122 1.051 
R indices (final) [I>2(I)]    
R1 0.0799 0.0914 0.0280 
wR2 0.2029 0.2610 0.0695 
R indices (all data)    
R1 0.0873 0.1132 0.0310 
wR2 0.2096 0.2784 0.0706 
Largest diff. peak and hole 
[eÅ3] 
0.736/0.499 1.951/1.114 0.403/0.695 
a
 Data common for all structures: T = 173(2) K. 
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bonds as observed by Etter.10b 
 
 
 
 
 
 
 
Crystal structures of 2-aminobenzimidzolium salts have also been reported in the 
literature, but none with BArf
 as the counter anion.67 Similarly to the guanidinium salt 
mentioned above, colorless blocks of 4+ BArf
H2O(CH2Cl2)0.5 were obtained from a 
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wet CH2Cl2 solution. X-ray data were collected and refined as described in Table 2.1 
and the experimental section. The resulting structure is shown in Figure 2.3 (bottom). 
Key metrical parameters are summarized in Table 2.3. Several of the CF3 groups and 
C(NH) groups were disordered. Efforts to model the disorder did not improve the R 
factor. For the final refinement, some of the CF3 groups were left with elongated thermal 
ellipsoids. The asymmetric unit contained two unique 4+ BArf
 salts, two molecules of 
H2O and one molecule of CH2Cl2. There were two asymmetric units in the unit cell (Z = 
4; Z′ = 2). 
 
 
 
Table 2.2 Key bond lengths [Å], bond angles [°], and torsion angles [°] for 3+ 
BArf
·H2O.
a 
N(1)-C(1) 1.324(2) N(1)-C(1)-N(2) 116.86(2) 
N(2)-C(1) 1.321(3) N(1)-C(1)-N(3) 126.27(2) 
N(3)-C(1) 1.330(3) N(2)-C(1)-N(3) 116.83(2) 
H(3B)-O(1W) 2.076 H(1A)-N(1)-N(2)-H(2A) 0.08 
H(2B)-O(1W) 2.109 H(2B)-N(2)-N(3)-H(3B) 0.36 
N(2)-O(1W) 2.897(2) H(3A)-N(3)-N(1)-H(1A) 2.82 
N(3)-O(1W) 2.871(3)   
a For atom numbers see Figure 2.3 (top). 
 
 
 
The cations differed slightly in C1-N(1/2/3) bond lengths (1.316(9) vs. 1.317(9) 
Å, 1.332(9) vs. 1.363(9) Å, and 1.353(7) vs. 1.303(9) Å). Each of the cations was 
hydrogen bonded to a H2O molecule by a DD type NH dyad. The cation with the 
shortest C-N bond length (1.303(9) Å) gave the shortest average hydrogen bonding 
contacts (2.097 Å and 2.174 Å vs. 2.119 Å and 2.293 Å, see Table 2.3). 
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Table 2.3 Key bond lengths [Å], bond angles [°], and torsion angles [°] for 4+ 
BArf
H2O(CH2Cl2)0.5.
a 
4+ (cation 1) 
N(1)-C(1) 1.317(9) N(1)-C(1)-N(2) 121.96(6) 
N(2)-C(1) 1.363(9) N(1)-C(1)-N(3) 129.41(2) 
N(3)-C(1) 1.303(9) N(2)-C(1)-N(3) 108.59(6) 
H(1B)-O(2) 2.097 H(1A)-N(1)-N(3)-H(3) 1.50 
H(2)-O(2) 2.174 H(1B)-N(1)-N(2)-H(2) 0.69 
N(1)-O(2) 2.853(1) H(2)-N(2)-N(3)-H(3) 0.02 
N(2)-O(2) 2.864(9)   
4+ (cation 2) 
N(4)-C(8) 1.316(9) N(4)-C(8)-N(6) 125.87(6) 
N(6)-C(8) 1.332(9) N(4)-C(8)-N(5) 125.60(6) 
N(5)-C(8) 1.353(7) N(6)-C(8)-N(5) 108.52(6)(2) 
H(4A)-O(1) 2.119 H(4A)-N(4)-N(6)-H(6A) 1.43 
H(6A)-O(1) 2.293 H(4C)-N(4)-N(5)-H(5A) 0..22 
N(4)-O(1) 2.874(7) H(5A)-N(5)-N(6)-H(6A) 0.82 
N(6)-O(1) 2.961(7)   
a
 For atom numbers see Figure 2.3 (bottom). 
 
 
 
In a fortuitous event, a bromide salt of diprotonated GBI, [1-H]2+ 2Br, was 
accidentally obtained when GBI was refluxed in EtOH with (η5-C5H5)Fe(CO)2(Br) and 
Na+ PF6
. Details are described in the experimental section. Brown column shaped 
crystals of [1-H]2+ 2BrH2O were obtained when a CH2Cl2 solution of the crude 
mixture was concentrated. X-ray data were collected and refined as described in Table 
2.1 and the experimental section. The resulting structure is shown in Figure 2.4. Key 
metrical parameters are summarized in Table 2.4. 
The dication was hydrogen bonded through the N1-H1 unit to the H2O molecule 
and through the N2-H2 unit to one of the bromide counter anions. The N3-H3 and N4-
H4A units hydrogen bonded to the other bromide counter anion in a dual NH motif 
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similar to thioureas.8e,13a From the H-N-N-H torsion angles, it was evident that each 
cation contained two pairs of synperiplanar NH protons (DD dyad). 
The N1-C7 and N2-C7 bond lengths (1.328(4) vs. 1.331(4) Å) were essentially 
identical, consistent with the positive charge being distributed equally between both 
imidazolium nitrogen atoms, and appreciable double bond character. The N4-C8 and 
N5-C8 bonds exhibited comparable double bond character (1.309(4) and 1.321(4) Å), 
while the N3-C7 and N3-C8 bond lengths (1.375(4) and 1.356(4) Å) were closer to those 
of single bonds.  
 
 
 
 
 
 
 
The N1-C7-N3-C8 and N2-C7-N3-C8 torsion angles, 138.6(3)° and 46.6(5)°, 
clearly indicated that the plane of the protonated guanidine fragment was not parallel to 
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the plane of the 2-aminobenzimidazolium unit. The H3-N3-C8-N5, H4A-N4-C8-N5, and 
H4B-N4-C8-N5 torsion angles, 155.11°,179.99°, and 0.10°, indicated N5 to be anti 
to H(3) and H(4A). The NH protons of N3-H3 and N4-H4A or N4-H4B and N5-H5A 
displayed a syn relationship to each other (torsion angles 22.05° and.°) while N1-
H1 and N3-H3 or N1-H1 and N4-H4 avoided synperiplanar orientations, as reflected 
by torsion angles of 40.61° and 63.42°.  
 
 
 
Table 2.4. Key bond lengths [Å], bond angles [°], and torsion angles [°] for [1-H]2+ 
2Br·2H2O.
a 
N(1)-C(7) 1.328(4) N(1)-C(7)-N(3)-C(8) 138.6(3) 
N(2)-C(7) 1.331(4) N(2)-C(7)-N(3)-C(8) 46.6(5) 
N(3)-C(7) 1.375(4) H(1)-N(1)-N(3)-H(3) 40.61 
N(3)-C(8) 1.356(4) H(1)-N(1)-N(4)-H(4A) 63.42 
N(4)-C(8) 1.309(4) H(3)-N(3)-N(4)-H(4A) 22.05 
N(5)-C(8) 1.321(4) H(3)-N(3)-C(8)-N(5) 155.11 
N(1)-C(7)-N(2) 110.5(3) H(4A)-N(4)-C(8)-N(5) 179.99 
N(1)-C(7)-N(3) 123.3(3) H(4B)-N(4)-C(8)-N(5) 0.10 
N(2)-C(7)-N(3) 125.9(3) H(4B)-N(4)-N(5)-H(5A) 
N(3)-C(8)-N(5) 120.2(3)   
N(4)-C(8)-N(3) 117.4(3)  
N(4)-C(8)-N(5) 122.3(3)  
a
 For atom numbering and distances involving hydrogen bonds, see Figure 2.4. 
 
 
 
2.2.3 Catalysis with organic hydrogen bond donors 
 
The preceding data establish the hydrogen bonding capabilities of GBI and 
related cationic compounds. This set the stage to investigate their efficacies as catalysts 
in reactions catalyzed by hydrogen bond donors. As an additional reference point, a 
neutral molecule with two NH donor groups, N,N'-diphenylthiourea (DPT), was 
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simultaneously investigated. This molecule was randomly selected for no obvious 
reason.  
The Friedel-Crafts alkylation of 1-methylindole (5a) by trans-β-nitrostyrene (6) 
is a benchmark reaction promoted by many hydrogen bond donor catalysts.68 Hence, 
this reaction was investigated with the aforementioned compounds. As shown in Table 
2.5, 5a (2.0 equiv) and 6 (1.0 equiv) were combined in CD2Cl2 at room temperature in 
the presence of 10 mol% of the hydrogen bond donor under aerobic conditions. The 
reaction was monitored by 1H NMR against an internal standard, Ph2SiMe2. The 
condensation product 1-methyl-3-(2-nitro-1-phenylethyl)-1H-indole (7a) has been 
prepared before and is well characterized.68a The yield of 7a was used to compare the 
reactivities of the catalyst. 
 
 
 
 
 
 
 39 
 
In the absence of the catalyst or in the presence of GBI, no 7a could be detected 
after 48 h (Table 2.5, entries 1-2). In the case of DPT, 7a was present in 2% yield after 
48 h (entry 3). Similar reactions were carried out under identical conditions with the salts 
1-4+ BArf
– (Table2.5, entries 4-9). In all of the cases, the condensations were clean and 
7a formed as the only product.  
In terms of activity, 1+ BArf
– was superior to 2+ BArf
– (entries 4 and 5, yield 
97% in 1 h vs. 25% in 1 h). The salts 3+ BArf
– and 4+ BArf
– were active catalysts and 
were superior to 2+ BArf
– (Table 2.5, entries 5-10). Interestingly, 1+ BArf
– and 4+ BArf
– 
showed similar activities, giving 7a in 95% and 90% yields, respectively, in 1 h. In 
contrast, 3+ BArf
– formed 7a in 44% yield in 1 h. With 2+ BArf
–, a comparable yield of 
7a (40%) was attained after 3 h. Thus, 2+ BArf
– was the least active of all the salts 
tested. 
 
2.2.4 Syntheses of ruthenium complexes 
 
The ruthenium bis(phosphine) complex (5-C5H5)Ru(PPh3)2(Cl) was 
synthesized by a literature method.69 As shown in Scheme 2.6, (5-C5H5)Ru(PPh3)2(Cl) 
and GBI were reacted in refluxing toluene. Workup gave the racemic "chiral-at-metal" 
cationic monophosphine complex [(5-C5H5)Ru(PPh3)(GBI)]
+ Cl (8+ Cl) as a yellow 
powder in 96% yield.70,71 The salt was insoluble in benzene and toluene, slightly 
soluble in CHCl3 or CH2Cl2, and soluble in polar solvents such as MeOH, EtOH, and 
DMSO.  
Like most complexes below, 8+ Cl was characterized by NMR (1H, 13C, 31P), 
IR, and UV-visible spectroscopy, as summarized in Tables 2.6-2.8. Based upon detailed 
literature 1H and 13C NMR studies, all proton and carbon signals could be 
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unambiguously assigned.35a,b,40b,c All data supported the coordination of the 
benzimidazole C=NAr and guanidine C=NH groups.  
Next, as shown in Scheme 2.6 (step A1), simple metatheses allowed the chloride 
anion of 8+ Cl to be replaced by the weakly coordinating anions PF6
 and 
BArf
.59,70,71 The new salts 8+ X were isolated in 83-85% yields as slightly air-
sensitive yellow powders with increased solubility in CH2Cl2. They were characterized 
similarly to 8+ Cl, including 19F NMR spectra. The cyclopentadienyl 1H NMR signals 
exhibited progressively downfield chemical shifts (Table 2.6), suggesting the ruthenium 
center in 8+ BArf
 to have a more cationic character than that in 8+ Cl.72  
In general, electron withdrawing substituents lead to stronger hydrogen bond 
donors. Thus, to fine tune catalyst activity, it was sought to replace the PPh3 ligand by a 
more weakly donating or stronger π-accepting ligand. As shown in Scheme 2.6 (step 
B1), a solution of 8+ Cl was stirred under a static CO atmosphere. Workups gave the 
substitution product [(5-C5H5)Ru(CO)(GBI)]
+ Cl (9+ Cl) as an off white powder in 
91% yield.70,71 Analogous carbonylations were conducted with 8+ PF6
, and 8+ BArf
 
(step A2).70,71 These afforded the corresponding salts 9+ X as yellow powders in 87-
92% yields.  
Alternatively, 9+ PF6
 and 9+ BArf
 could be accessed in 87-88% yields by 
exchange of the chloride ion of 9+ Cl, as shown in Scheme 2.6 (step B2). Both overall 
routes from 8+ Cl to 9+ X, "A" and "B" (Scheme 2.6), have been repeated several 
times, and "B" has been found to be the most easily reproducible.73 Another refinement 
involves an alternative starting material, the cationic bis(acetonitrile) complex [(5-
C5H5)Ru(CO)(NCCH3)2]
+ PF6
 employed in Scheme 2.6, step C1. As with the starting 
material (5-C5H5)Ru(PPh3)2(Cl), this educt is easily prepared in one step from a 
commercially available precursor.74 Addition of GBI directly affords the 
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hexafluorophosphate salt 9+ PF6
 in 81% yield, saving two steps. The aforementioned 
ruthenium salts were originally prepared by Dr. A. Scherer, but were repeated as part of 
this work.70 
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Table 2.6 NH 1H NMR signals of 8-9+ X ().a  
 
Complexa NH(5) NH(2) NH(1) NH2(4) 
8+ Cl 11.83 10.19 6.12 6.28 
8+ PF6
 12.13 10.82 6.45 6.63 
8+ BArf
 11.75 9.68 6.12 6.03 
9+ Cl 11.42b 11.42b 6.39 6.72 
9+ PF6
 12.48 10.43 6.34 6.46 
9+ BArf
 12.02b 12.02b 6.45 6.63 
a
 Spectra were recorded in DMSO-d6 (500 or 300 MHz). The  values are given in ppm. 
b These two NH 
signals overlap. 
 
 
 
Table 2.7 13C{1H} NMR signals of the GBI ligand in 8-9+ X ().a  
Complex C(1) C(2) C(3) C(4) C(5) C(6) C(7) C(8) 
GBI b 159.8 158.9 142.6 132.5 119.9 119.9 114.8 109.1 
8+ Cl b 154.1 144.7 142.4 131.6 121.6 121.2 117.2 110.5 
8+ PF6
 b 152.7 145.3 143.5 132.3 123.4 122.8 118.9 111.4 
8+ BArf
 b 152.6 145.3 143.9 132.3 123.3 122.7 118.8 111.5 
9+ Cl d 153.6 145.4 142.5 131.6 123.0 122.5 116.9 111.5 
9+ PF6
 c 152.9 144.7 142.7 131.2 124.3 123.8 117.9 111.6 
9+ BArf
 c 152.4 144.1 142.6 130.8 124.9 124.5 118.4 111.4 
a
 Spectra were recorded at 100 MHz. The  values are given in ppm. For the atom numbering scheme, see 
Table 2.6. b In DMSO-d6. 
c In CD2Cl2. 
d In CDCl3.  
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Table 2.8 C5H5 
1H NMR signals of 8-9+ X,a and IR νCO values (brackets)
b for 9+ X. 
 Cation 
Anion 8+ 9+  
Cl 4.41 5.19 (1938) 
PF6
 4.61 5.20c (1942)c 
BArf
 5.02 5.30 (1961) 
a
 , DMSO-d6, 300 or 500 MHz, ppm. 
b cm−1. c Data for 9+ (P)-Phos–: 4.85/4.80 ppm in CD2Cl2 and 
1938 cm−1. 
 
 
 
The cyclopentadienyl 1H NMR chemical shifts of 9+ X were downfield of those 
of 8+ X ( 5.19-5.30 vs. 4.41-5.02; Table 2.8), suggesting reduced electron density at 
ruthenium.72 Accordingly, 9+ X exhibited good air stability both in solution and the 
solid state; powders showed no noticeable decomposition after five years. Curiously, 
microanalyses gave consistently low nitrogen values, as summarized in the experimental 
section.  
 
2.2.5 Hydration, hydrogen bonding in the second coordination sphere, H/D exchange, 
and nonracemic ruthenium complexes 
 
2.2.5.1 Hydration, hydrogen bonding in the second coordination sphere 
 
As Na+ BArf
 is commonly obtained as a hydrate,65 8-9+ BArf
 all contained 
low levels of H2O (2.0-1.0 H2O). The H2O could be removed by crystallization, as 
reported in the full paper associated with this chapter.75  
In the same paper, the addition of 6 to 9+ BArf
 has been probed by 1H NMR. 
Due to NHO interactions between 6 and the cation, three NH units of the ruthenium 
complex shifted downfield (Δδ = 0.02-0.09 ppm) while the other NH unit was 
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unaffected. Sequential addition of dimethyl malonate ester (10a), a dual acceptor (AA 
type) molecule, to 9+ BArf
2H2O was probed by 
1H NMR (Figure 2.5). A gradual shift 
of the NH and H2O protons was observed. 
The proton signals of three of the four types of NH units (H5 (orange) /H2 
(green) /H4 (purple)) shifted further and further downfield with addition of 10a (0.5 and 
1.0 equiv). At 1.0 equiv of 10a the  values (ppm) were 0.89, 0.50, and 0.27, 
respectively. On the other hand, one NH unit (H1 (magenta)) and the H2O signal (H 
(red)) shifted upfield and at 1.0 equiv of 10a the  (ppm) values were .11 and 0.24.  
Based on the  (ppm) data, the two most possible host-guest adducts would be 
XLVIIa and XLVIIb, as shown in Figure 2.5 (top). Out of these two, XLVIIa is most 
likely the dominant form as NH5 signal is shifted to a greater extent than the NH4 
signal. However, it should be kept in mind that there are two protons on N4, as opposed 
only one on N5. These two remain in rapid equilibrium on the NMR time scale in the 
presence of 10a, as evidenced by a single signal. Hence, adduct formation will have an 
intrinsically greater effect on the NH5 signal. 
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2.2.5.2 H/D exchange with ruthenium complexes 
 
When DMSO-d6 or CDCl3 solutions of 9
+ BArf
 were treated with CD3OD (6 
equiv), the NH protons underwent rapid H/D exchange. As shown in Figure 2.6, the NH 
signals disappeared.75 A variety of cationic coordination compounds of GBI have been 
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quantitatively deprotonated by weak bases such as pyridine, NaOMe, and 
Na2CO3.
40c,70,75 Hence, it is not surprising that rapid exchange can be observed in the 
absence of added base. Also, the GBI ligand is in principle capable of numerous 
prototropic equilibria, some of which entail formal 1,3-shifts of protons from the non-
coordinating NH/NH2 moieties to the coordinating C=NAr/C=NH moieties. These may 
participate in the exchange process, and examples are illustrated in Scheme 2.7. 
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2.2.5.3 Nonracemic ruthenium complexes 
 
In order to apply the preceding chiral-at-ruthenium complexes as enantioselective 
catalysis, nonracemic variants would be required. One possible route to enantiopure 
complexes is by forming diastereomeric salts with chiral anions. Towards this end, 9+ 
Cl was treated with Na2CO3 to form the neutral complex, 11, as shown in Scheme 2.8. 
This was subsequently protonated with the commercially available enantiopure axially 
chiral phosphoric acid (P)-12 ((P)-Phos-H),26 to form a mixture of diastereomeric salts 
in 94% yield. The 1H NMR spectrum showed two distinct signals for the 
cyclopentadienyl ligand due to the formation of two diastereomeric salts (RRu)-9
+
 (P)-
Phos and (SRu)-9
+
 (P)-Phos
). This is depicted in Scheme 2.8 (bottom). Two 
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cyclopentadienyl 13C NMR signals were also observed (δ (ppm) 82.2 and 82.1). 
To apply these salts in enantioselective organic transformations, they need to be 
resolved first. However, all attempts to separate the diastereomers of 9+ (P)-Phos
 by 
crystallization or precipitation were unsuccessful. The successful resolution and 
application of related enantiopure catalysts are mentioned in the next chapters. 
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2.2.6 Application of racemic chiral-at-ruthenium complexes in second coordination 
sphere promoted catalysis  
 
The Friedel-Crafts reactions in Table 2.5 were now extended to the GBI 
containing ruthenium salts salts 8-9+ X–, and the substrate indole (5b). The indoles 5a or 
5b (2.0 equiv) and 6 (1.0 equiv) were combined in CD2Cl2 in NMR tubes in the 
presence of a salt (0.10 equiv; 10 mol%) along with the internal standard Ph2SiMe2. 
Reactions of 5b were stopped after 48 h, irrespective of the state of completion. Results 
are summarized in Table 2.9, and selected rate profiles are given in Figure 2.7. 
 
 
 
 
 
 
 
With many salts, the 3-substitued indoles 7a,b (Table 2.9) were cleanly formed. 
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In all cases, 7a was produced faster, consistent with an electron donating effect of the N-
methyl group. However, the slower rate profiles with 7b are illustrated in Figure 2.7, for 
better reactivity comparisons.75 As shown in entries 1 and 2 of Table 2.9, no reactions 
were observed without catalyst, or in the presence of GBI alone. However, GBI is 
poorly soluble in CH2Cl2. Two soluble ruthenium-free systems comparable to 8-9
+ X– 
are described above (Table 2.5, 1+ BArf
– and 2+ BArf
–).  
The rates showed strong dependencies upon the counter anions of the salts. The 
chloride salts 8-9+ Cl (entries 3 and 6) did not exhibit any significant activity. The best 
results were obtained with 8-9+ BArf
, which gave yields of 46-97% (entries 5 and 8). 
Less productive were the hexafluorophosphate salts 8-9+ PF6
 (entries 4 and 7), which 
afforded 7b in yields up to 27%. Within each counter anion series, rates increased as the 
cations were varied in the order 8+ < 9+. Although these data are further interpreted in 
the Discussion section, note that the poorer hydrogen bond accepting anions60 and the 
less electron rich cations give faster rates.  
 
 
 
 
Figure 2.7 Rate profiles for the condensation of 5b (2.0 equiv) and 6 (1.0 equiv) with different catalysts (10 
mol%, rt, selected reactions from Table 2.9): (♦) 9+ BArf
 (■) 9+ PF6
 (♦) 8+ BArf
. 
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2.3 Discussion 
 
2.3.1 Importance of preorganization 
 
In order to understand the contribution of preorganization and NH acidities on 
the performance of GBI as hydrogen bond donor catalyst, the salts 1-4+ BArf
, GBI, 
and DPT were tested as catalysts (Table 2.5). The pKa of N,N'-diphenylthiourea (DPT) 
is 13.9.76 As noted above, 2-aminobenzimidazole and guanidine represent the two 
halves of GBI (Scheme 2.1), and have pKa values of 7.18
77 and 13.477 respectively. The 
pKa of GBI is 6.97.
78 Based solely on NH acidities, GBI should have been an efficient 
catalyst but GBI was catalytically inactive whereas DPT was active to a very slight 
extent (entry 3 vs. entry 2).  
The salts 3,4+ BArf
 are formed by protonation of 2-aminobenzimidazole and 
guanidine. These are expected to have lower pKa values and higher NH acidities than 
their parent compounds. Similarly, cationic species derived from GBI (1,2+ BArf
) 
would also possess NH protons with increased acidities. The difference between 1,2+ 
BArf
 and 3,4+ BArf
 is that the first two retain the flexibility of GBI whereas the last 
two are rigid.  
The comparable catalytic activity of 1+ BArf
– and 4+ BArf
– (Table 2.5, entries 4 
vs. 9) may indicate a similar functional group array in the catalytically active site. In 
contrast, the significantly different reactivity of 1+ BArf
– and 2+ BArf
– (Table 2.5, 
entries 4 vs. 5) suggests a dissimilar functional group array. The somewhat similar 
catalytic activity of 2+ BArf
– and 3+ BArf
– is again suggestive of a similar catalytically 
active site.  
The salt 1+ BArf
– might preorganize through intramolecular hydrogen bonding. 
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A proposed structure is shown in Figure 2.8 (left). In doing so, it attains a DDD triad 
retaining both the DD dyads from guanidine and 2-aminobenzimidazole. In contrast, 2+ 
BArf
– cannot attain this triad (right). It can retain the existing guanidine DD dyad with 
or without intramolecular hydrogen bonding similar to 1+ BArf
–. The poorer activity of 
2+ BArf
– compared to 3+ BArf
– may be a consequence of the rigidity proposed by 
Schreiner in thiourea systems.57 Moreover, both of the salts 3+ and 4+ BArf
– do not 
possess the flexibility of GBI or 2+ BArf
– and show better catalytic activity than 2+ 
BArf
–. (Table 2.5, entries 5-9). This suggest that preorganization is more important than 
NH acidities in turning GBI to an active catalyst.  
 
 
 
 
 
 
 
However, increased acidity of the NH protons due to generation of charge by 
protonation or methylation of GBI cannot be ignored. Both 1+ BArf
– and 2+ BArf
– are 
much more active catalysts than GBI (Table 2.5, entry 2 vs. entries 4 and 5). 
Successful catalysis with both 3+ BArf
– and 4+ BArf
– suggests that a dicationic 
GBI derivative might be an even better catalyst. To date, the successful preparation of a 
dicationic salt with a BArf
– counter anion has not been achieved. The crystal structure of 
a similar bromide salt, [1-H]2+ 2Br (Figure 2.4), reveals that the hydrogen bond that 
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restricts conformational degrees of freedom in 1+ BArf
– has been disrupted, and bromide 
anions, which are good hydrogen bond acceptors,60 interact with three NH moieties. The 
guanidinium fragment retains the dyad of syn NH units whereas the 2-
aminobenzimidazolium fragment is twisted (Table 2.4; torsion angles H1-N1-N3-H3, 
H3-N3-N4-H4A, and H1-N1-N4-H4A; 40.61°, 22.05°, and 63.42°) and the DD dyad 
from it is lost. Of course, many additional structures would be possible in solution, or 
with BArf
– counter anions.  
Hence, synthesizing metal chelated complexes of GBI was envisioned as an 
alternative and conformationally more "rigid" way of generating a cationic DDD unit 
from GBI, as opposed to the 1+ BArf
– as depicted in Figure 2.8. The superior 
preorganization offered by this approach is evident in the crystal structures of the 
ruthenium adducts 8+ X– (X– = BArf
–, PF6
–).75 The crystal structure of the former is 
shown below in Figure 2.7. 
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2.3.2 Ramification of chiral-at-metal systems 
 
Scheme 2.8 depicts an alternative deprotonation/acidification strategy for counter 
anion metathesis that differs from the more conventional strategies in Scheme 2.6. The 
resulting salt 9+ (P)-Phos
 features a chiral anion. Accordingly, the 1H NMR spectrum 
in CD2Cl2 shows two cyclopentadienyl signals of equal intensities (Δδ = 0.05 ppm or 25 
Hz). These are attributed to the diastereomeric salts (RRu)-9
+
 (P)-Phos
 and (SRu)-9
+
 
(P)-Phos). This rather large chemical shift difference suggests a substantial degree of 
association between the anion and cation, presumably involving hydrogen bonding.  
The corresponding salt with an alternative enantiopure chiral anion, 
TRISPHAT,26 has also been prepared, as reported in the full paper associated with this 
chapter.75 This anion is a poorer hydrogen bond acceptor. Thus, only a single 
cyclopentadienyl 1H NMR signal was observed in DMSO-d6. However, in C6D6 a small 
signal splitting could be detected (Δδ = 0.01 ppm or 3 Hz).  
A similar conclusion can be reached with the indenyl complex XLVIII79 and 
IL70,75 shown in Figure 2.10. The former is prochiral and the latter is chiral-at-metal. 
The 1H NMR signals of the three η5 protons of the indenyl ligand can be analyzed. In 
the parent compound XLVIII, two are enantiotopic to each other as shown in blue in 
Figure 2.10 (left), while both of these are heterotopic with respect to the third (shown in 
red). Upon replacement of one PPh3 and the chloride ligands by the chelating ligand 
GBI, a racemic complex IL is formed, which is chiral-at-metal. Because of the metal 
chirality, all of the three protons are inequivalent, with those shown in green and blue 
being diastereotopic.  
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This difference is clearly evident from the cyclopentadienyl 1H NMR signals. In 
XLVIII, the inner proton appeared as a triplet (1H, red) and the outer protons as a 
doublet (2H, blue). In contrast, in IL the external protons exhibit different chemical 
shifts, each as broad singlet (2  1H, blue and green) while the internal proton signal is a 
doublet of doublets (1H, red).  
To apply these chiral-at-metal complexes in enantioselective organic 
transformations they need to be resolved first. The resolution and application of closely 
related catalysts are described in the next chapters. 
 
2.3.3 Support for mechanisms involving second coordination sphere promoted 
catalysis  
 
Interactions between the malonate ester 10a and 9+ BArf
 were documented by 
1H NMR in Figure 2.5. Analogous experiments with the nitroalkene 6 have been 
reported in a full paper that incorporates much of this chapter.75 Thus, spectra of 
equimolar mixtures of 6 and 9+ BArf
 were recorded in CD2Cl2 and compared to that of 
9+ BArf
 under identical conditions. Of the four NH/NH2 signals of the GBI ligand that 
can be assigned (Table 2.6), only three shifted downfield. This is illustrated in Figure 
2.11; the shifts ranged from 0.09 to 0.02 ppm (top vs. bottom spectrum).  
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Similarly, the CH=CHNO2 proton of 6 shifted slightly downfield. Based upon 
the magnitudes of the NH shifts (Figure 2.10, box), it was proposed that 6 binds to the 
cation 9+ predominantly as shown in La. This agrees with the proposed dominant 
structure shown in Figure 2.5 (structure XLVIIa). Downfield shifts of NH signals have 
also been observed when carbonyl compounds have been added to urea based 
catalysts.80 The data in Table 2.5 and 2.9 and Figures 2.5 and 2.9 validate the underlying 
hypothesis of this study, namely that by chelation induced preorganization of the 
conformationally flexible GBI ligand by "spectator" transition metal fragments, an 
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otherwise unreactive species can be rendered an effective hydrogen bond donor catalyst.  
By analogy to ureas and thioureas (Figure 2.12), substrate activation would most 
likely involve two synperiplanar NH units. As illustrated by the crystal structures in the 
literature,75 chelation leads to a triad of three synperiplanar NH units, and an orthogonal 
dyad of two synperiplanar NH units (Figure 2.9). However, there remains a residual 
conformational degree of freedom about the NH2 group (Scheme 2.7). The NMR data in 
Figure 2.11 suggest that 6 preferentially binds to the two synperiplanar NH units not 
associated with the NH2 group, as depicted in La. Note that these two NH groups could 
adopt any number of conformations in the free ligand, including one in which they 
would be approximately anti. 
All of the above mentioned results support the hypothesis of host-guest 
interactions in the second coordination sphere, which thereby promote the organic 
transformation. Thus, the catalytic process can be termed second coordination sphere 
promoted catalysis (SCSPC). 
In any event, preorganization can be an important aspect of second coordination 
sphere binding to coordinated ligands. However, since the ruthenium fragment is 
cationic, there remains a question as to the effect of positive charge alone, as this should 
also enhance NH acidities and hydrogen bond donor strengths – even though evidence 
was provided to show preorganization has greater influence (Table 2.5 and 2.9).  
The counter anion also greatly affects the activities of the ruthenium catalysts 8-
9+ X. In each case, the same trend is observed, Cl– < PF6
– < BArf
– (Table 2.9). This 
parallels the diminishing hydrogen bond accepting properties of the anions.59 In 
particular, chloride is an excellent hydrogen bond acceptor,81 and a single such anion 
effectively "poisons" the catalyst. Accordingly, I suggest that (1) there is only one 
productive substrate binding site that leads to turnover, and (2) chloride preferentially 
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binds to the same two NH groups as the trans-ß-nitrostyrene in La.  
Finally, there is also a marked dependence of catalyst activities upon the cation 
(Table 2.9 and Figure 2.7). Since CO ligands are weaker donors and stronger π-acceptors 
than PPh3 ligands, the ruthenium should be less electron rich in 9
+ X as compared to 8+ 
X. This is reflected by the downfield shift of the cyclopentadienyl 1H NMR signals 
noted above (Table 2.8).72 It also increases the acidities of the NH units, and likewise 
their hydrogen bond donor strengths, ultimately leading to improved catalytic activities.  
 
2.4 Conclusion 
 
The preceding results and related studies70,75 have established that cationic 
transition metal chelates of GBI are effective hydrogen bond donors that can catalyze a 
variety of organic transformations. Chelation preorganizes GBI into a conformation with 
synperiplanar NH units. Unlike most transition metal catalyzed reactions, there is no 
direct interaction of the substrate with the ruthenium; rather, hydrogen bonds derived 
from NH groups remote from the metal center are involved. The hydrogen bonding 
interactions and the activation of the substrates occurs in the second coordination sphere. 
Hence, the catalysis can rightly be termed as second coordination sphere promoted 
catalysis. 
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2.5 Experimental section  
 
2.5.1 General data  
 
All reactions and workups were carried out under nitrogen atmospheres. 1H, 
13C{1H}, 31P{1H} and 19F{1H} NMR spectra were recorded on standard 300-500 MHz 
spectrometers at ambient probe temperature (24 °C) and referenced as follows (, ppm): 
1H, residual internal CHCl3 (7.26), acetone-d5 (2.05), DMSO-d5 (2.49), or CHD2OD 
(3.30); 13C{1H}, internal CDCl3 (77.0), acetone-d6 (29.9), DMSO-d6 (39.6), or CD3OD 
(49.1); 19F{1H}, internal C6F6, (–162.0); 
31P{1H}, external H3PO4 (0.0). IR spectra 
were recorded using a Shimadzu IRAffinity-1 spectrophotometer with a Pike MIRacle 
ATR system (diamond/ZnSe crystal). UV-visible spectra were measured using a 
Shimadzu UV-1800 UV spectrophotometer. Melting points were recorded with a 
Stanford Research Systems (SRS) MPA100 (Opti-Melt) automated device. 
Microanalyses were conducted by Atlantic Microlab.  
Solvents were treated as follows: toluene, hexanes, Et2O, and CH2Cl2 were dried 
and degassed using a Glass Contour solvent purification system; CHCl3 and CH3CN 
were distilled from CaH2; cyclopentadiene (Merck), freshly distilled; pentane (99.7%, J. 
T. Baker), MeOH (99.8%, BDH), 1,4-dioxane (97%, Alfa Aesar), and EtOH (99.9%, 
Alfa Aesar) were used as received; CDCl3, CD2Cl2, acetone-d6, DMSO-d6, and CD3OD 
(6  Cambridge Isotope Laboratories) were used as received. The Na+ PF6
 (98.5%, 
Acros), NH4
+ PF6
 (99.9%, Alfa Aesar), RuCl3xH2O (30-40% Ru, Acros), 2-
guanidinobenzimidazole (GBI; 95%, Acros), guanidinium hydrochloride (3+ Cl; 98%, 
Alfa Aesar), 2-aminobenzimidazole (95%, TCI), trans-β-nitrostyrene (6; 99%, Alfa 
Aesar), 1-methylindole (5a; 98%, Acros), indole (5b; >99%, Aldrich), 1,1'-binaphthyl-
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2,2'-diyl hydrogen phosphate (12; >99%, Alfa Aesar),26 and other chemicals were used 
as received from common commercial sources. 
 
2.5.2 Syntheses of GBI derivatives and catalysis 
 
1+ BArf
– (Scheme 2.5).26 A round bottom flask was charged with 1+ Cl– 35a 
(0.021 g, 0.10 mmol), Na+ BArf
 (0.089 g, 0.10 mmol),65 CH2Cl2 (3 mL), and H2O (2 
mL) with stirring. After 0.5 h, the organic layer was separated and washed with H2O (3 
× 1 mL). The solvent was removed by rotary evaporation. The residue was 
chromatographed on a silica gel column (5 × 1 cm; 98:2 v/v CH2Cl2/MeOH). The 
solvent was removed from the product containing fractions by oil pump vacuum to give 
1+ BArf
–(H2O)0.2 as a pale brown powder (0.084 g, 0.084 mmol, 84%), mp 172-174 °C 
(capillary). Anal. Calcd for C40H22BF24N5(H2O)0.2: C 46.06, H 2.16, N 6.71. Found C 
45.90, H 2.45, N 6.61.  
 
NMR (, CD2Cl2): 
1H (500 MHz) 7.73 (s, 8H, o-B(C6H3(CF3)2)4), 7.56 (s, 4H, 
p-B(C6H3(CF3)2)4), 7.43-7.37 (m, 4H, HNCCH(CH)2CHCNH), 5.65 (br s, 6H, NH), 
2.19 (s, 0.4H, H2O); 
13C{1H} (125 MHz) 162.0 (q, 1JCB = 49.8 Hz, i-C6H3(CF3)2), 
158.6 (s, NH=CNH2), 150.0 (s, N=C(NH)2), 135.1 (s, o-C6H3(CF3)2), 129.2 (q, 
2JCF = 
31.6 Hz, m-C6H3(CF3)2), 125.7 (s, HNCCHCHCHCHCNH), 124.9 (q, 
1JCF = 273.7 Hz, 
C6H3(CF3)2), 117.9 (s, p-C6H3(CF3)2), 112.3 (s, HNCCHCHCHCHCNH; 
19F{1H} 
(470 MHz) 62.9 (s).  
 
IR (cm1, powder film): 3500 (w), 3425 (w), 1631 (m), 1602 (m), 1543 (s), 1354 
(s), 1273 (s), 1138 (m), 1107 (s), 1083 (s), 858 (m), 837 (m). 
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2+ BArf
– (Scheme 2.5). A round bottom flask was charged with 2+ Cl– (0.022 g, 
0.10 mmol),35a Na+ BArf
 (0.089 g, 0.10 mmol),65 CH2Cl2 (2 mL) and H2O (1 mL) 
with stirring. After 2 h, the organic layer was separated and washed with H2O (3 × 1 
mL). The solvent was removed by rotary evaporation. The residue was chromatographed 
on a silica gel column (5 × 1 cm; 98:2 v/v CH2Cl2/MeOH). The solvent was removed 
from the product containing fractions by oil pump vacuum to give 2+ BArf
– as a pale 
pink powder (0.060 g, 0.058 mmol, 58%), mp 110-113 °C (capillary). Anal. Calcd for 
C41H24BF24N5: C 46.75, H 2.30, N 6.65. Found C 47.28, H 2.41, N 6.66.  
 
NMR (, CD2Cl2): 
1H (500 MHz) 7.71 (s, 8H, o-B(C6H3(CF3)2)4), 7.55 (s, 4H, 
p-B(C6H3(CF3)2)4), 7.11-7.04 (m, 4H, NCCH(CH)2CHCNCH3), 5.49 (br s, 4H, NH),
82 
3.62 (s, 3H, NCCH(CH)2CHCNCH3); 
13C{1H} (125 MHz) 162.0 (q, 1JCB = 49.8 Hz, i-
C6H3(CF3)2), 158.4 (s, NH=CNH2), 149.7 (s, N=C(NH)2), 135.1 (s, o-C6H3(CF3)2), 
130.8 and 128.1 (2 s, NCCHCHCHCHCNCH3), 129.1 (q, 
2JCF = 31.5 Hz, m-
C6H3(CF3)2), 124.9 (q, 
1JCF = 272.3 Hz, C6H3(CF3)2), 125.6 and 125.5 (2 s, 
NCCHCHCHCHCNCH3), 117.9 (s, p-C6H3(CF3)2), 112.0 and 111.0 (s, 
NCCHCHCHCHCNCH3), 39.6 (s, NCCHCHCHCHCNCH3).  
 
IR (cm1, powder film): 3520 (w), 3444 (w), 3419 (w), 1625 (m), 1585 (s), 1556 
(m), 1490 (m), 1456 (w), 1413 (w), 1354 (s), 1315 (w), 1273 (s), 1109 (s), 1097 (s), 931 
(w), 885 (s), 835 (s), 746 (s), 709 (s), 680 (s). 
 
3+ BArf
– (Scheme 2.5). A round bottom flask was charged with 3+ Cl– (0.038 g, 
0.40 mmol), Na+ BArf
 (0.354 g, 0.400 mmol),65 CH2Cl2 (4 mL) and H2O (4 mL) with 
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stirring. After 0.5 h, the organic layer was separated and washed with H2O (3 × 1.0 mL). 
The solvent was removed by rotary evaporation. The residue was chromatographed on a 
silica gel column (5 × 1 cm; 98:2 v/v CH2Cl2/MeOH). The solvent was removed from 
the product containing fractions by oil pump vacuum to give 3+ BArf
–H2O as a white 
powder (0.295 g, 0.307 mmol, 77%), mp 217-219 °C (capillary). Anal. Calcd for 
C33H18BF24N3H2O: C 42.11, H 2.14, N 4.46. Found C 42.00, H 1.96, N 4.52.  
 
NMR (, CD2Cl2): 
1H (500 MHz) 7.76 (s, 8H, o-B(C6H3(CF3)2)4), 7.61 (s, 4H, 
p-B(C6H3(CF3)2)4), 5.74 (br s, 6H, NH), 2.45 (s, 2H, H2O); 
13C{1H} (125 MHz) 162.1 
(q, 1JCB = 50.1 Hz, i-C6H3(CF3)2), 156.8 (s, H2N=CNH2), 135.2 (s, o-C6H3(CF3)2), 
129.3 (q, 2JCF = 30.9 Hz, m-C6H3(CF3)2), 125.0 (q, 
1JCF = 272.8 Hz, C6H3(CF3)2), 
117.9 (s, p-C6H3(CF3)2); 
19F{1H} (470 MHz) 62.9 (s).  
 
IR (cm1, powder film): 3518 (w), 1664 (m), 1606 (m), 1354 (s), 1273 (s), 1103 
(s), 887 (s), 837 (s), 711 (s), 680 (s), 667 (s). 
 
4+ Cl– (Scheme 2.5). A round bottom flask was charged with 2-
aminobenzimidazole (0.133 g, 1.00 mmol) and 1,4-dioxane (5 mL). Then HCl (2.0 M in 
Et2O; 2.5 mL, 5.0 mmol) was added dropwise with stirring. After 14 h, the solvent was 
evaporated by oil pump vacuum. The residue was washed with CH2Cl2 (3 × 5 mL), and 
dried by an oil pump vacuum to give crude 4+ Cl– as a yellow-orange oil (0.085 g, 0.50 
mmol, ca. 50%). This oily residue was used for the preparation of 4+ BArf
– without 
further purification. 
 
4+ BArf
– (Scheme 2.5). A round bottom flask was charged with 4+ Cl– (0.085 g, 
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ca. 0.50 mmol), Na+ BArf
 (0.443 g, 0.500 mmol),65 and CH2Cl2 (5 mL). The mixture 
was sonicated for 15 min, and filtered through a plug of celite (1 × 1 cm), which was 
rinsed with CH2Cl2 (5 mL). The solvent was removed from the filtrate by rotary 
evaporation and the residue was then chromatographed on a silica gel column (5 × 1 cm; 
98:2 v/v CH2Cl2/MeOH). The solvent was removed from the product containing 
fractions by oil pump vacuum to give 4+ BArf
– as a white powder (0.373 g, 0.375 mmol, 
ca. 75%), mp 151-153 °C (capillary). Anal. Calcd for C39H20BF24N3: C 46.97, H 2.02, 
N 4.21. Found C 46.53, H 2.26, N 4.15.  
 
NMR (, CD2Cl2): 
1H (500 MHz) 7.75 (s, 8H, o-B(C6H3(CF3)2)4), 7.58 (s, 4H, 
p-B(C6H3(CF3)2)4), 7.40 (m, 4H, HNCCH(CH)2CHCNH), 6.17 (br s, 3H, NH);
83 
13C{1H} (125 MHz) 162.2 (q, 1JCB = 49.9 Hz, i-C6H3(CF3)2), 149.1 (s, H2N=C(NH)2), 
135.2 (s, o-C6H3(CF3)2), 129.3 (q, 
2JCF = 31.3 Hz, m-C6H3(CF3)2), 128.1 (s, 
HNCCHCHCHCHCNH), 126.1 (s, HNCCHCHCHCHCNH), 125.0 (q, 1JCF = 276.0 
Hz, C6H3(CF3)2), 117.9 (s, p-C6H3(CF3)2), 112.4 (s, HNCCHCHCHCHCNH; 
19F{1H} 
(470 MHz) 63.0 (s).  
 
IR (cm1, powder film): 3700 (w), 3400 (w), 1638 (m), 1585 (s), 1354 (s), 1273 
(s), 1112 (s), 1097 (s), 889 (s), 837 (s), 746 (s), 713 (s), 709 (s), 680 (s), 667 (s). 
 
(5-C5H5)Ru(PPh3)2(Cl).
69-71,84 A three necked flask was charged with PPh3 
(14.458 g, 55.182 mmol) and EtOH (100 mL). The mixture was refluxed with stirring. 
After 15 min, RuCl3
.xH2O (3.581 g, 17.26 mmol for x = 0; 30-40% Ru) in EtOH (40 
mL) and then cyclopentadiene (18 mL) were added. The brown solution was refluxed for 
16 h, cooled to room temperature, and stored in a freezer. After 24 h, an orange 
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precipitate was collected by filtration, washed with cold EtOH (2 × 5 mL), H2O (2 × 10 
mL), cold EtOH (1 × 5 mL), and hexanes (2 × 15 mL), and dried by oil pump vacuum to 
give the product as a bright orange solid (8.105 g, 11.16 mmol, ca. 65%),85 mp 131-132 
°C (capillary).  
 
[(η5-C5H5)Ru(CO)(NCCH3)2]
+ PF6
–.74 A round bottom flask was charged 
with [(η5-C5H5)Ru(NCCH3)3]
+ PF6
– (0.504 g, 1.16 mmol)86 and CH3CN (25 mL). A 
stream of CO was passed through the brown orange solution. After 40 min, the solvent 
was removed by oil pump vacuum. The residue was chromatographed on a silica gel 
column (1 × 20 cm, 3:1 v/v CH2Cl2/CH3CN). The solvent was removed from the 
product containing fractions to give the product as a golden yellow solid (0.346 g, 0.823 
mmol, 71%).  
 
[(5-C5H5)Ru(PPh3)(GBI)]
+ Cl (8+ Cl).70,71,75 A Schlenk flask was charged 
with (5-C5H5)Ru(PPh3)2(Cl) (3.326 g, 4.580 mmol), GBI (0.842 g, 4.80 mmol), and 
toluene (15 mL). The mixture was refluxed with stirring. After 24 h, the mixture was 
cooled to room temperature. The solvent was decanted from a precipitate, which was 
washed with toluene (4 × 5 mL) and hexanes (2 × 15 mL) and dried by oil pump vacuum 
to give 8+ Cl as a yellow powder (2.798 g, 4.378 mmol, 96%).  
 
NMR (δ, DMSO-d6):
70,75 1H (500 MHz) 11.83 (br s, 1H, NH), 10.19 (br s, 1H, 
NH), 7.32-7.09 (m, 17H, P(C6H5)3 and NCCH(CH)2CHCN), 7.00-6.99 (m, 2H, 
NCCH(CH)2CHCN), 6.28 (s, 2H, NH2), 6.12 (s, 1H, NH), 4.41 (s, 5H, C5H5); 
13C{1H} 
(100 MHz) 154.1 (s, NH=CNH2), 144.7 (s, N=C(NH)2), 142.4 (s, NCCHCHCHCHCN), 
136.6 (d, 1JCP = 42.9 Hz, i-C6H5), 132.7 (d, 
2JCP = 13.2 Hz, o-C6H5), 131.6 (s, 
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NCCHCHCHCHCN), 129.0 (s, p-C6H5), 127.8 (d, 
3JCP = 9.9 Hz, m-C6H5), 121.6 (s, 
NCCHCHCHCHCN), 121.2 (s, NCCHCHCHCHCN), 117.2 (s, NCCHCHCHCHCN), 
110.5 (s, NCCHCHCHCHCN), 74.1 (s, C5H5); 
31P{1H} (161 MHz) 55.9 (s).  
 
IR (cm1, powder film,): 3347 (m), 3254 (m), 3200 (w), 3103 (w), 3080 (w), 
2798 (m), 2764 (m), 2729 (m), 1679 (s), 1640 (w), 1617 (m), 1590 (m), 1559 (s), 1463 
(m), 1436 (m), 1417 (m), 1274 (w), 1251 (m), 1096 (m), 833 (m), 791 (m), 749 (s), 695 
(s). 
 
[(5-C5H5)Ru(PPh3)(GBI)]
+ PF6
 (8+ PF6
).70,71,75 A Schlenk flask was 
charged with 8+ Cl (0.224 g, 0.350 mmol), Na+ PF6
 (0.295 g, 1.76 mmol), and 
CH2Cl2 (5 mL). The mixture was stirred for 12 h, and filtered through a plug of celite (1 
× 1 cm), which was rinsed with CH2Cl2 (3 × 5 mL). The filtrate was concentrated by oil 
pump vacuum (ca. 5 mL). Hexanes (25 mL) was added, and the CH2Cl2 was removed 
by oil pump vacuum. The solvent was decanted from the precipitate, which was 
dissolved in CH2Cl2 (5 mL). The solution was added dropwise to stirred hexanes (25 
mL), and the CH2Cl2 was removed by oil pump vacuum. The solvent was decanted from 
the precipitate, which was dried by oil pump vacuum to give 8+ PF6
 as a yellow powder 
(0.218 g, 0.291 mmol, 83%).73  
 
NMR (, DMSO-d6):
70,75 1H (300 MHz) 12.13 (s, 1H, NH), 10.82 (s, 1H, NH), 
7.53-7.20 (m, 19H, P(C6H5)3 and NCCH(CH)2CHCN), 6.63 (s, 2H, NH2), 6.45 (s, 1H, 
NH), 4.61 (s, 5H, C5H5); 
13C{1H} (75 MHz) 152.7 (s, NH=CNH2), 145.3 (s, 
N=C(NH)2), 143.5 (s, NCCHCHCHCHCN), 136.8 (d, 
1JCP = 39.2 Hz, i-C6H5), 133.8 
(s, o-C6H5), 132.3 (s, NCCHCHCHCHCN), 130.1 (s, p-C6H5), 128.7 (s, m-C6H5), 
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123.4 (s, NCCHCHCHCHCN), 122.8 (s, NCCHCHCHCHCN), 118.9 (s, 
NCCHCHCHCHCN), 111.4 (s, NCCHCHCHCHCN), 75.2 (s, C5H5); 
31P{1H} (161 
MHz) 56.3 (s, PPh3), 142.9 (sep, 
1JPF = 703.6 Hz, PF6
); 19F{1H} (282 MHz) 71.6 
(d, 1JFP = 707.3 Hz). 
 
IR (cm1, powder film): 3505 (w), 3435 (w), 3412 (w), 3377 (w), 1687 (s), 1637 
(w), 1586 (m), 1567 (s), 1478 (w), 1436 (m), 1401 (w), 1254 (m), 1092 (m), 880 (s), 862 
(s), 841 (s), 741 (s), 698 (s). 
 
[(5-C5H5)Ru(PPh3)(GBI)]
+ BArf
 (8+ BArf
).70,71,75 A Schlenk flask was 
charged with 8+ Cl (0.273 g, 0.427 mmol), Na+ BArf
 (0.415 g, 0.469 mmol),65 and 
CH2Cl2 (5 mL). The mixture was stirred for 12 h, and filtered through a plug of celite (1 
× 2.5 cm), which was rinsed with CH2Cl2 (15 mL). The filtrate was concentrated by oil 
pump vacuum (ca. 5 mL). Hexanes (25 mL) was added, and the solvent was decanted 
from the precipitate, which was dissolved in CH2Cl2 (5 mL). The solution was added 
dropwise to stirred hexanes (25 mL), and the CH2Cl2 was removed by rotary 
evaporation. The solvent was decanted from the precipitate, which was dried by oil 
pump vacuum to give 8+ BArf
.(H2O)2 as a yellow powder (0.545 g, 0.363 mmol, 
85%).73  
 
NMR (, DMSO-d6):
70,75 1H (300 MHz) 11.75 (s, 1H, NH), 9.68 (s, 1H, NH), 
8.31-8.03 (m, 31H, B(C6H3(CF3)2)4, P(C6H5)3, and NCCH(CH)2CHCN), 6.12 (s, 1H, 
NH), 6.03 (s, 2H, NH2), 5.02 (s, 5H, C5H5), 3.35 (s, 4H, H2O); 
13C{1H} (75 MHz) 
163.1 (q, 1JCB = 49.6 Hz, i-C6H3(CF3)2), 152.6 (s, NH=CNH2), 145.3 (s, N=C(NH)2), 
143.9 (s, NCCHCHCHCHCN), 137.1 (d, 1JCP = 27.9 Hz, i-C6H5), 135.2 (s, o-
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C6H3(CF3)2), 134.9 (s, o-C6H5), 132.3 (s, NCCHCHCHCHCN), 130.1 (s, p-C6H5), 
128.8 (s, m-C6H5), 129.5 (q, 
2JCF = 31.2 Hz, m-C6H3(CF3)2), 126.7 (q, 
1JCF = 270.7 
Hz, C6H3(CF3)2), 123.3 (s, NCCHCHCHCHCN), 122.7 (s, NCCHCHCHCHCN), 118.8 
(s, NCCHCHCHCHCN), 117.9 (s, p-C6H3(CF3)2), 111.5 (s, NCCHCHCHCHCN), 74.7 
(s, C5H5); 
31P{1H} (161 MHz) 56.4 (s); 19F{1H} (282 MHz) 63.7 (s).  
IR (cm1, powder film): 3443 (w), 3405 (w), 1679 (m), 1586 (m), 1563 (m), 
1459 (m), 1355 (s), 1274 (s), 1170 (s), 1119 (s), 1011 (w), 887 (m), 837 (m), 810 (m), 
737 (m), 714 (m), 683 (m). 
 
[(5-C5H5)Ru(CO)(GBI)]
+ Cl (9+ Cl).70,71,75 A Schlenk flask was charged 
with 8+ Cl (0.314 g, 0.491 mmol) and CHCl3 (25 mL). The sample was saturated with 
CO, fitted with a balloon filled with CO, and stirred. After 12 h, the solution was 
concentrated by rotary evaporation (5 mL), and filtered through a plug of celite (5 × 1 
cm), which was rinsed with CHCl3 (30 mL).
87 The filtrate was concentrated by rotary 
evaporation (ca. 25 mL), and added dropwise to stirred pentane (150 mL). The solvent 
was decanted from the precipitate, which was dissolved in CHCl3 (25 mL). The solution 
was added dropwise to stirred hexanes (100 mL), and the solvent was decanted from the 
precipitate. This sequence was repeated twice. The residue was triturated with benzene 
and dried by oil pump vacuum to give 9+ Cl as an off white powder (0.181 g, 0.447 
mmol, 91%).  
 
NMR ():70,75 1H (CDCl3/CD3OD, 500 MHz)
 7.21-7.18 (m, 1H, 
NCCH(CH)2CHCN), 7.09-7.06 (m, 2H, NCCH(CH)2CHCN), 6.99-6.96 (m, 1H, 
NCCH(CH)2CHCN), 4.87 (s, 5H, C5H5); 
1H (DMSO-d6, 400 MHz) 11.42 (br s, 2H, 
NH),88 7.40-7.38 (m, 1H, NCCH(CH)2CHCN), 7.20-7.13 (m, 3H, NCCH(CH)2CHCN), 
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6.72 (br s, 2H, NH2), 6.39 (s, 1H, NH), 5.19 (s, 5H, C5H5); 
13C{1H} (CDCl3, 100 
MHz) 204.1 (s, CO), 153.6 (s, NH=CNH2), 145.4 (s, N=C(NH)2), 142.5 (s, 
NCCHCHCHCHCN), 131.6 (s, NCCHCHCHCHCN), 123.0 (s, NCCHCHCHCHCN), 
122.5 (s, NCCHCHCHCHCN), 116.9 (s, NCCHCHCHCHCN), 111.5 (s, 
NCCHCHCHCHCN), 81.7 (s, C5H5).  
IR (cm1, powder film,): 3331 (w), 3266 (w), 3208 (m), 3138 (m), 3111 (w), 
1938 (s, CO), 1683 (s), 1652 (w), 1567 (s), 1494 (w), 1463 (m), 1420 (w), 1262 (m), 
1220 (w), 1092 (w), 1015 (m), 972 (w), 934 (w), 806 (m), 741 (m), 694 (s), 667 (m). 
 
[(5-C5H5)Ru(CO)(GBI)]
+ PF6
 (9+ PF6
).70,71,75 Route A. A Schlenk flask 
was charged with 8+ PF6
 (0.172 g, 0.229 mmol) and CH2Cl2 (5 mL). The sample was 
saturated with CO, fitted with a balloon filled with CO, and stirred. After 12 h, the 
mixture was filtered through a plug of celite (1 × 1 cm), which was rinsed with CH2Cl2 
(3 × 5 mL).87 The filtrate was concentrated by rotary evaporation (ca. 5 mL). Hexanes 
(25 mL) was added, and the CH2Cl2 was removed by rotary evaporation. The solvent 
was decanted from the precipitate, which was dissolved in CH2Cl2 (5 mL). The solution 
was added dropwise to stirred hexanes (25 mL), and the CH2Cl2 was removed by rotary 
evaporation. The solvent was decanted from the precipitate, which was dried by oil 
pump vacuum to give 9+ PF6
 as a yellow powder (0.105 g, 0.204 mmol, 89%).73 Route 
B. A Schlenk flask was charged with 9+ Cl (0.218 g, 0.538 mmol), Na+ PF6
 (0.452 g, 
2.69 mmol), and CH2Cl2 (5 mL). The mixture was stirred for 12 h, and filtered through a 
plug of celite (1 × 1 cm), which was rinsed with CH2Cl2 (3 × 5 mL).
87 The filtrate was 
concentrated by rotary evaporation (ca. 5 mL). Hexanes (25 mL) was added, and the 
CH2Cl2 was removed by rotary evaporation. The solvent was decanted from the 
precipitate, which was dissolved in CH2Cl2 (5 mL). The solution was added dropwise to 
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stirred hexanes (25 mL), and the CH2Cl2 was removed by rotary evaporation. The 
solvent was decanted from the precipitate, which was dried by oil pump vacuum to give 
9+ PF6
 as a yellow powder (0.241 g, 0.468 mmol, 87%). 
 
NMR (, DMSO-d6):
70,75 1H (300 MHz) 12.48 (s, 1H, NH), 10.43 (s, 1H, NH), 
7.43-7.39 (m, 1H, NCCH(CH)2CHCN), 7.24-7.16 (m, 3H, NCCH(CH)2CHCN), 6.46 (s, 
2H, NH2), 6.34 (s, 1H, NH), 5.20 (s, 5H, C5H5); 
13C{1H} (75 MHz) 203.9 (s, CO), 
152.9 (s, NH=CNH2), 144.7 (s, N=C(NH)2), 142.7 (s, NCCHCHCHCHCN), 131.2 (s, 
NCCHCHCHCHCN), 124.3 (s, NCCHCHCHCHCN), 123.8 (s, NCCHCHCHCHCN), 
117.9 (s, NCCHCHCHCHCN), 111.6 (s, NCCHCHCHCHCN), 82.0 (s, C5H5); 
31P{1H} (121 MHz) 142.7 (sep, 1JPF = 710.3 Hz); 
19F{1H} (282 MHz) 69.8 (d, 1JFP 
= 712.3 Hz). 
 
IR (cm1, powder film): 2347 (m), 1942 (s, CO), 1683 (m), 1652 (w), 1590 (m), 
1567 (m), 1521 (w), 1494 (w), 1463 (m), 1243 (m), 1104 (m), 1061 (w), 1015 (w), 837 
(s), 741 (m), 660 (w). 
 
Route C. A round bottom flask was charged with [(η5-
C5H5)Ru(CO)(NCCH3)2]
+ PF6
– (0.040 g, 0.095 mmol; see above), GBI (0.016 g, 0.095 
mmol), CH2Cl2 (2 mL), and MeOH (1 mL) with stirring. After 2 d at room temperature, 
the solvent was removed by oil pump vacuum and the residue was chromatographed on 
a silica gel column (0.5 × 15 cm, 3:1 v/v CH2Cl2/CH3CN). The solvent was removed 
from the product containing fractions to give a sticky yellow solid. This was dissolved in 
CH2Cl2 (5 mL) and pentane was added until a precipitate formed. The solvent was 
removed by oil pump vacuum. More pentane (5 mL) was added and removed by oil 
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pump vacuum (2 ×) to give 9+ PF6
– as a yellow powder (0.039 g, 0.076 mmol, 81%).  
 
[(5-C5H5)Ru(CO)(GBI)]
+ BArf
 (9+ BArf
).70,71,75 Route A. A Schlenk flask 
was charged with 8+ BArf
.(H2O)2 (0.257 g, 0.171 mmol) and CH2Cl2 (5 mL). The 
sample was saturated with CO, fitted with a balloon filled with CO, and stirred. After 24 
h, the mixture was filtered through a plug of celite (1 × 2.5 cm), which was rinsed with 
CH2Cl2 (2 × 10 mL).
87 The filtrate was concentrated by rotary evaporation (ca. 5 mL). 
Hexanes (25 mL) was added, and the CH2Cl2 was removed by rotary evaporation. The 
solvent was decanted from the precipitate, which was dissolved in CH2Cl2 (5 mL). The 
solution was added dropwise to stirred hexanes (25 mL), and the CH2Cl2 was removed 
by rotary evaporation. The solvent was decanted from the precipitate, which was dried 
by oil pump vacuum to give 9+ BArf
 as a yellow powder (0.194 g, 0.157 mmol, 92%). 
Route B. A Schlenk flask was charged with 9+ Cl (0.154 g, 0.381 mmol), Na+ BArf
 
(0.354 g, 0.401 mmol),65 and CH2Cl2 (5 mL). The mixture was stirred for 12 h, and 
filtered through a plug of celite (1 × 2.5 cm), which was rinsed with CH2Cl2 (2 × 25 
mL).87 The filtrate was concentrated by rotary evaporation (ca. 5 mL). Hexanes (25 mL) 
was added, and the CH2Cl2 was removed by rotary evaporation. The solvent was 
decanted from the precipitate, which was dissolved in CH2Cl2 (5 mL). The solution was 
added dropwise to stirred hexanes (25 mL), and the CH2Cl2 was removed by rotary 
evaporation. The solvent was decanted from the precipitate, which was dried by oil 
pump vacuum to give 9+ BArf
.(H2O)1.5
75 as a yellow powder (0.420 g, 0.333 mmol, 
88%).  
 
NMR ():70,75 1H (DMSO-d6, 400 MHz) 12.02 (br s, 2H, NH), 7.78 (s 8H, o-
B(C6H3(CF3)2)4), 7.71 (s, 4H, p-B(C6H3(CF3)2)4), 7.52-7.49 (m, 1H, 
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NCCH(CH)2CHCN), 7.32-7.27 (m, 3H, NCCH(CH)2CHCN), 6.63 (s, 2H, NH2), 6.45 
(s, 1H, NH), 5.30 (s, 5H, C5H5), 3.31 (s, H2O); 
13C{1H} (CD2Cl2, 75 MHz) 203.3 (s, 
CO), 163.1 (q, 1JCB = 49.6 Hz, i-C6H3(CF3)2), 152.4 (s, NH=CNH2), 144.1 (s, 
N=C(NH)2), 142.6 (s, NCCHCHCHCHCN), 135.2 (s, o-C6H3(CF3)2), 130.8 (s, 
NCCHCHCHCHCN), 129.5 (q, 2JCF = 31.2 Hz, m-C6H3(CF3)2), 126.7 (q, 
1JCF = 270.7 
Hz, C6H3(CF3)2), 124.9 (s, NCCHCHCHCHCN), 124.5 (s, NCCHCHCHCHCN), 118.4 
(s, NCCHCHCHCHCN), 117.9 (s, p-C6H3(CF3)2), 111.4 (s, NCCHCHCHCHCN), 81.9 
(s, C5H5); 
19F{1H} (CD2Cl2, 282 MHz) 63.2 (s). 
 
IR (cm1, powder film): 3713 (w), 3652 (w), 2362 (w), 2343 (w), 1961 (s, CO), 
1718 (m), 1687 (m), 1629 (w), 1575 (m), 1355 (s), 1278 (s), 1116 (s), 1061 (m), 934 
(w), 887 (w), 837 (w), 745 (m), 710 (m), 671 (m). 
 
(5-C5H5)Ru(CO)(GBIH) (11).
26,70,71 A round bottom flask was charged with 
9+ Cl (0.248 g, 0.612 mmol), Na2CO3 (0.211 g, 1.94 mmol), and CH2Cl2/H2O (6 mL, 
1.5:1 v/v). The mixture was stirred for 30 min. The aqueous phase was separated and 
extracted with CH2Cl2 (3 × 5 mL). The combined organic phases were dried (Na2SO4), 
filtered, and concentrated by rotary evaporation (ca. 5 mL). Hexanes (25 mL) was added, 
and the CH2Cl2 was removed by rotary evaporation. The solvent was decanted from the 
precipitate, which was dissolved in CH2Cl2 (5 mL). The solution was added dropwise to 
stirred hexanes (25 mL), and the CH2Cl2 was removed by rotary evaporation. The 
solvent was decanted from the precipitate, which was dried by oil pump vacuum to give 
11.(CH2Cl2)0.33 as a brown powder (0.173 g, 0.435 mmol, 71%), dec. pt. 247 °C 
(capillaery). Anal. Calcd for C14H13N5ORu(CH2Cl2)0.33: C 43.40, H 3.47, N 17.66. 
Found C 43.80, H 3.68, N 17.05.89 
 72 
 
 
NMR (, DMSO-d6):
70 1H (400 MHz) 10.15 (s, 1H, NH), 7.06-7.04 (m, 1H, 
NCCH(CH)2CHCN), 6.85-6.81 (m, 3H, NCCH(CH)2CHCN), 5.70 (s, 2H, NH2), 5.32 
(s, CH2Cl2), 5.17 (s, 1H, NH), 5.10 (s, 5H, C5H5); 
13C{1H} (100 MHz) 207.5 (s, CO), 
157.5 (s, NH=CNH2), 154.6 (s, N=C(NH)2), 146.1 (s, NCCHCHCHCHCN), 139.9 (s, 
NCCHCHCHCHCN), 118.7 (s, NCCHCHCHCHCN), 118.5 (s, NCCHCHCHCHCN), 
114.2 (s, NCCHCHCHCHCN), 111.8 (s, NCCHCHCHCHCN), 83.0 (s, C5H5), 54.9 (s, 
CH2Cl2). 
 
[(5-C5H5)Ru(CO)(GBI)]
+ (P)-Phos (9+ (P)-Phos).26 A round bottom flask 
was charged with 11 (0.025 g, 0.05 mmol), 12 (0.020 g, 0.05 mmol), and CH2Cl2 (2 mL) 
with stirring. After 0.5 h, the mixture was filtered through a plug of celite (1 × 2.5 cm), 
which was rinsed with CH2Cl2 (5 mL). Hexanes (20 mL) was added, and the CH2Cl2 
was removed by rotary evaporation. The solvent was decanted from the precipitate, 
which was dissolved in CH2Cl2 (2 mL). The solution was added dropwise to stirred 
hexanes (25 mL), and the CH2Cl2 was removed by rotary evaporation. The solvent was 
decanted from the precipitate, which was dried by oil pump vacuum to give 9+ (P)-
Phos as a dirty white powder (0.035 g, 0.050 mmol, >99%), dec. pt. 215 °C (capillary). 
Anal. Calcd for C34H26N5O5PRu: C 56.98, H 3.66, N 9.77. Found C 55.08, H 4.09, N 
10.00.89  
 
NMR (, CD2Cl2, diastereomers separated by "/"):
90 1H (500 MHz) 8.05-8.03 (d, 
2H, 2JCH = 9.0 Hz, H(P)-Phos), 7.95 (d, 2H, 
2JCH = 8.2 Hz, H(P)-Phos), 7.66-7.47, 7.41-
7.36, 7.25-7.18, 7.15-7.06, and 7.02-6.99 (5  m, 2H, 4H, 3H, 2H, and 1H, remaining 
H(P)-Phos and NCCH(CH)2CHCN), 6.14 (br s, 2H, NH), 5.82 (s, 2H, NH), 5.18/5.07 (2 
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 s, 1H/1H, NH), 4.85/4.80 (2  s, 5H/5H, C5H5); 
13C{1H} (125 MHz) 204.8/204.7 (2  
s, CO), 154.6/152.3 (2  s, NH=CNH2), 149.3/149.2 (2  s, C(P)-Phos), 147.3/147.2 (2  
s, N=C(NH)2), 143.3/143.2 (2  s, NCCHCHCHCHCN), 135.6/134.7 (2  C(P)-Phos), 
131.7/131.6 (2  s, NCCHCHCHCHCN), 131.0, 130.9, 128.8, 128.7, 127.3, 127.2, 
126.6, 126.5, 125.5, 125.4, (10  s, remaining C(P)-Phos), 122.4/121.9 (s, 
NCCHCHCHCHCN), 121.8 (s, NCCHCHCHCHCN), 117.0, 116.9 (2  s, 
NCCHCHCHCHCN), 111.6/111.5 (2  s, NCCHCHCHCHCN), 82.2/82.1 (2  s, 
C5H5). 
 
IR (cm1, powder film): 3375 (w), 1938 (s, CO), 1680 (m), 1566 (m), 1563 (s), 
1463 (w), 1354 (w), 1409 (w), 1261 (w), 1240 (w), 1215 (w), 1091 (s), 1068 (s), 960 (s), 
837 (m), 810 (m), 749 (m), 700 (m). 
 
Friedel-Crafts Alkylations (Table 2.5 and 2.9). An NMR tube was charged with 
catalyst (0.010 mmol), an indole (5a,b; 0.20 mmol), 6 (0.015 g, 0.10 mmol), an internal 
standard (Ph2SiMe2), and CD2Cl2 (0.5 mL). The tube was capped and 
1H NMR spectra 
were periodically recorded. The CH=CH signals of 6 and the product CH2NO2 signals at 
ca. 5 ppm were integrated versus those of the standards.  
 
1-methyl-3-(2-nitro-1-phenylethyl)-1H-indole (7a). NMR (, CDCl3): 
1H (500 
MHz): 7.47 (d, 1H, 3JHH = 7.6 Hz), 7.38–7.23 (m, 7H), 7.10 (m, 1H), 6.88 (s, 1H), 5.21 
(t, 1H, 3JHH = 8.0 Hz, CHCH2NO2), 5.06 (dd, 1H, 
3JHH = 12.4, 
2JHH = 8.0 Hz, 
CHH'NO2), 4.95 (dd, 1H, 
3JHH = 12.4, 
2JHH = 8.0 Hz, CHH'NO2), 3.75 (s, 3H, NCH3); 
Literature chemical shift values (CDCl3) agree within 0.01 ppm.
68a  
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3-(2-nitro-1-phenylethyl)-1H-indole (7b).70,75 NMR (, CDCl3): 
1H (500 
MHz): 8.08 (br s, 1H, C8H5NH), 7.55-6.96 (m, 10H, C8H5NH and C6H5), 5.19 (t, 1H, 
3JHH = 8.2 Hz, CHCH2NO2), 5.07 (dd, 1H, 
2JHH = 12.4 Hz, 
3JHH = 7.2 Hz, CHH'NO2), 
4.95 (dd, 1H, 2JHH = 12.4 Hz, 
3JHH = 8.2 Hz, CHH'NO2). Literature values (CDCl3)
91 
agree within 0.01 ppm, and data in CD2Cl2 are supplied elsewhere.
70  
 
Crystallography A. A CH2Cl2 (5 mL) solution of 3
+ BArf
–H2O (ca. 0.03 g) in 
an NMR tube was allowed to concentrate for 7 d. Grey blocks of 3+ BArf
–H2O with 
well defined faces formed.  
Data were collected as outlined in Table 2.1. The integrated intensity information 
for each reflection was obtained by reduction of the data frames with the program 
APEX2.92 Cell parameters were obtained from 180 frames using a 0.5° scan. Data were 
corrected for Lorentz and polarization factors, and using SADABS,93 absorption and 
crystal decay effects. The structure was solved by direct methods using SHELXTL 
(SHELXS).94 All non-hydrogen atoms were refined with anisotropic thermal 
parameters. Hydrogen atoms were placed in idealized positions using a riding model. 
Elongated thermal ellipsoids on several CF3 groups and the C(NH2)3 groups indicated 
disorder, which was modeled. A number of restraints and constraints were applied to the 
bond distances, angles, and thermal ellipsoids. The parameters were refined by weighted 
least squares refinement on F2 to convergence.94  
 
B. A wet CH2Cl2 (5 mL) solution of 4
+ BArf
– (ca. 0.03 g) in an NMR tube was 
allowed to concentrate for 7 d. Colorless blocks of 4+ BArf
–H2O(CH2Cl2)0.5 with well 
defined faces formed.  
Data were collected as outlined in Table 2.1. The integrated intensity information 
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for each reflection was obtained by reduction of the data frames with the program 
APEX2.92 Cell parameters were obtained from 180 frames using a 0.5° scan. Data were 
corrected for Lorentz and polarization factors, and using SADABS,93 absorption and 
crystal decay effects. The structure was solved by direct methods using SHELXTL 
(SHELXS).94 The asymmetric unit contained two unique 4+ BArf
 salts, two molecules 
of H2O and one molecule of CH2Cl2. There were two asymmetric units in the unit cell 
(Z = 4; Z′ = 2). All non-hydrogen atoms were refined with anisotropic thermal 
parameters. Hydrogen atoms were placed in idealized positions using a riding model. 
Several of the CF3 and C(NH) groups were disordered. Efforts to model the disorder did 
not improve the R value. For the final refinement, some of the CF3 groups were left with 
elongated thermal ellipsoids. The parameters were refined by weighted least squares 
refinement on F2 to convergence.94  
 
C. A round bottom flask was charged with (η5-C5H5)Fe(CO)2(Br) (0.0510 g, 
0.200 mmol), GBI (0.0386 g, 0.200 mmol), NH4
+ PF6
 (0.068 g, 0.400 mmol), and 
EtOH (10 mL). The mixture was refluxed with stirring. After 14 h, the mixture was 
cooled to room temperature and the solvent was removed by oil pump vacuum. Then 
CH2Cl2 was added to the residue, and the sample was stirred. The solution was filtered 
through a short plug of celite.  
A portion was allowed to concentrate in an NMR tube. After 1 d, brown column 
shaped crystals of [1-H]2+ 2BrH2O were obtained.  
Data were collected as outlined in Table 2.1. The integrated intensity information 
for each reflection was obtained by reduction of the data frames with the program 
APEX2.92 Cell parameters were obtained from 180 frames using a 0.5° scan. Data were 
corrected for Lorentz and polarization factors and using SADABS93 absorption and 
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crystal decay effects. The structure was solved by direct methods using SHELXTL 
(SHELXS).94 All non-hydrogen atoms were refined with anisotropic thermal 
parameters. Hydrogen atoms were placed in idealized positions using a riding model. 
The parameters were refined by weighted least squares refinement on F2 to 
convergence.94  
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3. EPIMERIC CHIRAL-AT-METAL RUTHENIUM COMPLEXES: 
SEPARATION AND APPLICATIONS* 
 
3.1 Introduction 
 
3.1.1 Modification of GBI to facilitate isolation of enantiopure ruthenium complexes 
 
Encouraged by the rich literature on the formation and separation of 
diastereomers of chiral-at-metal95-100 (specially ruthenium)62b,63a-h,96 piano stool 
complexes, a series of substituted GBI complexes was targeted (Figure 1.1, top). Some 
examples would involve achiral GBI derivatives that may afford more readily resolvable 
enantiomers, and others would involve chiral enantiopure GBI derivatives that would 
lead to mixtures of Ru,C configurational diastereomers. These would potentially be 
easier to separate, providing an alternative route to enantiopure catalysts. Considering 
the immense popularity and success of Takemoto's very effective and widely applied 
dimethylamino containing thiourea catalyst XII (Figure 3.1, bottom (left)),21a,d similar 
bifunctional systems were also sought (Figure 3.1, bottom (right)). 
 
 
 
 
 
 
* Reproduced in part with permission from Mukherjee, T.; Ganzmann, C.; Bhuvanesh, 
N.; Gladysz, J. A. Organometallics 2014, 33, 6723-6737. Copyright 2014 American 
Chemical Society. 
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3.2 Results 
 
3.2.1 Syntheses of substituted GBI derivatives 
 
It was first sought to replace the NH2 group of the GBI ligand by alkylated NHR 
groups, and then obtain enantiopure complexes. Towards this intention, a patent 
describing a reaction sequence involving the protonated methyl isothiourea 13-H+ I 
shown in Scheme 3.1 and o- methoxybenzylamine101 appeared promising. This afforded 
a GBI ligand with a NHCH2Ar group. Analogous reactions with other primary amines 
could easily be envisioned. According to the patent, 13-H+ I can be obtained by 
reacting the protonated thiourea 14-H+ CH3COO
 and methyl iodide. Compound 14-H+ 
CH3COO
 was in turn accessed from the ammonolysis of the known imidazole 
derivative 15 (Scheme 3.1). 
As a starting point for this work, 15 was prepared by combining aspects of two 
existing literature procedures involving 2-aminobenzimidazole and 1,1-thiocarbonyl 
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diimidazole, as depicted in Scheme 3.1 and detailed in the experimental section.102,103 
Workup gave 15 as a light yellow solid in 73% yield. Subsequent reactions as mentioned 
in the patent gave 14-H+ CH3COO
 as a pale yellow powder in 88% yield and 13-H+ I 
as a white solid in 55% yield. Given the variable degrees of detail and peer review 
associated with patent preparations, full procedures for both of these steps are given in 
the experimental section and in the full paper associated with this chapter.104  
As shown in Scheme 3.1, 13-H+ I was treated with benzyl amine and three other 
enantiopure chiral primary amines. In the first two cases, the amines were commercially 
available and excesses were employed. The other two amines, which furthermore 
incorporated pendant tertiary amines, had to be synthesized, and therefore were utilized 
in near stoichiometric quantities. Comparable conversions could be obtained by 
employing longer reactions times. Basic workups afforded the GBI derivatives 
16a,105,106 (SC)-16b,
105,107 (RCRC)-16c,
105,107 and (RCRC)-16d as white or pale yellow 
air stable solids in 40-61% yields. The first two chiral derivatives were originally 
prepared by Dr. C. Ganzmann, but were repeated as part of this work.105  
Compound 16a had previously been prepared in 28% yield from the reaction of 
2-cyanoaminobenzimidazole and benzyl amine in refluxing DMF.108 Here, the new 
route in Scheme 3.1 represents a distinct improvement. All of the above compounds 
were characterized by NMR (1H, 13C) and IR spectroscopy, and microanalysis, as 
summarized in the experimental section. 
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3.2.2 Syntheses of substituted GBI complexes  
 
The ligands 16a-d were complexed to the cyclopentadienyl carbonyl ruthenium 
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fragment by one of the methods established for GBI in the preceding chapter.75 As 
shown in Scheme 3.2, the readily available cationic bis(acetonitrile) complex [(η5-
C5H5)Ru(CO)(NCCH3)2]
+ PF6
– (17+ PF6
)74,104 was treated with 1.1-1.3 equiv of the 
ligands in CH2Cl2/MeOH to afford the crude chelates [(η
5-C5H5)Ru(CO)(16a-d)]
+ PF6
– 
(18a-d+ PF6
–).104 These and all other reactions involving ruthenium species below were 
conducted under aerobic conditions. As seen in chapter 2, the CO ancillary ligand in 
18a-d+ PF6
– makes for a stronger hydrogen bond donor than a PPh3 ligand (see Table 
2.9).75  
In the case of the achiral ligand 16a, the crude sample was chromatographed on 
silica gel (CH2Cl2/CH3CN) to give 18a
+ PF6
– as a yellow solid in 58% yield.104-106 
This and all new ruthenium complexes were characterized as described for the ligands 
above. NMR spectra showed only a single cyclopentadienyl 1H and 13C signal (δ 4.88 
and 83.0).104-106 As noted in the preceding chapter, the cyclopentadienyl carbonyl 
complexes commonly gave low microanalytical values for nitrogen. 
With the chiral enantiopure ligand (SC)-16b, the product was either 
chromatographed on silica gel using CH2Cl2/CH3CN or on alumina using a 
CH2Cl2/MeOH gradient.
104,107 In the latter case, nearly all of the PF6
– counter anion 
underwent exchange with alumina derived entities to give a material represented as 18b+ 
X–. Hence, aliquots were taken to dryness and treated with a CH2Cl2 solution of Na
+ 
PF6
– to regenerate 18b+ PF6
–.104,107 The silica gel based workup directly afforded 18b+ 
PF6
– as a greenish-brown solid in 71% yield.104,107 The 1H NMR spectrum exhibited 
two well separated cyclopentadienyl 1H NMR signals (δ 5.05 and 4.60, area ratio (54 ± 
2):(46 ± 2)), consistent with a mixture of Ru,C configurational diastereomers. The ratio 
did not change upon further silica gel chromatography, but alumina afforded a more 
enriched mixture. However, nothing approaching a preparatively useful separation could 
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be achieved.  
 
 
 
 
 
 
 
Similar protocols with the enantiopure ligands (RCRC)-16c,d provided salts 18c
+ 
PF6
– 109 and 18d+ PF6
– as (54 ± 2):(46 ± 2) and (53 ± 2):(47 ± 2) as mixtures of 
diastereomers, as assayed by 1H NMR of the crude samples. Silica gel chromatography 
led to decomposition, likely connected in some manner to the tertiary amine groups. 
However, alumina chromatography (CH2Cl2/MeOH gradient) afforded the intact 
cations, but with concomitant anion exchange to give 18c,d+ X–. Subsequent treatments 
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with Na+ PF6
– gave 18c,d+ PF6
– as greenish-brown solids in 57% and 39% yields, with 
the diastereomer ratios (dr) (always close to 50:50) depending somewhat on the column 
conditions.  
It would be preferable to separately assay the enantioselectivity achievable with 
each diastereomeric catalyst. Hence, the alumina chromatography conditions were 
varied. It was found that when higher loadings of 18c+ PF6
– were employed, together 
with an extended CH2Cl2/MeOH gradient, significant diastereomer separation could be 
achieved, as diagrammed in Scheme 3.3. Three cuts of fractions were collected: an 
initial series containing predominantly one diastereomer of 18c+ X– (>96:<4), an 
intermediate series containing both diastereomers (the least in terms of mass), and a final 
series containing predominantly the other diastereomer (<10:>90).  
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Now the anion exchange was conducted at –40 °C using CH2Cl2 solutions of 
18c+ X– (initial and final fractions) and the ammonium salt NH4
+ PF6
–. For the faster 
eluting diastereomer, assigned as RRuRCRC based upon data provided below, the dr 
ranged from >99:<1 to 96:04 (best and worst cases). For the slower moving SRuRCRC 
diastereomer, ratios ranged from 02:98 to 10:90. The masses recovered were >60% of 
the initial 18c+ X– charges. A similar approach with 18d+ PF6
– led to partial separation, 
with the best dr value for each diastereomer being 80:20. Extensive efforts to crystallize 
any of the salts 18b-d+ PF6
– were unsuccessful. 
 
3.2.3 Epimerization of GBI complexes, assignment of diastereomer configurations 
 
Complexes 18c,d+ PF6
– were configurationally stable as solids, but underwent 
slow epimerization in solution as sketched in Scheme 3.3. A number of other chiral-at-
metal d6 cyclopentadienyl adducts have also been observed to undergo epimerization, 
and detailed mechanistic studies have established ligand dissociation followed by 
inversion of the resulting pyramidal coordinatively unsaturated species, as shown in 
Scheme 3.4.110,111 Some of the data for 18c+ PF6
– are summarized in Table 3.1, and 
show that (1) rates are slightly faster in CD3CN than CD2Cl2, and (2) only moderate 
losses of diastereomeric purities occur over 24 h at room temperature.  
 
 
 
 85 
 
 
 
 
 
It was thought that other counter anions might yield salts that could crystallize 
and aid in the assignment of configurations. When crude (RRuRCRC)-18c
+ X– was 
treated with the salt Na+ BArf
– 26 under metathesis conditions similar to those used in 
the preceding chapter, it proved difficult to remove the excess tetraarylborate anion. 
Equimolar quantities did not give complete metatheses. However, workup of the reaction 
of (RRuRCRC)-18c
+ X– and ca. 1.0 equiv of the enantiopure chiral phosphate salt Na+ 
(Δ)-TRISPHAT– 26,112 gave (RRuRCRC)-18c
+ (Δ)-TRISPHAT– as a pale yellow powder 
of ca. 95% purity. This complex underwent slow epimerization in CD2Cl2 at room 
temperature, analogously to (RRuRCRC)-18c
+ PF6
–. 
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Table 3.1 Epimerization data for the diastereomers of 18c+ PF6
−.a 
%de (dr) of (RRuRCRC)-18c
+ PF6
−
 
 Solid Solution 
time 
(d) 
 −35 °C 
CD2Cl2 CD3CN 
−35 °C rt −35 °C Rt 
0.0 
95.0 
(97.5:2.5) 
98.0 
(99.0:1.0) 
96.0 
(98.0:2.0) 
98.0 
(99.0:1.0) 
92.4 
(96.2:3.8) 
1.0 - - 
85.2 
(92.6:7.4) 
- 
80.2 
(90.1:9.9) 
2.0 - - 
75.4 
(87.7:12.3) 
- 
69.6 
(84.8:15.2) 
3.0 - - 
66.8 
(83.4:16.6) 
- 
60.0 
(80.0:20.0) 
4.0 - - 
60.0 
(80.0:20.0) 
- 
51.6 
(75.8:24.2) 
5.0 
95.0 
(97.5:2.5) 
98.0 
(99.0:1.0) 
- 
98.0 
(99.0:1.0) 
- 
%de (dr) of (SRuRCRC)-18c
+ PF6
− 
 Solid Solution 
time 
(d) 
−35°C 
CD2Cl2 CD3CN 
−35 °C rt −35 °C Rt 
0.0 
88.0 
(6.0:94.0) 
90.0 
(10.0:90.0) 
88.0 
(6.0:94.0) 
90.0 
(10.0:90.0) 
45.8 
(27.1:72.9) 
1.0 - - 
75.4 
(12.3:87.7) 
- 
36.0 
(32.0:68.0) 
2.0 - - 
64.0 
(18.0:82.0) 
- 
29.8 
(35.1:64.9) 
3.0 - - 
55.2 
(22.4:77.6) 
- 
24.2 
(37.9:62.1) 
4.0 - - 
47.4 
(26.3:73.7) 
- 
20.2 
(39.9:60.1) 
5.0 
88.0 
(6.0:94.0) 
90.0 
(10.0:90.0) 
- 
90.0 
(10.0:90.0) 
- 
a Measured by 1H NMR. The C5H5 or NMe2 signals were integrated against the internal standard 
Ph2SiMe2 and the values were averaged.  
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Small colorless blocks of a CHCl3 monosolvate of (RRuRCRC)-18c
+ (Δ)-
TRISPHAT– could be grown from CHCl3/C6F6. A correct microanalysis was obtained, 
and the crystal structure was determined using synchrotron radiation as summarized in 
the experimental section and Appendix B (Table b1). Key metrical parameters are given 
in Table 3.2. Figure 3.2 shows the structures of the salt (top) and the cation (bottom). 
These confirm the configurational assignment given above. 
Hydrogen bonding is evident between the N10-H10 and N13-H13 linkages of the 
cation and two oxygen atoms of the (Δ)-TRISPHAT anion (Figure 3.2, top; see caption 
for distances). The structure of the anion is very similar to those found in other 
TRISPHAT salts.113,114 These include two ammonium salts that exhibit NH…O 
hydrogen bonding interactions, with distances comparable to those shown in Figure 
3.2.114  
As with the structures of the two ruthenium GBI complexes in the full paper 
associated with the previous chapter,75 the bond lengths of the coordinated C=NH and 
C=NAr linkages (1.298(5) and 1.321(5) Å) are shorter than the other four carbon-
nitrogen bonds about C2 and C11 (1.345(5)-1.386(5) Å). This provides further support 
for the ligand tautomer shown in Scheme 3.2 and 3.3 (see Figure 2.2 and Scheme 2.2, 
chapter 2). Alternative tautomers of the GBI would afford different bond length patterns 
(Scheme 2.3, chapter 2).  
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An approximately synperiplanar NH triad (N10-H10, N13-H13, N1-H1) is 
apparent, as reflected by H-N-N-H torsion angles close to 0° (–38.9°, 13.0°, –24.3°). 
However, the N13-H13 group, which as noted above hydrogen bonds to (Δ)-
TRISPHAT, similarly interacts with the nitrogen atom of the dimethylamino group 
(N20), as indicated in Figure 3.2 (bottom).  
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Table 3.2 Key bond lengths [Å], bond angles [°], and torsion angles [°] for (RRuRCRC)-
18c+ (Δ)-TRISPHAT−·CHCl3 and (RRuRCRC/SRuRCRC)-18c
+ (/)-TRISPHAT–
·(Et2O)2.
a 
 
(RRuRCRC)-18c
+ (Δ)- 
TRISPHAT−·CHCl3
 
(RRuRCRC/SRuRCRC)-18c
+ (/)-
TRISPHAT–·(Et2O)2 
  (RRuRCRC)-18c
+  (SRuRCRC)-18c
+  
Ru(1)-N(3) 2.119(3) 2.086(6) 2.083(6) 
Ru(1)-N(12) 2.094(3) 2.093(6) 2..069(6) 
Ru(1)-C(23) 1.861(4) 1.831(7) 1.862(8) 
C(2)-N(3) 1.321(5) 1.342(8) 1.320(9) 
C(2)-N(1) 1.350(5) 1.348(9) 1.379(9) 
C(2)-N(10) 1.360(5) 1.357(9) 1.340(9) 
C(11)-N(10) 1.386(5) 1.355(9) 1.370(10) 
C(11)-N(12) 1.298(5) 1.296(8) 1.280(9) 
C(11)-N(13) 1.345(5) 1.363(9) 1.395(9) 
C(14)-N(13) 1.455(5) 1.486(8) 1.480(8) 
C(23)-Ru(1)-N(3) 93.92(15) 92.6(3) 92.5(3) 
C(23)-Ru(1)-N(12) 92.17(15) 93.6(3) 94.0(3) 
N(3)-Ru(1)-N(12) 83.00(12) 82.5(2) 83.4(2) 
Ru(1)-N(3)-C(2) 125.0(3) 126.4(5) 124.8(5) 
N(3)-C(2)-N(1) 112.7(3) 111.1(6) 111.0(6) 
N(3)-C(2)-N(10) 126.8(3) 127.6(6) 130.3(7) 
N(1)-C(2)-N(10) 120.4(3) 121.3(6) 118.7(6) 
Ru(1)-N(12)-C(11) 130.6(3) 129.4(5) 130.3(5) 
N(12)-C(11)-N(10) 120.4(3) 124.1(7) 124.9(7) 
N(12)-C(11)-N(13) 125.8(4) 119.8(7) 119.9(7) 
N(10)-C(11)-N(13) 113.8(3) 116.1(6) 115.0(6) 
C(11)-N(13)-C(14) 123.0(3) 127.3(6) 129.6(6) 
C(23)-Ru(1)-N(3)-C(2) −111.6(3) −108.8(2) 109.4(2) 
C(23)-Ru(1)-N(12)-C(11) 122.3(4) 120.0(2) −114.4(3) 
Ru(1)-N(3)-C(2)-N(10) 3.6(5) −1.3(10) −1.8(11) 
Ru(1)-N(12)-C(11)-N(10) −18.7(5) −23.0(10) 13.7(11) 
Ru(1)-N(12)-C(11)-N(13) 160.8(3) 153.5(5) −172.3(5) 
N(3)-C(2)-N(10)-C(11) 19.0(6) 17.6(11) −15.9(12) 
N(12)-C(11)-N(10)-C(2) −11.4(6) −5.0(11) 9.7(11) 
N(13)-C(14)-C(19)-N(20) 49.4(4) −65.4(7) −66.0(8) 
N(12)-C(11)-N(13)-C(14) −1.47(5) 150.4(6) 140.8(7) 
H(10)-N(10)-N(13)-H(13) −38.9 −165.8 130.2 
H(10)-N(10)-N(1)-H(1) 13.0 13.6 −11.2 
H(1)-N(1)-N(13)-H(13) 24.3 −144.9 112.5 
C(11)-N(13)-C(14)-C(15) −69.5(8) −154.8(6) 166.5(7) 
C(11)-N(13)-C(14)-C(19) −166.3(2) 86.7(8) 73.5(9) 
a For distances involving hydrogen bonds, see the captions to Figures 3.2 and 3.3. 
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The analogous salt with the racemic TRISPHAT anion, (RRuRCRC)-18c
+ (Δ/-
TRISPHAT–, was similarly prepared. Two diastereomeric ion pairs are possible, but a 
1H NMR spectrum (CD2Cl2) showed only a single cyclopentadienyl signal, in contrast 
to the example with 9+ (P)-Phos (Scheme 2.8) in the previous chapter. Crystals were 
obtained over a three week period from Et2O/CH3CN, and the structure was determined 
by X-ray crystallography. As illustrated in Figure 3.3, the salt consisted of a 50:50 
mixture of both diastereomers of the ruthenium cation (RRuRCRC/SRuRCRC) and both 
enantiomers of the TRISPHAT– anion (/), together with two Et2O solvate molecules 
per ruthenium. Consistent with the data in Table 3.1, the ruthenium center epimerized on 
the time scale of the crystallization. Curiously, the cocrystallization of diastereomeric 
chiral-at-metal d6 cyclopentadienyl complexes has abundant precedent.115  
While this mixed salt does not aid in the assignment of configuration, it does 
provide a structure for the diastereomeric SRuRCRC cation, as well as a probe of the 
conformational flexibility of the RRuRCRC cation. As can be seen in Table 3.2, the bond 
lengths and angles are quite similar for all three cations in Figures 3.2 and 3.3; those 
involving ruthenium are very close to other (η5-C5R5)Ru(CO) adducts (R = H or Me) of 
nitrogen chelate ligands.75,116  
However, the RRuRCRC cation in Figure 3.3 adopts a different conformation 
about the C11-N13 bond from that in Figure 3.2, as reflected by the N12-C11-N13-C14 
torsion angles (150.4° vs. –1.47°). This reduces the number of synperiplanar NH 
linkages to two, as evidenced by a single H-N-N-H torsion angle close to 0° (H10-N10-
N1-H1, 13.0°; those involving H13-N13 are –165.8 and –144.9). Interestingly, the 
SRuRCRC cation in Figure 3.3 exhibits a comparable N12-C11-N13-C14 torsion angle 
(140.8°), similarly leading to only two synperiplanar NH linkages. 
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The N12-C11-N13-C14 torsion angles in the cations in Figure 3.3 have another 
consequence. Namely, when coupled with appropriate conformations about the N13-C14 
bonds (i.e., C11-N13-C14-C19 torsion angles of 73.5°-86.7°), the dimethylamino 
nitrogen atoms (N20) are able to intramolecularly hydrogen bond to the H10-N10 
moieties (see caption for distances). Hence, under catalytic conditions in solution, 
equilibrium quantities of at least two distinct intramolecular hydrogen bonding motifs 
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would also be expected with (RRuRCRC)-18c
+ (Δ)-TRISPHAT– and other salts (N13-
H13…N20 and N10-H10…N20). Proportions would decrease with counter anions that 
are stronger hydrogen bond acceptors. 
Prior to obtaining the crystal structure of (RRuRCRC)-18c
+ (Δ)-TRISPHAT–, 
other approaches to assigning configurations were investigated. Thus, CD spectra of 
(RRuRCRC)-18c
+ PF6
– and (SRuRCRC)-18c
+ PF6
– were recorded, as depicted in Figure 
3.4.116 These featured, as commonly seen for diastereomeric chiral-at-metal complexes 
with opposite metal configurations,98,117 two long wavelength absorptions of opposite 
signs (408, 406 nm). However, the positive band of (SRuRCRC)-18c
+ PF6
– was more 
than twice as intense. Together with additional positive adsorptions or shoulders at 369-
372 nm, this suggested the superposition of metal-centered transitions upon a common 
spectrum derived from the enantiopure ligand (matched absorptions for (SRuRCRC)-18c
+ 
PF6
–, mismatched for (RRuRCRC)-18c
+ PF6
–). A computational study (DFT), the results 
of which are presented in the Appendix B, was carried out to simulate these spectra.118 
This led to the same assignments as made crystallographically. 
 
 
 
 
 
Figure 3.4 CD spectra of (RRuRCRC)-18c
+ PF6
− (blue trace) and (SRuRCRC)-18c
+ PF6
− (red 
trace) in CH3CN. 
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3.2.4 Catalytic reactions 
 
3.2.4.1 Enantioselective second coordination sphere promoted catalysis 
 
With the successful separation of the diastereomers (RRuRCRC)-18c
+ PF6
– and 
(SRuRCRC)-18c
+ PF6
– shown in Scheme 3.3 and the configurational assignments 
established in Figures 3.2 and 3.4, the stage was set for their application as 
enantioselective catalysts. Accordingly, reactions of indoles (5a,b) and trans-β-
nitrostyrene (6) in the presence of (SRuRCRC)-18c
+ PF6
– were initially investigated 
using conditions similar to those described in the preceding chapter. This is a benchmark 
reaction that can be effected with many hydrogen bond donor catalysts.68,119 In all 
cases, the dr of the catalyst was at least >95:<5. The enantioselectivities were assayed by 
chiral HPLC as tabulated below and per the traces reproduced in the Appendix B. The 
absolute configurations were assigned according to previously reported relative retention 
times. 
First, 1-methylindole (5a; 2.0 equiv) was treated with 6 (1.0 equiv) in the 
presence of 10 mol% of (SRuRCRC)-18c
+ PF6
– in CD2Cl2 at room temperature under 
aerobic conditions (Table 3.3, entry 1). The reaction was clean and after 24 h, workup 
gave 1-methyl-3-(2-nitro-1-phenylethyl)-1H-indole (7a)68a in 60% yield. However, 
chiral HPLC analysis indicated an ee value of only 2%. Similarly, reaction of indole (5b) 
and 6 under analogous conditions gave, after 48 h, 3-(2-nitro-1-phenylethyl)-1H-indole 
(7b)119c in 70% yield with only 1% ee (Table 3.3, entry 2). As represented in the full 
paper associated with the previous chapter,75 the racemic complex [(η5-
C5H5)Ru(CO)(GBI)]
+ PF6
 (9+ PF6
) also catalyzed the reactions of 5a,b and 6 under 
identical conditions.75 In all cases the reaction of 5a was again considerably faster, 
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consistent with the electron releasing N-methyl group.  
 
 
 
 
 
 
 
Interestingly, the reaction of 5b and 6 was somewhat faster when catalyzed by 
(SRuRCRC)-18c
+ PF6
– than 9+ PF6
 (70% vs. 27% yield after 48 h). One possible 
explanation is that the –NMe2 moiety participates somehow in the reaction coordinate, 
rendering 18c+ PF6
– not only a hydrogen bond donor but also a bifunctional catalyst 
similar to Takemoto's system.21a,d  
As indicated in chapter 2, these ruthenium complexes interact with dimethyl 
malonate (10a) and 6 through second coordination sphere hydrogen bonding. Based on 
these results it was next sought to assay (SRuRCRC)-18c
+ PF6
– and (RRuRCRC)-18c
+ 
PF6
– as catalysts for carbon-carbon bond forming reactions involving these substrates. 
Michael additions of diethyl malonate (10b) to 6 are commonly used as benchmark 
reactions for chiral hydrogen bond donor catalysts, particularly those that incorporate 
tertiary amines.21a,d,120 Hence, reactions involving dialkyl malonates and nitroalkenes 
were investigated (Table 3.4). 
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First, 10b (2.0 equiv) was treated with 6 (1.0 equiv) in the presence of 10 mol% 
of (SRuRCRC)-18c
+ PF6
– or (RRuRCRC)-18c
+ PF6
– in CD2Cl2 at room temperature under 
aerobic conditions (Table 3.4, entry 1). In all cases, the catalyst dr was at least >95:<5. 
Similar reactions were monitored by 1H NMR (ca. 25% more dilute, 1.8 equiv malonate 
ester), and clean conversions to the addition product, ethyl-2-carboethoxy-4-nitro-3-
phenylbutyrate (19a),121 were observed over the course of 1-2 d, as represented by the 
rate profiles in Figure 3.5 (red and blue triangles). With all substrates, (SRuRCRC)-18c
+ 
PF6
– was the more reactive catalyst.  
After the time indicated in Table 3.4, 19a was isolated by column 
chromatography. The enantioselectivities (ee) were assayed by chiral HPLC as tabulated 
below and per the traces reproduced in the Appendix B. The absolute configurations 
were assigned according to previously reported relative retention times. Both catalyst 
diastereomers afforded 19a in high enantiomer excesses (93% and 91%) and isolated 
yields (95% and 92%).  
The free ligand (RCRC)-16c was also evaluated as a catalyst. As shown in Table 
3.4, entry 1, after 5 d, 19a was obtained in 65% yield and 41% ee. Hence, (RCRC)-16c is 
a less reactive catalyst, as further evidenced by the rate profile in Figure 3.5 (green 
triangles), and much less enantioselective. The lower reactivity is consistent with chelate 
mediated preorganization of the substituted GBI ligand in (SRuRCRC)-18c
+ PF6
– and 
(RRuRCRC)-18c
+ PF6
–, and other factors as analyzed in the discussion section. For all 
three catalysts in entry 1, the same enantiomer of 19a dominates (RC). This indicates that 
the ligand based carbon stereocenter, and not the ruthenium, controls the configuration 
of the new carbon stereocenter in the product, with very little "matched" or 
"mismatched" sense with the Ru,C diastereomers. 
Analogous reactions were carried out with (SRuRCRC)-18c
+ PF6
– or (RRuRCRC)-
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18c+ PF6
– and three additional aryl substituted nitroalkenes, as summarized in Table 3.3, 
entries 2-4. The two substrates with substituted phenyl groups (entries 2 and 3) gave 
rates and product enantioselectivities comparable to entry 1. The furyl substituted alkene 
used in entry 4 afforded the highest enantioselectivity (>99% ee) of all the reactions 
studied. 
The steric bulk of the malonate ester was varied (ethyl (10b)/isopropyl 
(10c)/methyl (10a), entries 1, 5, 6). With the smaller 10a, reactions were distinctly 
faster, per the rate profiles in Figure 3.5 (red and blue squares). Conversely, the larger 
10c gave slower rates (Figure 3.5, red and blue diamonds) and lower isolated yields. 
However, the ee values were essentially unchanged. In all of entries 2-6, the free ligand 
(RCRC)-16c exhibited greatly reduced activity (see also Figure 3.5, green diamonds), but 
there were no obvious trends other than that associated with the bulk of the malonate 
ester. The ee values also varied considerably, but not in any systematic manner. 
Finally, three synthesized nitroalkenes122 with aliphatic substituents were also 
investigated (Table 3.4, entries 7-9). With (E)-1-nitropent-1-ene122a and (E)-1-nitrohept-
1-ene122b (entries 8,7), clean additions occurred, but they required 6 d to go to ca. 50% 
completion. For many catalytic reactions, higher temperatures would be employed with 
less reactive substrates. However, this would increase the catalyst epimerization rates. In 
any event, the products 19g,h were obtained in 72-87% ee, enantioselectivies only 
slightly lower than with the aryl substituted substrates. The free ligand (RCRC)-16c was 
essentially ineffective. As shown in entry 9, the sterically more congested t-butyl 
substituted nitroalkene was nearly unreactive.  
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3.2.4.2 Other second coordination sphere promoted enantioselective organic 
transformations 
 
In order to help define the breadth of applicability of catalysts (SRuRCRC)-18c
+ 
PF6
– and (RRuRCRC)-18c
+ PF6
–, other reactions known to be catalyzed by thiourea 
based bifunctional hydrogen bond donor catalysts were investigated.8g,13,21b,123-126 
First, the additions of other types of 1,3-dicarbonyl compounds, or their equivalents, to 6 
were probed (Table 3.5).  
As shown in entry 1 of Table 3.5, the addition of 2,4-pentanedione (20) to 6 in 
CD2Cl2 using 1 mol% of (SRuRCRC)-18c
+ PF6
– or (RRuRCRC)-18c
+ PF6
– was 
investigated. A clean reaction occurred. After 24 h, workups gave 70-75% yields of 3-
(2-nitro-1-phenylethyl)pentane-2,4-dione (21).123 Gratifyingly, chiral HPLC analysis 
indicated an extremely high ee value (>99%) for both catalysts. 
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An analogous reaction with ethyl 2-oxocyclopentanecarboxylate (22) and 6 was 
carried out (Table 3.5, entry 2a). Due to the lower symmetry of 22, the condensation 
product 23120f,124 features two stereocenters. This leads to two diastereomeric pairs, 
(RCSC)-23 and enantiomer (SCRC)-23, and (RCRC)-23 and enantiomer (SCSC)-23. The dr 
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can be assigned from the distinct 1H NMR signals.120f Each of the enantiomers can be 
assigned according to the previously reported relative retention times obtained by chiral 
HPLC.120f,124a Numerous bifunctional hydrogen bond donors have catalyzed the above 
reaction with very high distereoselectivities (>99:<1) and enantioselectivities 
(>99%).124b  
After 14 h, workup of the reaction in entry 2a gave a 90% yield of an 88:12 
diastereomer mixture. The 1H NMR data indicated these to be the previously reported 
(RCSC/SCRC)-23 and (RCRC/SCSC)-23 diastereomers, respectively.
120f,124a Chiral HPLC 
analysis indicated 84% ee with the enantiomer (SCRC)-23 dominant and 92% ee with the 
enantiomer (SCSC)-23 dominant, for the major and minor diastereomer 
respectively.120f,124a  
Another reaction was carried out with benzyl acetoacetate (24) and 6 in CD2Cl2 
at room temperature, but with a slightly higher catalyst loading of 2 mol% (Table 3.5, 
entries 3a,b). Similar to 23, the product 25125 also features two stereocenters and can 
afford two diastereomers. Although both have been reported in the literature, 
configurations have not been assigned. Nonetheless, the dr can be determined by 1H 
NMR.125  
After 24 h, workup of the reactions with (SRuRCRC)-18c
+ PF6
– or (RRuRCRC)-
18c+ PF6
– gave 82-86% yields of nearly a 1:1 mixture of the diastereomers of 25. Chiral 
HPLC analysis provided ee values of 87-88% for the diastereomer in slight excess but 
37-91% for the other.  
Malononitrile (26) and 6 were reacted in the presence of 1-2 mol% (SRuRCRC)-
18c+ PF6
– or (RRuRCRC)-18c
+ PF6
– in CD2Cl2 at the temperatures specified in Table 
3.5, entries 4a-d. A clean reaction occurred in all cases. After 24 h, workups gave 40-
90% yields of the product 27.21b The product was also analyzed by chiral HPLC. Entry 
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4a, with 1% catalyst loading, gave an ee value of 42%. A higher 2% catalyst loading 
improved the yield and ee moderately (entry 4a vs. 4b). Lowering the temperature to 35 
°C slightly improved the ee values (entry 4a vs. 4c). When (SRuRCRC)-18c
+ PF6
– was 
employed as catalyst (2 mol%) at 78 °C, 27 was isolated in 40% yield with only 11% 
ee. Thus, the highest ee, 54% was achieved utilizing 2 mol% of (RRuRCRC)-18c
+ PF6
– 
as the catalyst at room temperature. 
Next, additions of 1,3-dicarbonyl compounds to dialkyl azodicarboxylates were 
investigated as shown in Table 3.6. The reaction of 22 and diisopropyl azodicarboxylate 
(36) in CD2Cl2 was carried out with 10 mol% of (SRuRCRC)-18c
+ PF6
– or (RRuRCRC)-
18c+ PF6
– at 78 °C, as shown in Table 3.6 (entries 1a,b). The addition was monitored 
by TLC. A clean reaction occurred in all the cases. After 8 h, workup gave >99% yields 
of diisopropyl 1-(1-(ethoxycarbonyl)-2-oxocyclopentyl)hydrazine-1,2-dicarboxylate 
(37).126 Chiral HPLC analysis indicated moderate ee values (33-35%). Although this 
compound has been prepared earlier in nonracemic form,126 the absolute configuration 
of the major enantiomer was not assigned. 
Interestingly, with (SRuRCRC)-18c
+ PF6
–, the major enantiomer of 37 
corresponded to the first chiral HPLC peak, whereas with (RRuRCRC)-18c
+ PF6
–, the 
major enantiomer corresponded to the second HPLC peak. Unlike the results shown in 
Tables 3.3 and 3.4, the chiral ruthenium center, and not the ligand based carbon 
stereocenter, controls the favored product configuration (SRu vs. RRu, entry 1a vs. 1b). 
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Intrigued by the results, an analogous reaction was carried out with the bulkier 
azo compound di-t-butyl azodicarboxylate (38) and 22 in CD2Cl2 at 78 °C (entries 2a-
c). After 8 h, workup of the reaction with (SRuRCRC)-18c
+ PF6
– gave the product 39126 
in 90% yield and 82% ee (entry 2a). Interestingly, (RRuRCRC)-18c
+ PF6
– under similar 
conditions did not promote the reaction (entry 2b). At higher temperature and after a 
longer reaction time, 39 was isolated in 80% yield and 88% ee (entry 2c). In contrast to 
entries 1a,b, both catalysts gave predominantly the same enantiomer of 39 (SC), which 
could be assigned from previously reported relative retention times.126  
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3.3 Discussion 
 
3.3.1 Ruthenium catalysts 
 
This study has demonstrated the efficacy of a new class of hydrogen bond donor 
catalysts for Friedel-Crafts alkylations and highly enantioselective Michael addition 
reactions (Tables 3.4-3.6). They are indefinitely stable in the solid state, persist for 
weeks in non-degassed solutions, and can be utilized under aerobic conditions. 
As discussed in the previous chapter, chelate complexes of GBI attain 
conformationally more rigid and organized structures. This is exemplified by the crystal 
structures of the ruthenium adducts [(η5-C5H5)Ru(PPh3)(GBI)]
+ X– (8+ X–; X– = BArf
–
, PF6
–),75 the first of which is depicted in Figure 2.9 (chapter 2), and the diastereomers 
of 18c+ TRISPHAT depicted in Figures 3.2 and 3.3. In the cases of 8+ X– and 
(RRuRCRC)-18c
+ ()-TRISPHAT, DDD triads are obtained, although the N13-H13 unit 
can engage in hydrogen bonding in the latter (Figure 3.2).42c,127,128 With the other 
diastereomers of 18c+ X, the N13-H13 terminus rotates so as to direct a N13-C linkage 
syn to the N10-H10 unit, resulting in a DD dyad. This allows the N10-H10 unit to 
hydrogen bond to the pendant NMe2 group. Nonetheless, this would be an equilibrium 
interaction in solution. In any case, 1H NMR data for samples in which 6 or 10a was 
added to 9+ BArf
– in chapter 2 (Figures 2.5 and 2.11) suggest that binding preferentially 
occurs to the N1-H1 and N10-H10 linkages. These are synperiplanar in all of these 
structures, as depicted in the transition state models proposed below. 
The advantages of preorganization with respect to both thermodynamic and 
kinetic phenomena are well established.42c,43,129 Accordingly, the conformationally 
flexible free ligand (RCRC)-16c is a much less active catalyst than the chelates 
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(RRuRCRC)-18c
+ PF6
– and (SRuRCRC)-18c
+ PF6
–. However, the ruthenium also 
introduces positive charge, which should enhance NH acidities and therefore hydrogen 
bond donor strengths. Hence, a cationic derivative of (RCRC)-16c would provide a more 
informative comparison. In the preceding chapter it was shown that a cationic 
methylated derivative of GBI, 2+ BArf
–, remained a much less active catalyst than [(η5-
C5H5)Ru(PPh3)(GBI)]
+ BArf
– (8+ BArf
–) and [(η5-C5H5)Ru(CO)(GBI)]
+ BArf
– (9+ 
BArf
–) for the condensation of 5a and 6. Unfortunately, an expedient synthesis of a 
similar derivative of (RCRC)-16c was not achieved, due in part to the pendant 
dimethylamino group.  
The effect of the counteranion upon the activity of the ruthenium catalyst was 
studied in the preceding chapter. In all cases, BArf
− salts were considerably more 
reactive than hexafluorophosphate salts. This was ascribed to the residual hydrogen bond 
accepting properties of the PF6
– anion and competition with the substrate for the DD 
active site. Although as described above the synthesis of (RRuRCRC)-18c
+ BArf
− has 
proved problematic, samples of ca. 85% purity have been obtained. These proved to be 
much more active catalysts, pointing the way to possible future enhancements. Using an 
activated substrate (pKa values lower than 10b
130,131) can be another way of improving 
the catalytic efficiencies as demonstrated in Table 3.5. Here, catalyst loadings as low as 
1-2 mol% efficiently catalyze Michael additions of 1,3 dicarbonyl equivalents (20,130 
22,131a 24131b or 26131c) to 6 in reasonable yields and enantioselectivities.  
The above analyses of the DD dyad and DDD triads in crystalline 
(RRuRCRC/SRuRCRC)-18c
+ (/)-TRISPHAT–·(Et2O)2 and (RRuRCRC)-18c
+ (Δ)-
TRISPHAT−·CHCl3 provide a conceptual bridge to a subtle design flaw in catalysts 
(SRuRCRC)-18c
+ PF6
– and (RRuRCRC)-18c
+ PF6
–. Specifically, Figures 3.2 and 3.3 
show that intramolecular hydrogen bonding is possible between the dimethylamino 
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nitrogen atom (N20) and the H13-N13 and H10-N10 linkages. The latter equilibrium 
lowers the concentration of the DD site thought to activate the electrophile, and both tie 
up a dimethylamino group that is intended to activate the nucleophile (see below). In 
principle, these interactions might be inhibited with a conformationally restricted ligand 
or perhaps a bulkier tertiary amine. However, such modifications may also adversely 
affect interactions with the reactants, and thus can only be empirically investigated. 
The epimeric catalysts (SRuRCRC)-18c
+ PF6
– and (RRuRCRC)-18c
+ PF6
– give 
essentially the same ee values for the reactions in Table 3.4, implying as noted above 
that the ligand based stereocenters essentially control the product configurations. 
However, in entries 3 and 4 of Table 3.5, and 1a,b of Table 3.6, the ruthenium 
configuration can make a difference. This suggests fundamentally different types of 
transition state assemblies, possibly connected to the change in the type of educts.  
Catalysts that would epimerize more slowly are desirable. It has been shown that 
d6 pentamethylcyclopentadienyl complexes are much less configurationally stable than 
cyclopentadienyl analogs.132 To the extent that this represents an electronic effect, 
cyclopentadienyl ligands that bear electronegative substituents could be helpful. Also, 
one might consider expanding the steric influence of the ruthenium center with several 
large cyclopentadienyl substituents, such as phenyl or pentafluorophenyl.  
 
3.3.2 Literature catalysts and mechanisms 
 
The condensations in Table 3.4 compare favorably to those previously effected 
with other types of hydrogen bond donor catalysts. The best ee values that I am aware of 
for additions of 10b to 6 have been obtained with catalysts LXIII and LXIV-LXVII as 
summarized Figure 3.6 (85-96% ee vs. 91-93% ee for Table 3, entry 1). Nearly all of 
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these contain an NH based DD dyad and a tertiary amine. They furthermore catalyze a 
broad spectrum of additional reactions,8g,13,21d suggesting much yet untapped potential 
for (SRuRCRC)-18c
+ PF6
– and (RRuRCRC)-18c
+ PF6
–. 
 
 
 
  
 
 
 
A somewhat less enantioselective catalyst, LXIII, is also included in Figure 3.6. 
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Compound LXIII can be viewed as a stripped down version of ligand (RCRC)-16c that 
retains the benzimidazole and dimethylated trans-1,2-cyclohexanediamine termini. By 
itself, LXIII (10 mol%) catalyzes the addition of 10b to 6 over the course of 24 h in 
78% ee (toluene solvent) or 70% ee (CH2Cl2). Hence, the rate – but not the 
enantioselectivity – is similar to that of (SRuRCRC)-18c
+ PF6
– in the absence any 
conformational preorganization. However, there are too many differences for LXIII, 
(RCRC)-16c, and the ruthenium adducts to be regarded as rigorously comparable 
systems. 
Although these examples are not "stacked" to put the systems reported herein in 
an undeservedly favorable light, the catalyst LXIX has been added to round out the 
presentation.133 This species, as well as an epimer of LXIV,120a catalyze the addition of 
the alternative educt 10a to 6 in 98-93% yields and 99% ee, enantioselectivities that beat 
the other examples in Figure 3.6.133 To my knowledge, no data for 10b have been 
reported.  
The mechanism of addition of malonate esters to 6 with dimethylamino 
containing thiourea hydrogen bond donor catalysts (e.g., XII) has been investigated both 
experimentally and computationally.21b,c Takemoto has suggested transition state 
assemblies of the type LXX shown in Figure 3.7.21b These feature the "conventional" 
activation of the nitroalkene by the synperiplanar thiourea NH linkages, and the 
malonate ester by the tertiary amine, and rationalize the dominant product configuration. 
However, it has also been proposed that the roles could be reversed, as in LXXI.21c 
Analogous transition state assemblies can be formulated for the ruthenium containing 
catalysts, as shown by LXXII and LXXIII (Figure 3.6). In both cases, I suggest that the 
additional NH linkage acts in concert with the dimethylamino group. There are 
additional nuances in all of these assemblies, such as the conformation of the C=CPh 
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moiety with respect to the nitro group. 
 
 
 
  
 
 
 
3.4 Conclusion 
 
This study has established the viability of using chiral enantiopure transition 
metal complexes containing ligand based NH hydrogen bond donors to catalyze 
condensations of organic molecules in high yields and enantioselectivities. In this work, 
the hydrogen bond donors are remote from the metal, part of a bidentate ligand, and 
thought to be preorganized and thus activated toward substrate binding upon chelation. 
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3.5 Experimental section 
 
3.5.1 General data 
 
1H, 13C{1H}, 31P{1H} and 19F{1H} NMR spectra were recorded on standard 
300-500 MHz spectrometers at ambient probe temperature (24 °C) and referenced as 
follows (, ppm): 1H, residual internal CHCl3 (7.26), acetone-d5 (2.05), DMSO-d5 
(2.49), CHD2OD (3.30), or CHD2CN (1.94); 
13C, internal CDCl3 (77.0), acetone-d6 
(29.9), DMSO-d6 (39.6), CD3OD (49.1), or CD3CN (1.3); 
19F{1H}, internal 1-bromo-
3,5-bis(trifluoromethyl)benzene (–63.56). IR spectra were recorded using a Shimadzu 
IRAffinity-1 spectrophotometer with a Pike MIRacle ATR system (diamond/ZnSe 
crystal). UV-visible spectra were measured using an Shimadzu UV-1800 UV 
spectrophotometer. Circular dichroism spectra were obtained using a Chirascan CD 
Spectrometer (Applied Photophysics). Melting points were recorded with a Stanford 
Research Systems (SRS) MPA100 (Opti-Melt) automated device. Microanalyses were 
conducted by Atlantic Microlab. HPLC analyses were conducted with a Shimadzu 
instrument package (pump/autosampler/detector LC-20AD/SIL-20A/SPD-M20A; 
columns Chiralpak AD, Chiralpak AD-H, Chiralpak AS-H, Chiralcel OD, Chiralcel OD-
H).  
Solvents were treated as follows: THF, toluene, hexanes, Et2O, and CH2Cl2 were 
dried and degassed using a Glass Contour solvent purification system; CH3CN was 
distilled from CaH2; pentane (99.7%, J. T. Baker), MeOH (99.8%, BDH), and t-BuOH 
(99.5%, Acros) were used as received; CDCl3, CD3CN, CD2Cl2, acetone-d6, DMSO-d6, 
and CD3OD (6  Cambridge Isotope Laboratories) were used as received. The 2-
guanidinobenzimidazole (GBI; 95%, Aldrich), 1,1-thiocarbonyldiimidazole (90%, Alfa 
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Aesar), 2-aminobenzimidazole (99+%, Acros), methyl iodide (99%, Alfa Aesar), [(η5-
C5H5)Ru(NCCH3)3]
+ PF6
– (98%, Acros), benzylamine (99+%, Merck), (SC)-1-
phenylethylamine (98%, Aldrich), Ph2SiMe2 (97%, Aldrich), 1-bromo-3,5-
bis(trifluoromethyl)benzene (98%, Alfa Aesar), 1-methylindole (5a; 98%, Acros), indole 
(5b; >99%, Aldrich), trans-β-nitrostyrene (6; 99%, Alfa Aesar), 3,4-methylenedioxy-β-
nitrostyrene (98%, Alfa Aesar), 3,4-dichloro-β-nitrostyrene (98+%, Alfa Aesar), 1-(2-
furyl)-2-nitroethylene (98%, Alfa Aesar), dimethyl malonate (10a; 98+%, Alfa Aesar), 
diethyl malonate (10b; 99%, Alfa Aesar), diisopropyl malonate (10c; 99%, TCI), 2,4-
pentanedione (20; 99%, Aldrich), ethyl 2-oxocyclopentanecarboxylate (22; >95%, 
Aldrich), NH4
+ PF6
–
 (99.5%, Alfa Aesar), benzyl acetoacetate (24; 97%, Aldrich),
malononitrile (26; 98%, TCI), diisopropyl azodicarboxylate (36; 98%, Aldrich), di-t-
butyl azodicarboxylate (38; ≥98%, Aldrich), NEt3 (99%, Alfa Aesar), silica gel 
(SiliFlash F60, Silicycle), neutral alumia (Brockmann I, 50-200 μm, Acros), and Celite 
were used as received. 
All reactions and workups were carried out under air unless noted. Other 
chemicals were used as received. (E)-1-nitropent-1-ene and (E)-3,3-dimethyl-1-nitrobut-
1-ene were prepared according to literature procedures;122a (E)-1-nitrohept-1-ene122b 
was prepared analogously.  
3.5.2 Syntheses of GBI derivatives and catalysis 
N-(1H-Benzimidazol-2-yl)-1H-imidazole-1-carbothioamide (15).102 Method
A.105,107 A round bottom flask was charged with 1,1-thiocarbonyldiimidazole (3.00 g, 
16.8 mmol) and dry THF (30 mL), and 2-aminobenzimidazole (2.24 g, 16.8 mmol) was 
added with stirring. A yellow precipitate formed, which after 14 h was collected by 
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filtration, washed with THF (20 mL), and dried by oil pump vacuum to give 10 as a light 
yellow solid (2.24 g, 9.24 mmol, 55%). Method B.102,103 A round bottom flask was 
charged with 1,1-thiocarbonyldiimidazole (6.94 g, 39.0 mmol) and CH3CN (30 mL), and 
2-aminobenzimidazole (3.99 g, 30.0 mmol) was added with stirring. The flask was 
protected from light using a black cloth102 and placed in a 50 °C oil bath.103 A 
precipitate rapidly formed. After 22 h, the mixture was cooled to room temperature. The 
precipitate was collected by filtration, washed with CH3CN (4  80 mL), transferred to a 
flask using EtOAc (20 mL), and dried by oil pump vacuum (40 ºC, 1 h and then rt 
overnight) to give 15 as a light yellow solid (6.91 g, 28.4 mmol, 73%).  
 
NMR (δ, DMSO-d6):
102,104,105 1H (300 MHz) 13.35 (br s, 1H, NH), 8.55 (s, 1H, 
(C=S)NCHN), 7.93 (s, 1H, (C=S)NCHNCHCH), 7.62-7.59 (m, 2H, CH4/7), 7.35-7.32 
(m, 2H, CH5/6), 6.99 (s, 1H, (C=S)NCHNCHCH), 3.29 (br s, 1H, NH); 13C{1H} (125 
MHz) 179.0 (s, C=S), 152.2 (s, N(C=N)N), 136.1, 129.4, 128.9 (3 × s, 
(C=S)NCHNCHCH and C8/9), 124.0 (s, C5/6), 117.9 (s, (C=S)NCHNCHCH), 112.6 (s, 
C4/7). 
 
IR (cm–1, powder film): 1625 (m), 1583 (s), 1509 (m, 1451 (m), 1208 (s), 1050 
(s), 741 (vs).  
 
N-(1H-Benzimidazol-2-yl)thiourea acetate (14-H+ CH3COO
).101 A round 
bottom flask was charged with N-(1H-benzimidazol-2-yl)-1H-imidazole-1-
carbothioamide (15; 5.75 g, 23.6 mmol) and EtOH (180 mL), and NH4
+ CH3COO
 
(18.2 g, 236 mmol) was added with stirring. The mixture was heated at 90 °C, and after 
1.5 h cooled to room temperature. The solvent was removed by rotary evaporation to 
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give an orange oil. Water (300 mL) was added and a white precipitate formed. Addition 
of ethyl acetate (200 mL) gave two clear phases, which were separated. The aqueous 
phase was extracted with ethyl acetate (5 × 200 mL) and the combined organic phases 
were dried (Na2SO4). The solvent was removed by oil pump vacuum to give 14-H
+ 
CH3COO
 as a pale yellow powder (5.24 g, 20.7 mmol, 88%).  
 
NMR (δ, acetone-d6):
104,134 1H (500 MHz) 10.3 (br s, 1H, NH or COOH), 8.17 
(br s, 1 NH), 7.47-7.44 (m, 2H, CH4/7), 7.17-7.14 (m, 2H, CH5/6), 1.97 (s, 3H, 
CH3COO); 
13C{1H} (DMSO-d6, 75.5 MHz) 179.7 (s, C=S), 172.2 (s, CH3COO), 147.9 
(s, N(C=N)N), 122.7 (s, C5/6), 21.2 (s, CH3COO).
135  
 
IR (cm–1, powder film): 3401 (m), 3289 (w), 3165 (w), 1706 (m), 1625 (s), 1598 
(m), 1409 (m), 1054 (m), 749 (vs).  
 
N-(1H-Benzimidazol-2-yl)methylisothiourea iodide (13-H+ I).101 A round 
bottom flask was charged with 14-H+ CH3COO
 (2.34 g. 9.20 mmol) and MeOH (80 
mL). The flask was placed in a 39 °C oil bath and methyl iodide (1.43 g, 10.1 mmol) 
was added dropwise with stirring. After 4 h, the oil bath was removed. The solvent was 
removed by oil pump vacuum and the residue washed with Et2O (3 × 150 mL) to give 
13-H+ I as a white solid (1.68 g, 5.60 mmol, 55%).  
 
NMR (δ, CD3OD):
104 1H (500 MHz) 7.49-7.46 (m, 2H, CH4/7), 7.38-7.34 (m, 
2H, CH5/6), 2.55 (s, 3H, CH3); 
13C{1H} (125 MHz) 170.3 (s, CSMe), 151.2 (s, 
N(C=N)N), 130.7 (s, C8/9), 124.3 (s, C5/6), 112.7 (s, C4/7), 14.7 (s, SCH3).  
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IR (cm–1, powder film): 3240 (w), 3077 (m), 1615 (m), 1581 (s), 1495 (m), 1405 
(m), 750 (vs); UV-visible (nm, 2.94 × 10–5 M in MeOH (ε, M–1cm–1)): 250 (9570), 307 
(20000).  
 
N-(1H-Benzimidazol-2-yl)-N'-(phenylmethyl)guanidine (16a).105,106 A round 
bottom flask was charged with 13-H+ I (0.900 g, 2.69 mmol), benzylamine (1.24 mL, 
1.22 g, 11.4 mmol), and t-BuOH (8 mL), and fitted with a condenser. The mixture was 
heated at 100 °C for 14 h with stirring and cooled to 50 °C. The solvent was removed by 
oil pump vacuum to give a sticky yellow residue, and 3% aqueous NaOH (30 mL) was 
added. The sample was extracted with 95:5 v/v CH2Cl2/MeOH (3 × 30 mL). The 
combined organic phases were dried (Na2SO4). The solvent was removed by rotary 
evaporation and the oily residue was chromatographed on a silica gel column (1.5 × 20 
cm, 95:5 → 90:10 v/v CH2Cl2/MeOH). The solvent was removed from the product 
containing fractions by oil pump vacuum to give 16a as a white solid (0.413 g, 1.56 
mmol, 58%), mp 140 °C (capillary). Anal. Calcd for C15H15N5: C 67.90, H 5.70, N 
26.40. Found: C 67.90, H 5.67, N 25.54.136 
 
NMR (δ, DMSO-d6):
104,105,134 1H (300 MHz) 7.35-7.21 (m, 6H, NH and 
C6H5), 7.20-7.17 (m, 2H, CH4/7), 6.96-6.92 (m, 2H, CH5/6), 4.50 (d, 2H, 
3JHH = 5.4 
Hz, CH2);
137 13C{1H} (75 MHz) 158.5 and 157.8 (2 × s, 2 N(C=N)N), 137.0 (s, C8/9), 
140.1 (s, i-C6H5), 129.8 and 127.3 (2 × s, o- and m-C6H5), 126.9 (s, p-C6H5), 119.8 (s, 
C5/6), 111.9 (s, C4/7), 43.9 (s, CH2).  
 
IR (cm–1, powder film): 3396 (w), 3052 (w), 1608 (m), 1515 (s), 1453 (s), 1268 
(s), 732 (vs); UV-visible (nm, 3.82 × 10–5 M in MeOH (ε, M–1cm–1)): 243 (12300), 300 
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(21500).  
 
N-(1H-Benzimidazol-2-yl)-N'-((S)-1-phenylethyl)guanidine ((SC)-
16b).104,105,107 A round bottom flask was charged with 13-H+ I (0.900 g, 2.69 mmol), 
(SC)-1-phenylethylamine (1.72 mL, 1.63 g, 13.5 mmol), and t-BuOH (8 mL), and fitted 
with a condenser. The mixture was heated at 100 °C for 2 d with stirring and cooled to 
50 °C. The solvent was removed by oil pump vacuum to give a sticky yellow residue, 
and 3% aqueous NaOH (30 mL) was added. The sample was extracted with 95:5 v/v 
CH2Cl2/MeOH (3 × 30 mL). The combined organic phases were dried (Na2SO4). The 
solvent was removed by rotary evaporation and the oily residue was chromatographed 
on a silica gel column (1.5 × 28 cm, 95:5 v/v CH2Cl2/MeOH). The solvent was removed 
from the product containing fractions by oil pump vacuum to give (SC)-16b as a white 
solid (0.345 g, 1.23 mmol, 46%), mp 103 °C (capillary). Anal. Calcd for C16H17N5: C 
68.79, H 6.13, N 25.07. Found C 68.72, H 6.15, N 24.83.  
 
NMR (δ, CDCl3):
104,105,134 1H (500 MHz) 7.33-7.26 (m, 7H, C6H5 and CH4/7), 
7.07-7.04 (m, 2H, CH5/6), 4.59 (q, 1H, 3JHH = 6.8 Hz, CH), 1.54 (d, 3H, 
3JHH = 6.8 Hz, 
CH3);
137 13C{1H} (125 MHz) 157.0 and 156.4 (2 × s, 2 N(C=N)N), 137.0 (C8/9), 142.7 
(s, i-C6H5), 129.2 (s, m-C6H5),
138 125.6 (s, o-C6H5), 127.9 (s, p-C6H5); 120.8 (s, C5/6), 
112.8 (s, C4/7), 52.4 (s, CH), 24.3 (s, CH3).  
 
IR (cm–1, powder film): 3398 (w), 3054 (w), 1597 (m), 1514 (s), 1454 (s), 1282 
(s), 737 (s); UV-visible (nm, 2.65 × 10–5 M in MeOH (ε, M–1cm–1)): 245 (6910), 300 
(16200); [α]24
589 = 17.3° ± 0.2° (2.82 mg mL–1, MeOH).  
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N-(1H-Benzimidazol-2-yl)-N'-((1R,2R)-N'',N''-dimethyl-1,2-
diaminocyclohexyl)guanidine ((RCRC)-16c).
104,105,107 A round bottom flask was 
charged with 13-H+ I (0.473 g, 1.42 mmol), (RCRC)-N'',N''-dimethyl-1,2-
diaminocyclohexane (0.222 g, 1.56 mmol),139 and t-BuOH (10 mL), and fitted with a 
condenser. The mixture was heated at 100 °C for 2 d with stirring and cooled to 50 °C. 
The solvent was removed by oil pump vacuum to give a beige solid, and 3% aqueous 
NaOH (30 mL) was added. The sample was extracted with 95:5 v/v CH2Cl2/MeOH (3 × 
30 mL). The combined organic phases were dried (Na2SO4). The solvent was removed 
by rotary evaporation and the oily residue was chromatographed on a silica gel column 
(1.5 × 25 cm, 8.0:2.0:0.05 → 8.0:2.0:0.10 v/v/v CH2Cl2/MeOH/NEt3). The solvent was 
removed from the product containing fractions by oil pump vacuum to give (RCRC)-16c 
as a white solid (0.255 g, 0.850 mmol, 61%). An analytical sample was further purified 
by precipitation from CH2Cl2/pentane and subsequent recrystallization from Et2O, mp 
186 °C (capillary). Anal. Calcd for C16H24N6: C 63.97, H 8.05, N 27.98. Found C 
62.78, H 8.06, N 27.10.136  
 
NMR (δ, CDCl3):
104,105,134 1H (400 MHz) 7.30-7.27 (m, 2H, CH4/7), 7.04-7.01 
(m, 2H, CH5/6), 3.44 (td, 1H, 3JHH = 10.4 Hz, 
3JHH = 3.6 Hz, CHNH), 2.38-2.33 (m, 
2H), 2.24 (s, 6H, N(CH3)2), 1.83-1.77, 1.75-1.68, 1.63-1.57, 1.25-1.05 (4 x m, 1H, 1H, 
1H, 4H, remaining aliphatic CH);137 13C{1H} (100 MHz) 158.5 and 158.1 (2 × s, 2 
N(C=N)N), 137.3 (s, C8/9), 120.2 (s, C5/6), 112.6 (s, C4/7), 67.2 (s, CHN(CH3)2), 52.8 
(s, CHNH), 39.9 (s, N(CH3)2), 33.7, 24.8, 24.4, 21.9 (4 × s, remaining CH2).  
 
IR (cm–1, powder film): 3398 (w), 2931 (m), 2858 (m), 1603(m), 1518 (vs), 1454 
(s), 1261 (s), 734 (s); UV-visible (nm, 2.77 × 10–5 M in MeOH (ε, M–1cm–1)): 245 
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(5860), 300 (15100); [α]24
589 = –35.4° ± 0.4° (2.78 mg mL–1, MeOH).  
 
N-(1H-benzimidazol-2-yl)-N'-((1R,2R)-N''-piperidinyl-1,2-
diaminocyclohexyl)guanidine ((RCRC)-16d). A round bottom flask was charged with 
13-H+ I (0.781 g, 2.34 mmol), (RCRC)-N''-piperidinyl-1,2-diaminocyclohexane (0.468 
g, 2.57 mmol),140 and t-BuOH (16 mL), and fitted with a condenser. The mixture was 
heated at 100 °C for 3 d with stirring and cooled to 50 °C. The solvent was removed by 
oil pump vacuum to give a beige solid, and 3% aqueous NaOH (30 mL) was added. The 
sample was extracted with 95:5 v/v CH2Cl2/MeOH (3 × 30 mL). The combined organic 
phases were dried (Na2SO4). The solvent was removed by rotary evaporation and the 
oily residue was chromatographed on a silica gel column (1.5 × 25 cm, 8.0:2.0:0.05 → 
8.0:2.0:0.10 v/v/v CH2Cl2/MeOH/NEt3). The solvent was removed from the product 
containing fractions by oil pump vacuum to give (RCRC)-16d as a pale yellow solid 
(0.318 g, 0.936 mmol, 40%), mp 283 °C (capillary). Anal. Calcd for C19H28N6: C 67.03, 
H 8.29, N 24.68. Found C 66.90, H 8.38, N 24.60. 
 
NMR (δ, CD3OD):
134 1H (500 MHz) 7.27-7.25 (m, 2H, CH4/7), 7.02-7.00 (m, 
2H, CH5/6), 3.73-3.68 (m, 1H, CHNH), 2.90 (br s, 2H), 2.59 (br s, 2H), 2.52-2.48, 2.31-
2.29, 2.01-1.99, 1.85-1.83, 1.74-1.72, 1.65-1.50, 1.44-1.24 (7 x m, 3H, 1H, 1H, 1H, 1H, 
5H, 7H, remaining aliphatic CH);137 13C{1H} (125 MHz) 159.4 and 158.9 (2 × s, 2 
N(C=N)N), 133.7 (s, C8/9), 121.5 (s, C5/6), 113.3 (s, C4/7), 70.6 (s, 
CHNCH2(CH2)3CH2), 52.8, 51.1 (2 × s , CH2NCH2 and CHNH), 34.5, 27.0, 26.3, 25.8, 
25.2 (5 × s, CH2CH2CH2CH2 and CH2CH2NCH2CH2). The NCH2CH2CH2 signal was 
not observed and the remaining signals were of approximately equal intensity, although 
that for CH2CH2NCH2CH2 should be doubled. 
 117 
 
 
IR (cm–1, powder film): 3273 (w), 2929 (m), 2854 (m), 1610 (m), 1517 (vs), 
1456 (s), 1271 (s), 734 (s).  
 
[(η5-C5H5)Ru(CO)(16a)]
+ PF6
– (18a+ PF6
–).105,106 A round bottom flask was 
charged with [(η5-C5H5)Ru(CO)(NCCH3)2]
+ PF6
– (17+ PF6
–;74,104 0.100 g, 0.237 
mmol), 16a (0.063 g, 0.24 mmol), CH2Cl2 (2 mL), and MeOH (1 mL) with stirring. 
After 2 d, the solvent was removed by oil pump vacuum and the residue was 
chromatographed on a silica gel column (1 × 15 cm, 3:1 v/v CH2Cl2/CH3CN). The 
solvent was removed from the product containing fractions. The sticky yellow solid was 
dissolved in CH2Cl2 (5 mL), and pentane was added until a precipitate formed. The 
solvent was removed by oil pump vacuum. More pentane (5 mL) was added and 
removed by oil pump vacuum (2 ×) to give 18a+ PF6
– as a yellow powder (0.082 g, 
0.136 mmol, 58%). Anal. Calcd for C21H20F6N5OPRu: C 41.73, H 3.34, N 11.59. 
Found C 41.48, H 3.64, N 10.72.136  
 
NMR (δ, CD3CN):
104,105,134 1H (300 MHz) 7.43-7.35, 7.26-7.19 (2 × m, 6H, 
3H, CH4-7 and C6H5), 6.38 (br s, 1H, NH), 5.34 (br s, 1H, NH), 4.88 (s, 5H, C5H5), 
4.44 (d, 2H, 3JHH = 6.0 Hz, CH2);
137 13C{1H} (75 MHz) 205.9 (s, CO), 153.5 (s, C11), 
146.5 (s, C2), 143.5 (s, C9), 132.5 (s, C8), 138.0 (s, i-C6H5), 128.5 and 128.2 (2 × s, o- 
and m-C6H5), 128.8 (s, p-C6H5), 124.4 and 123.9 (2 × s, C5 and C6), 118.5 (s, C4), 
112.1 (s, C7), 83.0 (s, C5H5), 45.6 (s, CH2); 
31P{1H} (121 MHz) –143.3 (sep, 1JPF = 
706.5 Hz).  
 
IR (cm–1, powder film): 3391 (m), 1940 (s, νCO), 1671 (s), 1570 (s), 1536 (s), 
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1463 (s), 1230 (m), 831 (vs), 736 (s), 556 (vs); UV-visible (nm, 1.99 × 10–5 M in MeOH 
(ε, M–1cm–1)): 292 (8150).  
 
(RRuSC/SRuSC)-[(η
5-C5H5)Ru(CO)(16b)]
+ PF6
– ((RRuSC/SRuSC)-18b
+ PF6
–
).104,105,107 A round bottom flask was charged with 17+ PF6
– (0.100 g, 0.237 mmol), 
(SC)-16b (0.066 g, 0.24 mmol), CH2Cl2 (2 mL), and MeOH (1 mL) with stirring. After 2 
d, the solvent was removed by oil pump vacuum and the residue was chromatographed 
on a silica gel column (1 × 15 cm, 3:1 v/v CH2Cl2/CH3CN). The solvent was removed 
from the product containing fractions. The sticky yellow solid was dissolved in CH2Cl2 
(5 mL), and pentane was added until a precipitate formed. The solvent was removed by 
oil pump vacuum. More pentane (5 mL) was added and removed by oil pump vacuum (2 
×) to give (RRuSC/SRuSC)-18b
+ PF6
– as a yellow powder (0.103 g, 0.168 mmol, 71%) 
and a 54:46 mixture of Ru,C configurational diastereomers. Anal. Calcd for 
C22H22F6N5OPRu: C 42.72, H 3.59, N 11.32. Found C 43.00, H 4.19, N 10.38.
136  
 
NMR (δ, CD3CN; signals for diastereomers are separated by slashes):
104,105,134 
1H (300 MHz) 7.47-7.18 (m, 9H, CH4-7 and C6H5), 6.26 (br m, 1H, NH), 5.11 (br s, 
1H, NH), 5.05/4.60 (2 × s, 54:46, 5H, C5H5), 4.77-4.66 (m, 1H, CH), 1.51/1.49 (2 × d, 
3H, 3JHH = 4.8/4.8 Hz, CH3);
137 13C{1H} (75 MHz) 205.9/205.4 (2 × s, CO), 
152.9/152.7 (2 × s, C11), 146.2/146.0 (2 × s, C2), 143.8, 143.35, 143.31, 143.26 (4 × s, 
C9 and i-C6H5 diastereomers), 132.4/132.3 (2 × s, C8), 129.90/129.87 (2 × s, m-
C6H5),
138 126.9/126.8 (2 × s, o-C6H5), 128.9/128.8 (2 × s, p-C6H5), 124.47/124.45, 
124.03/124.00 (4 × s, C5 and C6), 118.60/118.53 (2 × s, C4), 112.1 (s, C7), 83.1/82.8 (2 
× s, C5H5), 52.7/52.5 (2 × s, CH), 23.7/23.6 (2 × s, CH3); 
31P{1H} (121 MHz) –143.2 
(sep, 1JPF = 706.6 Hz).  
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IR (cm–1, powder film): 3402 (m), 1943 (s, νCO), 1670 (s), 1570 (s), 1537 (s), 
1463 (s), 1229 (m), 833 (vs), 738 (s), 556 (vs); UV-visible (nm, 1.88 × 10–5 M in MeOH 
(ε, M–1cm–1)): 295 (8050), 322 (4480); [α]24
589 = –15.4° ± 0.4° (1.94 mg mL–1, 
MeOH).  
 
(RRuRCRC/SRuRCRC)-[(η
5-C5H5)Ru(CO)(16c)]
+ PF6
– ((RRuRCRC/SRuRCRC)-
18c+ PF6
–).104,109 A round bottom flask was charged with 17+ PF6
– (0.090 g, 0.21 
mmol), (RCRC)-16c (0.064 g, 0.21 mmol), CH2Cl2 (2 mL), and MeOH (1 mL) with 
stirring. After 2 d, the solvent was removed by oil pump vacuum and the residue was 
chromatographed on an alumina column (1 × 10 cm, 100:1 → 95:5 v/v CH2Cl2/MeOH). 
An impurity eluted first, followed by impurity/product fractions, and then product 
containing fractions. The solvent was removed from the last set to give a yellow brown 
solid. The solid was dissolved in CH2Cl2 (5 mL) and added to a suspension of Na
+ PF6
– 
(0.143 g, 0.851 mmol) in CH2Cl2 (5 mL). The mixture was stirred overnight, and filtered 
through a plug of Celite (1 × 5 cm), which was washed with CH2Cl2 (150 mL). The 
solvent was removed from the filtrate by rotary evaporation. The sticky yellow solid was 
dissolved in CH2Cl2 (5 mL), and pentane was added until a precipitate formed. The 
solvent was removed by oil pump vacuum. More pentane (5 mL) was added and 
removed by oil pump vacuum (2 ×) to give (RRuRCRC/SRuRCRC)-18c
+ PF6
– as a green 
brown powder (0.078 g, 0.119 mmol, 57%) as a mixture of Ru,C configurational 
diastereomers.141  
 
NMR (δ, CD3CN; signals for diastereomers are separated by slashes):
104,134 1H 
(300 MHz) 7.36-7.25 (m, 1H, CH4/7), 7.19-7.05 (m, 3H, CH7/4, CH5, and CH6), 5.17-
5.12 (br m, 1H, NH), 5.08/5.05 (2 × s, 5H, C5H5), 3.71-3.53 (two overlapping br m, 1H, 
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CHNH), 3.07-2.84 (m, 1H, CHN(CH3)2), 2.77/2.75 (2 × s, 6H, N(CH3)2), 2.09-2.00, 
1.92-1.81, 1.80-1.70, 1.55-1.23 (4 × m, 2H, 1H, 1H, 4H, remaining aliphatic CH);137 
13C{1H} (125 MHz) 207.7/207.1 (2 × s, CO), 157.0 (br s, C11), 151.0 (br s, C2), 
144.6/144.5 (2 × s, C9), 132.92/132.85 (2 × s, C8), 123.1/123.0142/122.9 (3 × s, C5 and 
C6), 117.63/117.59 (2 × s, C4), 111.0/110.8 (2 × s, C7), 83.6/83.5 (2 × s, C5H5), 
72.0/70.9 (2 × s, CHN(CH3)2), 53.0/52.0 (2 × s, CHNH), 41.2/41.0 (2 × br s, N(CH3)2), 
33.3/33.2 (2 × s, CH2), 24.90, 24.87, 24.52, 24.46, 24.42, 24.00 (6 × s, remaining 3 
CH2).  
 
IR (cm–1, powder film): 3395 (m), 2948 (m), 2866 (w), 1927 (s, νCO), 1673 (m), 
1588 (m), 1535 (s), 1464 (s), 1256 (m), 823 (vs), 738 (s), 555 (vs); UV-visible (nm, 2.20 
× 10–5 M in MeOH (ε, M–1cm–1)): 296 (4480), 318 (4180).  
 
Separation of diastereomers of 18c+ PF6
–. A round bottom flask was charged 
with 17+ PF6
– (0.545 g, 1.29 mmol), (RCRC)-16c (0.510 g, 1.70 mmol), CH2Cl2 (12 
mL), and MeOH (6 mL) with stirring. After 3 d, the solvent was removed by oil pump 
vacuum and the residue was chromatographed on alumina column (3 × 20 cm with 
CH2Cl2/MeOH, 100:2.5 v/v (1000 mL) → 100:3.0 v/v (500 mL) → 100:3.5 v/v (500 
mL) → 100:4.0 v/v (500 mL) → 100:6.0 v/v (500 mL) → 100:10.0 v/v (500 mL)). 
Three fractions, the first and the third containing one diastereomer and the second a 
mixture, were collected. The solvents were removed from the first and third fractions by 
rotary evaporation to give (RRuRCRC)-18c
+ X– (0.290 g) and (SRuRCRC)-18c
+ X– (0.220 
g) as pale yellow brown and pale brown solids, respectively, where X– is principally 
derived from the alumina (<10% PF6
–). 
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(RRuRCRC)-18c
+ X–. NMR (δ, CD3CN):
134 1H (500 MHz) 7.24-7.22 (m, 1H, 
CH4/7), 7.07-6.98 (m, 3H, CH5, CH6, and CH4/7), 6.42 (br s, 2H, NH), 6.14 (br s, 1H, 
NH), 5.22 (br s, 1H, NH), 5.04 (s, 5H, C5H5), 3.33-3.31 (m, 1H, CHNH), 2.31-2.27 (m, 
1H, CHN(CH3)2), 2.23-2.19 (m, 1H), 2.08 (s, 6H, N(CH3)2), 1.80-1.74, 1.67-1.65, 1.32-
1.13 (3 × m, 1H, 1H 4H, remaining aliphatic CH); 13C{1H} (125 MHz) 207.6 (s, CO), 
157.0 (s, C11), 153.2 (s, C2), 146.0 (s, C9), 138.4 (s, C8), 121.3, 121.0 (2 × s, C5 and 
C6), 116.5 (s, C4), 112.9 (s, C7), 83.4 (s, C5H5), 67.9 (s, CHN(CH3)2), 52.9 (s, 
CHNH), 40.3 (s, N(CH3)2), 33.5 (s, CH2), 25.6, 25.1, 22.7 (3 × s, remaining 3 CH2).  
 
(SRuRCRC)-18c
+ X–. NMR (δ, CD3CN):
134 1H (500 MHz) 7.19-7.18 (m, 1H, 
CH4/7), 7.05-6.98 (m, 2H, CH5 and CH6), 5.92 (br s, 1H, NH), 5.27 (br s, 2H, NH), 
5.07 (s, 5H, C5H5), 4.89 (br s, 1H, NH), 3.41-3.28 (m, 1H, CHNH), 2.39-2.33 (m, 1H, 
CHN(CH3)2), 2.26 (s, 6H, N(CH3)2), 2.09-2.05, 1.86-1.84, 1.77-1.74, 1.65-1.62, 1.34-
1.10 (5 × m, 1H, 1H, 1H, 1H, 4H, remaining aliphatic CH);137 13C{1H} (125 MHz) 
207.6 (s, CO), 157.7 (s, C11), 153.4 (s, C2), 145.8 (s, C9), 136.8 (s, C8), 121.4, 121.3 (2 
× s, C5 and C6), 116.4 (s, C4), 112.0 (s, C7), 83.7 (s, C5H5), 68.1 (s, CHN(CH3)2), 53.0 
(s, CHNH), 40.5 (s, N(CH3)2), 34.4 (s, CH2), 25.5, 25.2, 22.9 (3 × s, remaining 3 CH2). 
 
 
A round bottom flask was charged with (RRuRCRC)-18c
+ X– (0.049 g, ca. 0.1 
mmol if the mass is considered to represent the cation) and CH2Cl2 (5 mL) and was 
placed in a –40 °C cold bath. Then NH4
+ PF6
– (0.143 g, 0.851 mmol) was added with 
stirring. After 17 h, the mixture was filtered through a plug of Celite (0.1 × 3 cm), which 
was washed with additional CH2Cl2 (2 mL). The solvent was removed from the filtrate 
by rotary evaporation. The sticky yellow brown solid was dissolved in CH2Cl2 (1 mL), 
and pentane was added until a precipitate formed. The solvent was removed by oil pump 
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vacuum. More pentane (5 mL) was added and removed by oil pump vacuum (2 ×) to 
give (RRuRCRC)-18c
+ PF6
– as a yellow brown powder (0.032 g, 0.050 mmol; 99:01 
RRuRCRC/SRuRCRC, configurations assigned crystallographically). Anal. Calcd for 
C22H29F6N6OPRu: C 41.32, H 4.57, F 17.82, N 13.14. Found C 40.92, H 4.92, F 16.24, 
N 12.19.136  
 
NMR (δ, CD3CN):
134 1H (500 MHz) 7.22 (d, 1H, 3JHH = 7.7 Hz, CH4/7), 7.12-
7.05 (m, 3H, CH5, CH6, and CH4/7), 5.04 (s, 5H, C5H5), 4.97 (br s, 1H, NH) 4.65 (br s, 
1H, NH), 3.59-3.55 (m, 1H, CHNH), 2.82-2.74 (m, 1H, CHN(CH3)2), 2.74 (s, 6H, 
N(CH3)2), 2.05-2.03, 1.86-1.83, 1.75-1.77, 1.48-1.40, 1.36-1.24 (5 × m, 2H, 1H, 1H, 
1H, 3H, remaining aliphatic CH);137 13C{1H} (125 MHz) 208.1 (s, CO), 160.2 (s, C11), 
153.7 (s, C2), 144.9 (s, C9), 133.1 (2 × s, C8), 122.5, 122.4 (2 × s, C5 and C6), 117.3 (s, 
C4), 110.4 (s, C7), 83.6 (s, C5H5), 72.8 (s, CHN(CH3)2), 53.4 (s, CHNH), 41.3 (s, 
N(CH3)2), 33.1, 24.9, 24.6, 24.6 (4 × s, remaining 4 CH2); 
19F{1H} (470 MHz) –72.89 
(d, 1JFP = 706.41 Hz).  
 
IR (cm–1, powder film): 3412 (m), 2937 (m), 2866 (w), 1923 (s, νCO), 1680 (m), 
1589 (m), 1535 (s), 1463 (s), 1255 (m), 1222 (m), 833 (vs), 740 (s); UV-visible (nm, 
2.20 × 10–5 M in MeOH (ε, M–1cm–1)): 294 (11923), 314 (10384); CD (nm, 2.6 × 10–3 
M in CH3CN ([θ], deg·L·mol
–1cm–1 and Δε, L·mol–1cm–1)): 408 (–268 and –0.089), 
368 (+58.0 and +0.019). 
 
A round bottom flask was charged with (SRuRCRC)-18c
+ X– (0.049 g, 0.1 mmol 
if the mass is considered to represent the cation) and CH2Cl2 (5 mL) and was placed in a 
–40 °C cold bath. Then NH4
+ PF6
– (0.143 g, 0.851 mmol) was added with stirring. After 
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17 h, mixture was filtered through a plug of Celite (0.1 × 3 cm), which was washed with 
additional CH2Cl2 (2 mL). The solvent was removed from the filtrate by rotary 
evaporation. The sticky yellow brown solid was dissolved in CH2Cl2 (1 mL), and 
pentane was added until a precipitate formed. The solvent was removed by oil pump 
vacuum. More pentane (5 mL) was added and removed by oil pump vacuum (2 ×) to 
give (SRuRCRC)-18c
+ PF6
– as a green brown powder (0.028 g, 0.045 mmol; 02:98 
RRuRCRC/SRuRCRC, configurations assigned crystallographically). Anal. Calcd for C22-
H29N6F6PORu: C 41.32, H 4.57, F 17.82, N 13.14. Found C 40.90, H 4.88, F 17.16, N 
12.40.136  
 
NMR (δ, CD3CN):
134 1H (500 MHz) 7.19 (d, 1H, 3JHH = 7.2 Hz, CH4/7), 7.11-
7.05 (m, 2H, CH5 and CH6), 6.99 (d, 1H, 3JHH = 7.3 Hz, CH4/7), 5.08 (s, 5H, C5H5), 
4.84 (br s, 1H, NH) 4.68 (br s, 1H, NH); 3.74-3.70 (m, 1H, CHNH), 2.86-2.81 (m, 1H, 
CHN(CH3)2), 2.75 (s, 6H, N(CH3)2), 2.04-2.02, 1.87-1.84, 1.76-1.75, 1.50-1.24 (4 × m, 
2H, 1H, 1H, 4H, remaining aliphatic CH);137 13C{1H} (125 MHz) 208.1 (s, CO), 159.7 
(s, C11), 154.0 (s, C2), 145.2 (s, C9), 133.0 (s, C8), 122.3, 122.1 (2 × s, C5 and C6), 
117.0 (s, C4), 110.1 (s, C7), 83.9 (s, C5H5), 72.4 (s, CHN(CH3)2), 52.6 (s, CHNH), 41.2 
(s, N(CH3)2), 33.4 (s, CH2), 25.0, 24.6, 24.1 (3 × s, remaining 3 CH2); 
19F{1H}(470 
MHz) –72.88 (d, 1JFP = 706.37 Hz). 
 
 
IR (cm–1, powder film): 3392 (m), 2937 (m), 2864 (w), 1925 (s, νCO), 1672 (m), 
1589 (m), 1535 (s), 1463 (s), 1255 (m), 1220 (m), 833 (vs), 738 (s); UV-visible (nm, 
2.20 × 10–5 M in MeOH (ε, M–1cm–1)): 294 (10400), 315 (8400); CD (nm, 2.7 × 10–3 
M in CH3CN ([θ], deg·L·mol
–1cm–1 and Δε, L·mol–1cm–1)): 406 (+672 and +0.204), 
372 (sh, +441 and +0.133). 
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(RRuRCRC)-18c
+ (Δ)-TRISPHAT–. A round bottom flask was charged with 
(RRuRCRC)-18c
+ X– (0.010 g, ca. 0.2 mmol based upon cation mass), CH2Cl2 (1.0 mL), 
and water (0.5 mL). Then Na+ (Δ)-TRISPHAT– (0.015 g, 0.019 mmol; ca. 95% purity 
by 1H NMR)26 was added with stirring. After 1.5 h, the organic layer was washed with 
water (2  0.5 mL). The organic layer was dried (Na2SO4) and filtered through a plug of 
Celite. The solvent was removed from the filtrate by rotary evaporation. The sticky 
yellow brown solid was dissolved in CH2Cl2 (1 mL), and hexane was added until a 
precipitate formed. The solvent was removed by oil pump vacuum. More hexane (1 mL) 
was added and removed by oil pump vacuum (2 ×) to give (RRuRCRC)-18c
+ (Δ)-
TRISPHAT– as a yellow powder (0.015 g, >99:<01 RRuRCRC/SRuRCRC) of ca. 95% 
purity. For a microanalysis, see the sample used for crystallography below. 
 
NMR (δ, CDCl3):
134 1H (500 MHz) 9.56 (br s, 1H, NH) 7.32-7.29 (m, 1H, 
CH4/7), 7.26-7.21 (m, 2H, CH5, CH6), 7.17-7.15 (m, 1H CH7/4), 5.85 (br s, 1H, NH), 
5.03 (s, 5H, C5H5), 4.81 (s, 1H, NH), 2.95-2.90 (m, 1H, CHNH), 2.00 (s, 6H, N(CH3)2), 
1.98-1.91, 1.88-1.70, 1.68-1.55, 1.22-1.09 (4 × m, 1H, 3H, 3H, 4H, CHN(CH3)2, NH, 
and remaining aliphatic CH); 13C{1H} (125 MHz) 203.8 (s, CO), 153.4 (s, C11), 145.7 
(s, C2), 142.3 (s, C9), 141.1 (d, 2JCP = 6.4 Hz, P(O2C6Cl4), 130.9 (s, C8), 123.6 (s, 
C5/C6), 123.5 (s, P(O2C6Cl4), 123.3 (s, C5/C6), 117.2 (s, C4), 114.5 (d, 
2JCP = 19.2 
Hz, P(O2C6Cl4), 111.4 (s, C7), 81.8 (s, C5H5), 66.8 (s, CHN(CH3)2), 51.4 (s, CHNH), 
39.9 (s, N(CH3)2), 34.7 (s, CH2), 25.3, 24.7, 24.1, (3 × s, remaining 3 CH2); 
31P{1H} 
(202 MHz) –81.2 (s, P(O2C6Cl4)).
 
 
IR (cm–1, powder film): 3383 (m), 2958 (m), 2864 (w), 1940 (s, νCO), 1668 (m), 
1591 (m), 1537 (m), 1446 (s), 1390 (m), 1236 (m), 989 (s), 821 (vs), 740 (m), 719 (m), 
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671 (s).  
 
(RRuRCRC)-18c
+ (/)-TRISPHAT–. A round bottom flask was charged with 
(RRuRC RC)-18c
+ X– (0.010 g, ca. 0.02 mmol based upon cation mass) and CH2Cl2 (0.5 
mL). Then (n-Bu)3NH
+ (±)-TRISPHAT– (0.057 g, 0.059 mmol)143 was added with 
stirring. After 10 min, the mixture was filtered and the filtrate was cooled to −35 °C. 
After a few hours, white crystals began to form. After 48 h, the mixture was filtered and 
the solvent was removed from the filtrate by rotary evaporation to give a pale white solid 
containing a 1:2 mixture of the cations (RRuRCRC)-18c
+ and (n-Bu)3NH
+, as assayed by 
1H and 13C NMR, together with X– and (±)-TRISPHAT– anions. The NMR signals for 
(RRuRCRC)-13c
+ were very similar to those from the preceding preparation. A crystal 
structure of a complex derived from this sample is described below.  
 
(RRuRCRC/SRuRCRC)-[(η
5-C5H5)Ru(CO)(16d)]
+ PF6
– (RRuRCRC/SRuRCRC)-
18d+ PF6
–). A round bottom flask was charged with 17+ PF6
– (0.090 g, 0.21 mmol), 
(RCRC)-16d (0.064 g, 0.21 mmol), CH2Cl2 (2 mL), and MeOH (1 mL). The mixture was 
stirred for 2 d at room temperature. The solvent was removed by oil pump vacuum and 
the residue was chromatographed on an alumina column (1 × 10 cm, 100:1 v/v → 95:5 
v/v CH2Cl2/MeOH). The solvent was removed from the product containing fractions. 
The yellow brown solid was dissolved in CH2Cl2 (5 mL) and added to a suspension of 
Na+ PF6
– (0.143 g, 0.851 mmol) in CH2Cl2 (5 mL). The mixture was stirred overnight, 
and filtered through a plug of Celite (1 × 5 cm), which was washed with CH2Cl2 (150 
mL). The solvent was removed from the filtrate by rotary evaporation. The sticky yellow 
solid was dissolved in CH2Cl2 (5 mL), and pentane was added until a precipitate formed. 
The solvent was removed by oil pump vacuum. More pentane (5 mL) was added and 
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removed by oil pump vacuum (2 ×) to give (RRuRCRC/SRuRCRC)-18d
+ PF6
– as a green 
brown powder (0.055 g, 0.082 mmol, 39%) as a mixture of Ru,C configurational 
diastereomers.141 Anal. Calcd for C25H33F6N6PORu: C 44.18, H 4.89, F 16.77, N 
12.37. Found C 43.90, H 4.88, F 16.56, N 11.70.136  
 
NMR (δ, CD2Cl2; signals for diasteromers are separated by slashes):
134 1H (500 
MHz) 8.24 (br s, 2H, NH), 7.28-7.75 (m, 1H, CH4/7), 7.15-7.03 (m, 3H, CH5, CH6, 
and CH7/4), 6.52-6.18 (2  br s, 1.5H, NH), 5.08/5.05 (2 × s, 5H, C5H5), 4.80 (s, 0.5H, 
NH), 3.44-3.38, 3.22-3.16 (2 × m, 1H, CHNH), 2.65-2.67, 2.59-2.51, 2.47-2.37, 2.32-
2.07, 1.95-1.84, 1.82-1.10 (6 × m, 1H, 1H, 3H, 1H, 4H, 11H, remaining aliphatic CH); 
13C{1H} (125 MHz) 205.8/205.4 (2 × s, CO), 156.1/156.0 (2 × s, C11), 150.0/149.7 (2 
× s, C2), 143.9 (s, C9), 134.1/133.8 (2 × s, C8), 122.2/122.0/121.9/121.7 (4 × s, C5 and 
C6), 116.7/116.1 (2 × s, C4), 112.4/111.7 (2 × s, C7), 82.6 (s, C5H5), 69.8/68.7 (2 × s, 
CHNCH2(CH2)3CH2), 53.2/50.2 (2 × s, CHNH), 34.3/33.4 (2 × s, 
CHNCH2(CH2)3CH2), 30.1 (s, CH2), 26.8/26.6, 25.7/25.6, 25.2/25.1, 25.0/24.9, 
24.3/24.2 (5 × s, remaining CH2).
 
 
Friedel-Crafts alkylation of indoles with trans-β-nitrostyrene (Table 3.3). An 
NMR tube was charged with catalyst (0.0013 g, 0.0020 mmol), an indole (5a,b; 0.040 
mmol), 6 (0.0029 g, 0.020 mmol), an internal standard (Ph2SiMe2), and CD2Cl2 (0.3 
mL). The tube was capped and 1H NMR spectra were periodically recorded. The 
CH=CH signals of 6 and the product CH2NO2 signals at ca. 5 ppm were integrated 
versus those of the standard. After the specified time (Table 3.3), the solvent was 
removed. The residue was taken up in hexane/ethyl acetate (30:70 v/v) and passed 
through a short silica gel column, which was washed with additional hexane/ethyl 
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acetate (50:50 v/v, 5 mL). The solvent was removed, and a second silica gel 
chromatography step was carried out (column length substrate dependent). The solvent 
was removed from the product containing fractions (yields, Table 3.3). 
 
1-Methyl-3-(2-nitro-1-phenylethyl)-1H-indole (7a, entry 1). NMR (, CDCl3) 
1H (500 MHz): 7.47 (d, 1H, 3JHH = 7.6 Hz), 7.38–7.23 (m, 7H), 7.10 (m, 1H), 6.88 (s, 
1H), 5.21 (t, 1H, 3JHH = 8.0 Hz, CHCH2NO2), 5.06 (dd, 1H, 
3JHH = 12.4, 
2JHH = 8.0 
Hz, CHH'NO2), 4.95 (dd, 1H, 
3JHH = 12.4, 
2JHH = 8.0 Hz, CHH'NO2), 3.75 (s, 3H, 
NCH3); Literature chemical shift values (CDCl3) agree within 0.01 ppm.
68a  
 
The enantiomeric excess was determined by HPLC with a Chiralpak AS-H 
column, hexane/2-PrOH (90:10 v/v), 1.0 mL/min, λ = 210 nm; tR = 14.6 min (minor, R), 
18.6 min (major, S).144,145  
 
3-(2-Nitro-1-phenylethyl)-1H-indole (7b, entry 2). NMR (, CDCl3) 
1H (500 
MHz): 8.08 (br s, 1H, C8H5NH), 7.55-6.96 (m, 10H, C8H5NH and C6H5), 5.19 (t, 1H, 
3JHH = 8.2 Hz, CHCH2NO2), 5.07 (dd, 1H, 
2JHH = 12.4 Hz, 
3JHH = 7.2 Hz, CHH'NO2), 
4.95 (dd, 1H, 2JHH = 12.4 Hz, 
3JHH = 8.2 Hz, CHH'NO2). Literature values 
(CDCl3)
119b agree within 0.01 ppm, and data in CD2Cl2 are supplied elsewhere.
70  
 
The enantiomeric excess was determined by HPLC with a Chiralcel AD column, 
hexane/2-PrOH (70:30 v/v), 0.9 mL/min, λ = 210 nm; tR = 18.2 min (minor, R), 19.6 
min (major, S).145,146  
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Additions of dialkyl malonates to nitroalkenes (Table 3.4, Figure 3.5). A J. 
Young NMR tube was charged with 6 (e.g. Table 3.4, entry 1 or Figure 3.5, red/blue 
triangles: 0.0149 g, 0.100 mmol), catalyst (0.010 mmol, 10 mol%), Ph2SiMe2 (ca. 0.050 
mmol; internal standard), and CD2Cl2 (0.5 mL, Table 3.4; 0.7 mL, Figure 3.5). Then the 
malonate ester (10a-c; 0.200 mmol, Table 3.4; 0.180 mmol, Figure 3.5) was added and 
the tube was capped. Product formation was monitored vs. the standard by 1H NMR 
(Figure 3.5). After the specified time (Table 3.4), the solvent was removed. The residue 
was taken up in hexane/ethyl acetate (30:70 v/v) and passed through a short silica gel 
column, which was washed with additional hexane/ethyl acetate (30:70 v/v, 5 mL). The 
solvent was removed, and a second silica gel chromatography step was carried out 
(column length substrate dependent). The solvent was removed from the product 
containing fractions (yields, Table 3.4).  
 
Ethyl-2-carboethoxy-4-nitro-3-phenylbutyrate (19a, entry 1).121,147 NMR (δ, 
CDCl3): 
1H (500 MHz) 7.32-7.23 (m, 5H), 4.92 (dd, 1H, J = 13.2, 4.7 Hz), 4.86 (dd, 1H, 
J = 13.2, 9.5 Hz), 4.26-4.17 (m, 3H), 4.00 (q, 2H, J = 7.1 Hz), 3.82 (d, 1H, J = 9.3 Hz), 
1.25 (t, 3H, J = 7.1 Hz), 1.03 (t, 3H, J = 7.1 Hz); 13C{1H} (125 MHz) 167.4, 166.7, 
136.2, 128.8, 128.3, 127.9, 77.6, 62.1, 61.8, 55.0, 42.9, 13.9, 13.6. 
 
The enantiomeric excess was determined by HPLC with a Chiralpak AS-H 
column, hexane/2-PrOH (90:10 v/v), 1.0 mL/min, λ = 220 nm; tR = 11.8 min (minor, S), 
13.4 min (major, R).145,148  
 
Ethyl-2-carboethoxy-4-nitro-3-(3,4-dichlorophenyl)butyrate (19b, entry 
2).147,149 NMR (δ, CDCl3): 
1H (500 MHz) 7.40 (d, 1H, J = 8.3 Hz), 7.36 (d, 1H, J = 2.0 
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Hz), 7.11 (dd, 1H, J = 2.0, 8.3 Hz), 4.87 (m, 2H), 4.22 (m, 3H), 4.08 (q, 2H, J = 7.3 Hz), 
3.76 (d, 1H, J = 8.8 Hz), 1.27 (t, 3H, J = 7.1 Hz), 1.13 (t, 3H, J = 7.1 Hz); 13C{1H} (125 
MHz) 167.2, 166.6, 136.8, 133.3, 132.9, 131.0, 130.4, 127.6, 77.2, 62.5, 62.3, 54.8, 42.2, 
14.1, 13.9.  
 
The enantiomeric excess was determined by HPLC with a Chiralcel OD column, 
hexane/2-PrOH (94:06 v/v), 1.0 mL/min, λ = 215 nm; tR = 20.3 min (major), 22.8 min 
(minor).150  
 
Ethyl-2-carboethoxy-4-nitro-3-(3,4-methylenedioxyphenyl)butyrate (19c, 
entry 3).121,147 NMR (δ, CDCl3): 
1H (500 MHz) 6.73-6.67 (m, 3H), 5.93 (s, 2H), 4.87 
(dd, 1H, J = 13.2, 4.6 Hz), 4.78 (dd, 1H, J = 13.2, 9.4 Hz), 4.27-4.17 (m, 2H), 4.14 (ddd, 
1H, J = 9.4, 9.4, 4.6 Hz), 4.04 (q, 2H, J = 7.1 Hz), 3.74 (d, 1H, J = 9.4 Hz), 1.26 (t, 3H, J 
= 7.1 Hz), 1.10 (t, 3H, J = 7.1 Hz); 13C{1H} (125 MHz) 167.4, 166.7, 147.9, 147.5, 
129.7, 121.5, 108.5, 108.2, 101.2, 77.8, 62.1, 61.8, 55.0, 42.7, 13.9, 13.8.  
 
The enantiomeric excess was determined by HPLC with a Chiralpak AS-H 
column, hexane/2-PrOH (90:10 v/v), 1.0 mL/min, λ = 215 nm; tR = 29.6 min (major, R), 
34.3 min (minor, S).121,145,151  
 
Ethyl-2-carboethoxy-4-nitro-3-(2-furyl)butyrate (19d, entry 4).147,149 NMR 
(δ, CDCl3): 
1H (500 MHz) 7.31 (app d, 1H, J = 2.0 Hz), 6.26 (app dd, 1H, J = 2.9, 2.0 
Hz), 6.19 (app d, 1H, J = 2.9 Hz), 4.91-4.84 (m, 2H), 4.34 (ddd, 1H, J = 7.8, 7.8, 5.4 
Hz), 4.19 (dq, 2H, J = 7.2, 2.0 Hz), 4.11 (q, 2H, J = 7.2 Hz), 3.87 (d, 1H, J = 7.8 Hz), 
1.23 (t, 3H, J = 7.1 Hz), 1.16 (t, 3H, J = 7.1 Hz); 13C{1H} (125 MHz) 167.0, 166.7, 
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149.5, 142.6, 110.4, 108.3, 75.3, 62.0, 52.9, 36.7, 13.8, 13.7.  
 
The enantiomeric excess was determined by HPLC with a Chiralpak AS-H 
column, hexane/2-PrOH (99:01 v/v), 1.0 mL/min, λ = 215 nm; tR = 26.3 min (minor, R), 
29.0 min (major, S).145,148,151  
 
1-Methylethyl-2-(1-methylethoxycarbo)-4-nitro-3-phenylbutyrate (19e, entry 
5).121,147 NMR (δ, CDCl3): 
1H (500 MHz) 7.32-7.22 (m, 5H), 5.08 (sep, 1H, J = 6.3 
Hz), 4.92 (dd, 1H, J = 12.9, 4.5 Hz), 4.84 (dd, 1H, J = 12.9, 9.7 Hz), 4.83 (sep, 1H, J = 
6.3 Hz), 4.2 (ddd, 1H, J = 9.5, 9.5, 4.4 Hz), 3.67 (d, 1H, J = 9.3), 1.24 (d, 3H, J = 6.3 
Hz), 1.23 (d, 3H, J = 6.3 Hz), 1.06 (d, 3H, J = 6.3 Hz), 1.01 (d, 3H, J = 6.3 Hz); 
13C{1H} (125 MHz) 167.0, 166.3, 136.3, 128.8, 128.2, 128.10, 128.08, 77.9, 69.9, 69.5, 
55.1, 42.9, 21.5, 21.4, 21.24, 21.20.  
 
The enantiomeric excess was determined by HPLC with a Chiralcel OD column, 
hexane/2-PrOH (95:05 v/v), 0.75 mL/min, λ = 220 nm; tR = 10.7 min (minor, S), 13.0 
min (major, R).145,148  
 
Methyl-2-carbomethoxy-4-nitro-3-phenylbutyrate (19f, entry 6).121,147 NMR 
(δ, CDCl3): 
1H (500 MHz) 7.34-7.26 (m, 3H), 7.24-7.21 (m, 2H), 4.92 (dd, 1H, J = 13.2, 
4.8 Hz), 4.88 (dd, 1H, J = 13.2, 9.2 Hz), 4.24 (ddd, 1H, J = 9.0, 9.0, 4.9 Hz), 3.86 (d, 1H, 
J = 8.8 Hz), 3.75 (s, 3H), 3.55 (s, 3H); 13C{1H} (125 MHz) 167.8, 167.2, 136.1, 129.0, 
128.4, 127.8, 77.3, 54.7, 53.0, 52.8, 42.9.  
 
The enantiomeric excess was determined by HPLC with a Chiralpak AS-H 
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column, hexane/2-PrOH (90:10 v/v), 1.0 mL/min, λ = 215 nm; tR = 17.0 min (minor, S), 
19.5 min (major, R).148,151  
 
Ethyl-2-carboethoxy-3-(1-nitromethyl)nonanoate (19g, entry 7).147,152 NMR 
(δ, CDCl3): 
1H (300 MHz) 4.72-4.65 (m, 1H), 4.55-4.47 (m,1H), 4.24-4.16 (m, 4H), 
3.60 (d, 1H, J = 5.9 Hz), 2.90-2.81 (m, 1H), 1.54 (br s, 2H), 1.45-1.41 (m, 2H), 1.28-
1.24 (m, 12H), 0.86 (t, J = 6.4 Hz, 3H); 13C{1H} NMR (75): 168.0, 167.8, 77.2, 61.9, 
61.8, 52.7, 37.0, 31.5, 30.1, 28.9, 26.6, 22.5, 14.0.  
 
The enantiomeric excess was determined by HPLC with a Chiralcel OD column, 
hexane/2-PrOH (99:01 v/v), 0.60 mL/min, λ = 215 nm; tR = 11.6 min (minor, S), 18.1 
min (major, R).151,152  
 
Ethyl-2-carboethoxy-3-(1-nitromethyl)hexanoate (19h, entry 8).147,153 NMR 
(δ, CDCl3): 
1H (300 MHz) 4.71 (dd, 1H, J = 8.7, 4.8 Hz), 4.54 (dd, 1H, J = 6.9, 6.3 Hz), 
4.19-4.26 (m, 4H), 3.62 (d, 1H, J = 5.7 Hz), 2.88-2.94 (m, 1H), 1.35-1.49 (m, 4H), 1.28 
(t, 6H, J = 7.2 Hz), 0.92 (t, 3H, J = 6.9 Hz); 13C{1H} (125 MHz) 168.0, 167.8, 76.7, 
61.9, 61.7, 52.6, 36.6, 32.1, 29.6, 19.8, 14.0, 13.7.  
 
The enantiomeric excess was determined by HPLC with a Chiralcel OD column, 
hexane/2-PrOH (99:01 v/v), 0.60 mL/min, λ = 215 nm; tR = 13.3 min (major), 22.8 min 
(minor).150  
 
Additions of Michael donors to 6 catalyzed by 18c+ PF6
 (Table 3.5). A J. 
Young NMR tube was charged with a Michael donor (e.g. 2,4-pentanedione (entry 1), 
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0.0184 g, 0.200 mmol), 6 (e.g. entry 1, 0.0298 g, 0.200 mmol,), and CD2Cl2 (1.0 mL). 
Then the catalyst (e.g. entry 1, 0.0013 g, 0.0020 mmol, 1 mol%) was added. The tube 
was capped. Product formation was monitored by TLC. After the specified time (Table 
3.5), the solvent was removed. The residue was taken up in hexane/ethyl acetate (30:70 
v/v) and passed through a short silica gel column, which was washed with additional 
hexane/ethyl acetate (50:50 v/v, 5 mL). The solvent was removed, and a second silica 
gel chromatography step was carried out (column length substrate dependent). The 
solvent was removed from the product containing fractions (yields, Table 3.5).  
 
3-(2-Nitro-1-phenylethyl)pentane-2,4-dione (21, entry 1).123 NMR (δ, 
CDCl3):
123a,147 1H (500 MHz) 7.34-7.25 (m, 3H), 7.19-7.16 (m, 2 H), 4.64-4.61 (m, 2 
H), 4.36 (d, 1H, J = 10.7 Hz), 4.27-4.20 (m, 1H), 2.28 (s, 3H), 1.93 (s, 3H); 13C{1H} 
(125 MHz) 201.6, 200.9, 135.9, 129.3, 128.5, 127.9, 78.2, 70.7, 42.9, 30.5, 29.7. 
 
The enantiomeric excess was determined by HPLC with a Chiralpak AS-H 
column, hexane/2-PrOH (85:15 v/v), 1.0 mL/min, λ = 215 nm; tR = 14.9 min (minor, S), 
22.6 min (major, R).123b,145  
 
Ethyl 1-(2-nitro-1-phenylethyl)-2-oxo-cyclopentanecarboxylate (23, entry 
2).124 NMR (δ, CDCl3; signals for diasteromers are separated by slashes):
120f,124,147 1H 
(300 MHz) 7.21-7.35 (m, 5H); 5.29/5.18 (dd, 1H, J = 13.5/13.5, 11.1/3.9 Hz), 5.02/4.83 
(dd, 1H, J = 13.5/13.5, 11.0/4.0 Hz), 4.15-28 (m, 2H), 4.08 (dd, 1H, J = 10.8, 3.9 Hz), 
2.30-2.42 (m, 2H), 1.80-2.09 (m, 4H), 1.28 (m, 3H); 13C{1H} (75 MHz) 215.5/212.3, 
171.0/169.2, 135.4/135.3, 129.3/129.2, 128.7/128.4, 128.2/128.1, 76.9/76.4, 62.4, 62.1, 
47.2/46.1, 39.5/37.8, 33.5/31.0, 19.5/19.3, 14.0/13.9. 
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The enantiomeric excess was determined by HPLC with a Chiralcel OD column, 
hexane/2-PrOH (90:10 v/v), 1.0 mL/min, λ = 220 nm; major diastereomer, tR = 8.4 min 
(minor, RCSC), 10.9 min (major, SCRC);
124a,145 minor diastereomer, tR = 7.3 min 
(minor, RCRC), 9.9 min (major, SCSC).
120f,145  
 
Phenylmethyl 2-acetyl-4-nitro-3-phenyl-butyrate (25, entry 3). NMR (δ, 
CDCl3; signals for diasteromers are separated by slashes):
125,147 1H (300 MHz) 7.28-
7.07 (m, 10H), 5.19/4.93 (s, 2H), 4.80-4.73 (m, 2H), 4.28-4.15/4.06-4.03 (m, 2H), 
2.25/2.00 (s, 3H); 13C{1H} (75 MHz) 200.86/199.92, 167.33/166.68, 136.21, 
134.59/134.45, 129.10/128.96, 128.75/128.69, 128.53/128.46, 128.32/128.24, 
127.83/127.78, 77.74, 67.82, 67.64, 61.83/61.16, 42.50/42.23, 30.17/30.07. 
 
The enantiomeric excess was determined by HPLC with a Chiralcel AD-H 
column, hexane/2-PrOH (85:15 v/v), 0.75 mL/min, λ = 230 nm; tR = 13.2 min (minor), 
20.9 min (major), 17.4 min (major), 27.1 min (minor).125  
 
2-(2-Nitro-1-phenylethyl)propanedinitrile (27, entry 4). NMR (δ, 
CDCl3):
21b,147 1H (500 MHz) 7.54-7.41 (m, 3H), 7.41-7.29 (m, 2H), 4.99 (dd, 1H, J = 
14.3, 8.2 Hz), 4.91 (dd, 1H, J = 14.3, 6.1 Hz), 4.43 (d, 1H, J = 5.8 Hz), 4.15-4.03 (m, 
1H); 13C{1H} (125 MHz) 131.8, 130.4, 129.4, 127.7, 110.5, 110.4, 74.9, 43.5, 27.5. 
 
The enantiomeric excess was determined by HPLC with a Chiralcel OD column, 
hexane/2-PrOH (50:50 v/v), 0.50 mL/min, λ = 215 nm; tR = 19.5 min (major), 54.7 min 
(minor).21b,154  
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Additions of 22 to dialkyl azodicarboxylates (Table 3.6). A J. Young NMR 
tube was charged with 22 (e.g. entry 1, 0.0062 g, 0.040 mmol), dialkyl azodicarboxylate 
(entry 1, 0.0040 g, 0.020 mmol,), and CD2Cl2 (0.3 mL) and cooled to the specified 
temperature. Then the catalyst (0.0013 g, 0.0020 mmol, 10 mol%) was added. The tube 
was capped. Product formation was monitored by TLC. After the specified time (Table 
3.6), the solvent was removed. The residue was taken up in hexane/ethyl acetate (30:70 
v/v) and passed through a short silica gel column, which was washed with additional 
hexane/ethyl acetate (50:50 v/v, 5 mL). The solvent was removed, and a second silica 
gel chromatography step was carried out (column length substrate dependent). The 
solvent was removed from the product containing fractions (yields, Table 3.6).  
 
Diisopropyl 1-(1-(ethoxycarbonyl)-2-oxocyclopentyl)hydrazine-1,2-
dicarboxylate (37, entry 1). NMR (δ, CDCl3):
126,147 1H (500 MHz) 6.64 (m, 1H), 4.90 
(septet, 2H, J = 5.9 Hz), 4.21 (q, 2H, J = 6.8 Hz), 1.68-2.63 (m, 6H), 1.21-1.29 (m, 
15H); 13C{1H} (125 MHz) 206.3, 167.5, 155.8, 155.1, 70.0, 63.8, 62.4, 36.7, 31.8, 21.8, 
18.5, 14.0. 
 
The enantiomeric excess was determined by HPLC with a Chiralcel AD column, 
hexane/2-PrOH (95:05 v/v), 1.0 mL/min, λ = 215 nm; tR = 9.0 min, 11.5 min.
126,154  
 
Di(t-butyl) 1-(1-(ethoxycarbonyl)-2-oxocyclopentyl)hydrazine-1,2-
dicarboxylate (39, entry 2). NMR (δ, CDCl3):
126,147 1H (500 MHz) 6.51 (s, 1H), 4.21 
(m, 2H), 2.60-1.73 (6H, m), 1.60-1.40 (m, 18H), 1.28 (t, 3H, J = 7.0 Hz); 13C{1H} (125 
MHz) 205.3, 167.8, 155.0, 154.1, 82.4, 81.1, 63.8, 61.9, 36.1, 32.5, 27.8, 27.7, 25.0, 
18.4, 13.8. 
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The enantiomeric excess was determined by HPLC with a Chiralcel AD column, 
hexane/2-PrOH (98:02 v/v), 1.0 mL/min, λ = 215 nm; tR = 13.7 min (minor, R), 18.0 
min (major, S).126,151  
 
Crystallography A. A CHCl3/C6F6 (0.50/0.05 mL) solution of (RRuRCRC)-18c
+ 
Δ-TRISPHAT– (ca. 0.03 g, >99:01 RRuRCRC/SRuRCRC) in an NMR tube was allowed to 
concentrate (6 h). Colorless blocks of (RRuRCRC)-18c
+ (Δ)-TRISPHAT−·CHCl3 with 
well defined faces formed. Anal. Calcd for C40H29Cl12N6O7PRu·CHCl3: C 35.62, H 
2.19, Cl 38.49, N 6.08. Found: C 35.04, H 2.05, Cl 38.24, N 5.84. The blocks were too 
small to analyze with in-house facilities. Thus, synchrotron radiation (Advanced Light 
Source, Lawrence Berkeley National Laboratory, beamline 11.3.1) was employed for 
unit cell determination and data collection on a D8 goniostat equipped with a CCD 
detector.
 
 
The integrated intensity information for each reflection was obtained by 
reduction of the data frames with the program APEX2.92 Cell parameters were obtained 
from 60 frames using a 0.5° scan. Data were corrected for Lorentz and polarization 
factors, and using SADABS,93 absorption and crystal decay effects. The structure was 
solved by direct methods using SHELXTL (SHELXS).94 All non-hydrogen atoms were 
refined with anisotropic thermal parameters. Hydrogen atoms were placed in idealized 
positions using a riding model. One chlorine atom and the hydrogen atom of the CHCl3 
molecule showed displacement disorder (Cl53:Cl54, H50:H50A), which was refined to a 
72:28 occupancy ratio. The parameters were refined by weighted least squares 
refinement on F2 to convergence.94 The absolute configuration was confirmed using the 
Flack parameter.155 
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B. Et2O vapor was allowed to slowly diffuse into a CH3CN solution of the ca. 
1:2 mixture of (RRuRCRC)-18c
+ X and (n-Bu)3NH
+ (/)-TRISPHAT– generated 
above. After 3 weeks, colorless needles of (RRuRCRC/SRuRCRC)-18c
+ (/)-
TRISPHAT–·(Et2O)2 (a 1:1 mixture of two diastereomers of 18c
+ and two enantiomers 
of TRISPHAT–, with two Et2O molecules per ruthenium) with well defined faces were 
obtained. A Bruker GADDS diffractometer was employed for unit cell determination 
and data collection.  
The integrated intensity information for each reflection was obtained by 
reduction of the data frames with the program APEX2.92 Cell parameters were obtained 
from 180 frames using a 0.5° scan. Data were corrected for Lorentz and polarization 
factors, and using SADABS93 absorption and crystal decay effects. The structure was 
solved by direct methods using SHELXTL (SHELXS) (Z = 4; Z' = 2).94  
All non-hydrogen atoms were refined with anisotropic thermal parameters. 
Hydrogen atoms were placed in idealized positions using a riding model. The oxygen 
atom and a carbon atom of one of the four Et2O molecules in the unit cell showed 
displacement disorder (O3D:O3E, C1D:C2D), which was refined to a 60:40 occupancy 
ratio. The parameters were refined by weighted least squares refinement on F2 to 
convergence.94 The absolute configuration was confirmed using the Flack parameter.155  
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4. ENANTIOPURE CHIRAL-AT-METAL RUTHENIUM 
COMPLEXES: SYNTHESES, RESOLUTION, AND APPLICATIONS 
IN SECOND COORDINATION SPHERE PROMOTED CATALYSIS 
 
4.1 Introduction 
 
4.1.1 Applications of chiral phosphoric acid derivatives in literature 
 
Chiral phosphoric acids have seen immense uses in catalytic organic 
transformations.156 Out of many, those with a biphenyl based axial chiral core have been 
at the heart of this chemistry.156 Chiral biphenyl systems are atropisomers.157 By 
analyzing the Newman projection along the biaryl axis, the absolute axial configuration 
can be deduced as P or M, as shown in Scheme 4.1, top (box).157 The concept has been 
illustrated with two enantiomers, (M)-Phos-H ((M)-12) and (P)-Phos-H ((P)-12),26 of a 
chiral phosphoric acid.  
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Recently, atropisomers of phosphoric acid derivatives have been used as chiral 
anions, Brønsted acids, Lewis acids, and Lewis bases.156h One typical application has 
been for the resolution of chiral amines and amino acids with enantiopure phosphoric 
acids (Scheme 4.1, bottom).158 Compound (SC)-LXXIII is a potent neurotransmitter and 
has been used to treat Parkinson's disease.159 The absolute configuration of this 
enantiopure amine is well established in literature.160 The acid (P)-12 has been used 
with this racemic amino acid, (RC/SC)-LXXIII, to form a pair of diastereomeric salts. 
These salts were separated by recrystallization from MeOH/CH3COCH3. The 
recrystallized product was diastereomerically pure and its neutralization afforded the 
enantiopure amino acid (SC)-LXXIII.
158,160  
The anions derived from chiral phosphoric acids have also been applied in 
numerous enantioselective organic transformations.156f One example from the Mikami 
group is illustrated in Scheme 4.2. A silver salt derived from a chiral phosphoric acid 
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((P)-LXXIV) was used to abstract a chloride ligand from a neutral gold complex 
(LXXV) to form a cationic gold species (Scheme 4.2).161 Concomitant loss of silver 
chloride led to the formation of a single diastereomeric salt. Temperature controlled 
treatment of the product with HCl and subsequent silica gel chromatography led to the 
resolved neutral gold species in quantitative yield. 
 
 
 
 
 
 
 
4.1.2 Utilization of chiral phosphoric acid with chiral-at-metal ruthenium complexes 
 
As mentioned in chapter 2 (Scheme 2.8), when commercially available 
enantiopure chiral phosphoric acid (P)-12 was used to protonate the ruthenium complex 
(η5-C5H5)Ru(CO)(GBIH) (11),
26 a cationic GBI complex [(η5-C5H5)Ru(CO)(GBI)]
+ 
(P)-Phos (9+ (P)-Phos)26 was isolated. Here, (P)-Phos is the conjugate base of (P)-12 
and acts as the chiral anion for the cationic chiral-at-metal ruthenium complex. The 1H 
NMR spectrum showed two distinct signals for the cyclopentadienyl ligand due to the 
formation of two diastereomeric salts, (RRu)-9
+
 (P)-Phos
 and (SRu)-9
+
 (P)-Phos
. This 
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is depicted in Scheme 2.8 (bottom). Any attempt to separate these ionic species led only 
to partial enrichment.  
In this chapter, this concept has been extended to modified ruthenium systems to 
achieve better resolution of chiral-at-metal ruthenium GBI complexes (Figure 4.1). This 
modification includes substituting the parent cyclopentadienyl (C5H5) ligand to give a 
bulky and electron withdrawing pentaphenylcyclopentadienyl (C5Ph5) ligand.
162 The 
bulkier substituent would be expected to create a bigger difference between matched and 
mismatched ion pairs. This might result in greater differences in solubilities and 
chromatographic retention times.  
 
 
 
 
 
 
 
As described below, this approach has allowed diastereomerically pure salts to be 
isolated. The chiral (P)-Phos counter anion has been subsequently metathesized to an 
achiral BArf
26 counter anion, which is also a very poor hydrogen bond acceptor. This 
sets the stage for probing the catalytic ability of the enantiopure complex in 
enantioselective second coordination sphere promoted catalysis (SCSPC).  
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4.2 Results 
 
4.2.1 Synthesis and resolution of modified ruthenium GBI complexes 
 
4.2.1.1 Synthesis of ruthenium precursor 
 
The pentaphenylcyclopentadienyl ruthenium complex (η5-C5Ph5)Ru(CO)2(Br) 
(42) has been reported in the literature.163 A number of derivatives have also been 
prepared.163c,164 Hence, 42 was investigated for the syntheses of ruthenium GBI 
complexes that can act as hydrogen bond donor catalysts similar to [(η5-
C5H5)Ru(CO)(GBI)]
+ X (9+ X, Chapter 2) and the bifunctional analog 18c+ PF6
 
(Scheme 3.2, Chapter 3). Complexes 9+ X and 18c+ PF6
 have been previously 
prepared via different methods as described in chapter 2 and 3 as well as in the full 
papers associated with these chapters.75,104  
Complex 42 was prepared by refluxing Ru3(CO)12 and 5-bromo-1,2,3,4,5-
pentaphenyl-1,3-cyclopentadiene (43) in toluene (Scheme 4.3). A chromatographic 
workup (experimental section) gave 42 as a greenish yellow solid in better yields than 
reported in the literature (75% vs. 68%163).  
Compound 43 was in turn synthesized by brominating 1,2,3,4,5-
pentaphenylcyclopenta-2,4-dien-1-ol (44), following a literature procedure (Scheme 
4.3).165 Workup gave 43 as an orange-yellow solid in 76% yield. Similarly, 44 was 
prepared in 80% yield according to a literature procedure starting from 2,3,4,5-
tetraphenylcyclopentadienone (45).165 Compound 45 can in turn be easily prepared by a 
two fold aldol condensation of 1,3-diphenyl acetone (46) and benzil (47). This is a very 
popular experiment and is conducted in the undergraduate organic laboratory 
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program.166  
 
 
 
 
 
 
 
4.2.1.2 Synthesis of ruthenium GBI complexes 
 
In order to synthesize ruthenium GBI complexes, a paper used for preparing (η5-
C5Ph5)Ru(CO)(PEt3)(Br) and [(η
5-C5Ph5)Ru(CO)(PEt3)(MeC≡CMe)]
+ PF6
 starting 
from 42 was considered.163a According to that study, 42 was treated with Me3NO∙2H2O 
in the presence of excess PEt3 to remove the CO ligand as CO2 and form (η
5-
C5Ph5)Ru(CO)(PEt3)(Br) and the byproduct Me3N.
163a Treatment of the isolated 
product (η5-C5Ph5)Ru(PEt3)(CO)(Br) with Ag
+ PF6
 in the presence of excess but-2-
yne provided the bromide ligand substitution product [(η5-
C5Ph5)Ru(CO)(PEt3)(MeC≡CMe)]
+ PF6
.163a Thus, two of the monodentate ligands in 
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42 are easily replaced via a two step sequence.  
As shown in Schemes 2.6 (chapter 2) and 3.2 (chapter 3), the GBI or substituted 
GBI ligands can displace chloride, PPh3, and CH3CN ligands from cyclopentadienyl 
ruthenium complexes. Towards a similar end with 42, a CH3CN suspension was treated 
with Me3NO2H2O, GBI, and Ag
+ PF6
 (Scheme 4.4). After solvent removal the 
residue was further purified by chromatography, either using silica gel or alumina.  
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Silica gel chromatography provided racemic chiral-at-metal [(η5-
C5Ph5)Ru(CO)(GBI)]
+ PF6
 (48+ PF6
) as a bright green powder in 70% yield. The salt 
was soluble in CH2Cl2, CHCl3, CH3CN, DMSO, and MeOH but insoluble in toluene. 
Like all of the new complexes mentioned below, 48+ PF6
 was characterized by NMR 
(1H, 13C) and IR spectroscopy as summarized in Tables 4.1-4.4 and the experimental 
section. Based upon the 1H and 13C NMR studies for a similar compound [(η5-
C5H5)Ru(CO)(GBI)]
+ PF6
 (9+ PF6
) mentioned in chapter 2 (Tables 2.6-2.8) including 
2D NMR experiments (see Appendix C), all proton and carbon signals could be 
unambiguously assigned. These and other data supported the coordination of the 
benzimidazole C=NAr and guanidine C=NH groups, as verified by crystallography 
below. 
 
 
 
Table 4.1 NH 1H NMR signals of 48+ X and 49 ().a  
 
Complexa NH(5) NH(2) NH(1) NH2(4) 
48+ PF6
 -b -b 4.77 5.48 
48+ BArf
 9.47 8.36 5.13 5.03 
(RRu/SRu)-48
+ (P)-Phos c 13.67/13.16 12.03/10.81 4.45/4.92 5.56/6.12 
(SRu)-48
+ (P)-Phos 13.77 12.33 4.48 5.70 
49d -b -b -b -b 
9+ BArf
 9.21 8.19 5.41 4.92 
a
 Spectra were recorded in CD2Cl2 (500 MHz). The  values are given in ppm. 
b These NH signals were 
not observed. c Signals for diastereomers are separated by a "/"; the first entry is for (SRu)-48
+ (P)-Phos. d 
Spectra were recorded in CD2Cl2/CD3OD (500 MHz). 
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However, as shown in Scheme 4.4, chromatography over alumina led to 48+ X 
as a pale green powder. Here X denotes an unknown alumina derived anion, with a 
PF6
 content of <5%. Similar problems were encountered with 18c+ PF6
 (Scheme 4.4, 
box) as described in chapter 3 and the full paper associated with it.104 Similar to 18c+ 
PF6
, anion metathesis of 48+ X with either Na+ PF6
 or NH4
+ PF6
 did not lead to 
complete exchange of the unknown anion. In contrast, treatment of 48+ X with Na+ 
BArf
 26,65 under biphasic conditions (CH2Cl2/H2O) led to pure 48
+ BArf
 in 69% 
yield. Given the aqueous conditions, 48+ BArf
 was isolated as a hydrate (2.0-4.0 H2O). 
This new salt was characterized similarly to the hexafluorophosphate salt (Tables 4.1-
4.4). A satisfactory microanalysis was obtained. Compound 48+ BArf
 was soluble in 
toluene, along with CH2Cl2, CHCl3, CH3CN, DMSO, and MeOH.  
 
 
 
Table 4.2 13C{1H} NMR signals of the GBI ligand in 48+ X and 49 ().a  
Complex C(1) C(2) C(3) C(4) C(5) C(6) C(7) C(8) 
GBI b 159.8 158.9 142.6 132.5 119.9 119.9 114.8 109.1 
48+ PF6
 154.3 146.0 141.2 132.3 124.1 122.9 118.9 111.8 
48+ BArf
 152.9 144.0 140.9 132.4 125.3 124.1 119.6 111.5 
(RRu/SRu)-48
+ (P)-
Phos c 
155.02/ 
154.71 
147.08/ 
146.75 
141.46/ 
141.42 
132.78/ 
132.72 
123.36/ 
122.98 
122.14/ 
121.88 
118.36/ 
117.84 
111.92/ 
111.73 
(SRu)-48
+ (P)-Phos 155.1 147.2 141.5 132.8 123.3 122.1 118.4 111.9 
49d 158.9 154.4 143.9 137.9 120.7 119.9 117.3 111.7 
9+ BArf
 152.4 144.1 142.6 130.8 124.9 124.5 117.9 111.4 
a Spectra were recorded in CD2Cl2 (125 MHz) unless noted. The  values are given in ppm. 
b Spectra 
were recorded in DMSO-d6 (100 MHz). 
c Signals for diastereomers are separated by a "/"; the first entry is 
for (SRu)-48
+ (P)-Phos. d Spectra were recorded in CD2Cl2/CD3OD (125 MHz).  
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When a CH2Cl2 solution of 48
+ PF6
 and a H2O solution of K
+ t-BuO were 
combined, a biphasic yellow suspension was obtained. Workup gave the neutral chiral-
at-metal ruthenium complex (η5-C5Ph5)Ru(CO)(GBIH) (49) as a bright yellow powder 
in 72% yield (Scheme 4.4). The complex was characterized similarly to the salts 
mentioned above (Tables 4.1-4.4). An analogous deprotonation of [(η5-
C5H5)Ru(CO)(GBI)]
+ Cl (9+ Cl) was described in chapter 2 (Scheme 2.8). Similar 
transformations have been described in the literature.70 Here, GBIH is the conjugate 
base of GBI, which acts as an anionic ligand for the [(η5-C5Ph5)Ru(CO)]
+ fragment. 
Compound 49 was partially soluble in CH2Cl2 and CH3CN, and completely soluble in 
MeOH and DMSO. 
 
 
 
Table 4.3 13C{1H} NMR chemical shifts of the CO and pentaphenylcyclopentadienyl 
ligands () of 48+ X and 49.a 
Complex CO o-CPh i-CPh m-CPh p-CPh C5Ph5 
48+ PF6
  205.3 132.3 131.9 128.1 128.1 100.6 
48+ BArf
  204.5 132.2 131.5 128.4 128.2 100.4 
(RRu/SRu)-48
+ (P)-Phos 205.5 
132.28/ 
132.17 
132.11/ 
132.03 
127.97/ 
127.76 
127.90/ 
127.67 
100.64/ 
100.32 
(SRu)-48
+ (P)-Phos 205.5 132.3 132.1 128.0 127.9 100.7 
49b 207.8 133.0 132.6 127.7 127.4 101.6 
a Spectra were recorded in CD2Cl2 (125 MHz). The  values are given in ppm. 
b Spectra were recorded in 
CD2Cl2/CD3OD (125 MHz). 
 
 
 
 
 
 
 
 
 147 
 
Table 4.4 13C{1H} NMR chemical shifts of the CO ligand () and IR CO values (cm
1) 
for 48+ X, 49, 9+ X, and 11.a  
 
48+ 
BArf
 
9+ 
BArf
 
48+ 
PF6
 
9+ PF6
 49 11 
CO  204.5 203.3 205.3 203.9b 207.8c 207.5b 
CO 1977 1961
75 1948 194275 1934 192670 
a Spectra were recorded in CD2Cl2 (125 MHz). The  values are given in ppm. 
b Spectra were recorded in 
DMSO-d6 (100 MHz). 
c Spectra were recorded in CD2Cl2/CD3OD (125 MHz). 
 
 
 
4.2.1.3 Resolution of ruthenium GBI complexes 
 
As shown in chapter 2 (Scheme 2.8) and noted above, the neutral complex (η5-
C5H5)Ru(CO)(GBIH) (11) was subsequently protonated with the enantiopure axially 
chiral phosphoric acid (P)-12 to form a mixture of diastereomeric salts, (RRu)-9
+
 (P)-
Phos and (SRu)-9
+
 (P)-Phos
. With the racemic chiral-at-metal neutral ruthenium 
complex 49 in hand, a similar strategy was investigated. Thus, 49 was treated with 
equimolar amounts of (P)-12 in CH2Cl2 to generate a pair of diastereomeric salts with 
(P)-Phos as the counter anion (Scheme 4.5). Filtration through celite and evaporation 
of the solvent gave a pale green powder of (RRu/SRu)-48
+ (P)-Phos in 92% yield.  
The 1H NMR spectrum exhibited two sets of well separated NH proton signals (δ 
13.67/13.16, 12.03/10.81, 5.56/6.12, and 4.45/4.92; area ratios 50±2:50±2). The cations 
gave two sets of 13C NMR signals for most of the carbon atoms. These data are 
consistent with a mixture of diastereomeric salts, (RRu)-48
+
 (P)-Phos
 and (SRu)-48
+
 
(P)-Phos. 
Attempted separation of the salts by silica gel or neutral alumina chromatography 
was unsuccessfull. However, an appreciable solubility difference in cold toluene/hexane  
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was noted. When (RRu/SRu)-48
+ (P)-Phos was dissolved in 90:10 v/v toluene/hexane
and kept at –35 °C, a greenish black supernatant and a yellow precipitate formed 
(Scheme 4.5). Workup gave (SRu)-48
+ (P)-Phos in 35% yield, or 70% of theory. The
greenish black filtrate provided a mixture of diastereomers, (RRu/SRu)-48
+ (P)-Phos,
with the RRu configuration predominating, as a pale green salt in 60% yield. 
As shown in Figure 4.2, NMR (1H and 13C) spectroscopy was employed to assay 
the diastereomer ratio (dr). Based on the NH proton and carbon signals from the cation, 
the dr was determined. The 1H NMR spectrum of the mixture (Figure 4.2, bottom, red) 
and separated diastereomer (bottom, cyan) indicates that the latter contains only one set 
of NH signals; the other set is below the limits of detection. The 13C NMR spectrum of 
the separated diastereomer contained only one set of carbon signals for the cation 
(Tables 4.2 and 4.3 and Figure 4.2, top, cyan). In contrast, the diastrereomeric mixture 
exhibited two signals for each of the carbon atoms (Tables 4.2 and 4.3 and Figure 4.2, 
top, red). The 1H and 13C NMR spectrum together indicated that the resolved compound 
has a high dr. Since the NH signals do not exchange in CD2Cl2, the 
1H NMR spectrum
in Figure 4.2(b) suggests a minimum dr of >98:<02, when the peak at 4.48 ppm was 
integrated against a peak introduced at 4.92 ppm as an upper bound for the residual 
signal of the other diastereomer. 
The salt (SRu)-48
+ (P)-Phos was characterized similarly to the aforementioned
complexes. Microanalysis and 1H NMR (experimental section) showed that the isolated 
salt is a toluene monosolvate. Complex (SRu)-48
+ (P)-Phos was highly soluble in
CH2Cl2 and CHCl3 but not in CH3CN. The salt obtained from the greenish black filtrate 
had a dr of 80:20 (RRu/SRu) as similarly assayed by 
1H NMR spectroscopy.
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Next, (SRu)-48
+ (P)-Phos was treated with Na+ BArf
 under biphasic
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(CH2Cl2/H2O) conditions to give [(η
5-C5Ph5)Ru(CO)(GBI)]
+ BArf
 ((SRu)-48
+ BArf
)
in 80% yield (Scheme 4.5). As the anion exchange employed aqueous conditions, the 
salt was isolated as a hydrate (1.0-2.0 H2O). It was characterized analogously to the 
other new salts above, as well as CD spectroscopy (Figure 4.3a).  
As shown in Figure 4.3b and in chapter 3 (Figure 3.4), the cyclopentadienyl 
complex (SRuRCRC)-18c
+ PF6
– gives a positive long wavelength absorption (red trace,
408 nm). Accordingly, the enantiomer of 48+ BArf
 with a positive long wavelength
adsorption (red trace, Figure 4.3a; 425 nm with additional shoulders at 400 and 435 nm) 
was tentatively assigned an SRu ruthenium configuration. 
(a) 
(b) 
Figure 4.3 (a) CD spectrum of (SRu)-48
+ BArf
– (red trace) in CH3CN. (b) CD spectra of
(RRuRCRC)-18c
+ PF6
– (blue trace) and (SRuRCRC)-18c
+ PF6
– (red trace) in CH3CN.
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4.2.2 Physical characterization of ruthenium complexes and its precursors 
4.2.2.1 Spectroscopic characterization of ruthenium complexes 
Selected 1H and 13C{1H} NMR and IR data for the ruthenium complexes 48+ X 
are presented in Tables 4.1-4.4 and Figure 4.4. The spectroscopic properties are similar 
to those of 9+ X in chapter 2. The 1H NMR spectrum of 48+ BArf
 shows the NH
protons to be 0.26-0.11 ppm downfield of those in [(η5-C5H5)Ru(CO)(GBI)]
+ BArf
 (9+
BArf
, Table 4.1). This may be a consequence of the shielding anisotropy of the five
phenyl rings, which have a radial disposition about the cyclopentadienyl ligand. To the 
extent that this might also reflect enhanced NH acidities, 48+ X might also be a superior 
hydrogen bond donor. The IR CO values of 48
+ X are 16-6 cm1 higher in frequency
than those of 9+ X, consistent with the pentaphenylcyclopendienyl ligand being more 
electron withdrawing than cyclopendienyl, in accordance with past observations.162  
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The 1H NMR signals of the GBI protons in the neutral complex 49 are 0.27-0.21 
ppm upfield of those of the cationic complex 48+ BArf
 (7.16, 7.03, and 6.72 ppm vs.
7.37, 7.26, and 6.99 ppm). The 13C{1H} GBI signals also exhibit shifts (Tables 4.2, 4.3 
and Figure 4.4, top). The C1-C4 GBI carbon signals of 49 are shifted 10.4-3.9 ppm 
downfield from those in 48+ BArf
. The relatively low CO value of 49 (1934 cm
1)
indicates a more electron rich ruthenium center than in 48+ X (X = BArf
/PF6
,
1977/1948 cm1).72  
4.2.2.2 Crystallographic characterization of ruthenium complexes 
During the course of the synthesis described above, single crystals of 48+ 
PF6
(C5H12)1.5 were obtained. X-ray data were collected and refined as described in
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the experimental section and Table 4.3. The resulting structure is shown in Figure 4.5 
and the key metrical parameters are summarized in Tables 4.5-4.7.  
The cation is formally octahedral, with the pentaphenylcyclopentadienyl ligand 
occupying three coordinating sites, as evident from the OC-Ru-N and N-Ru-N bond 
angles of ca. 90°. The GBI ligand is slightly puckered as reflected by the many torsion 
angles with values near 0° or ±180°. The average differences from 0° and 180° are 
16.6(13)° and 19.1(15)°, respectively. The bond lengths of the coordinated C=NH (C1-
N1) and C=NAr (C2-N3) linkages (1.284(7) and 1.320(7) Å) are shorter than the other 
four carbon-nitrogen bonds about C1 and C2 (1.337(7)-1.374(7) Å). An alternative 
tautomer of the GBI ligand would afford different carbon-nitrogen bond length patterns 
as mentioned in the previous chapter and the two full papers associated with chapters 2 
and 3.75,104 The ruthenium-nitrogen bond lengths are similar to those in 
literature.75,104,116  
The three NH units on the nitrogen atoms remote from the ruthenium atom, N5-
H5, N2-H2, and N4-H4B, exhibit an approximately synperiplanar NH triad, as 
evidenced by H-N-N-H torsion angles that are reasonably close to 0° (–24.7°, –24.4°, –
51.2°; average difference from 0°, 33.5(15)°). The two other NH units, N1-H1 and N4-
H4A, exhibit an approximately synperiplanar NH dyad with a torsion angle of 25.2°. 
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Table 4.5 Summary of crystallographic data.a 
48+ PF6
(C5H12)1.5 48
+ BArf
.H2O 49 
Molecular formula C51.5H52F6N5OPRu C76H48BF24N5O2Ru C44H33N5ORu
Formula weight 1003.02 1631.07 748.82 
Crystal system Monoclinic Triclinic Tetragonal 
Space group P21/c P-1 I41/a
Diffractometer Bruker GADDS Bruker APEX 2 Bruker GADDS 
Wavelength [Å] 1.54178 0.71073 1.54178 
Unit cell dimensions: 
a [Å] 16.961(2) 12.9707(17) 34.0508(9) 
b [Å] 19.556(3) 14.5334(19) 34.0508(9) 
c [Å] 15.9890(19) 21.518(3) 13.84405(5) 
α [°] 90 76.628(2) 90 
β [°] 117.211(8) 82.008(2) 90 
γ [°] 90 78.719(2) 90 
V [Å3] 4716.3(10) 3851.4(9) 16051.5(8) 
Z 4 2 16 
calc [Mgm
3] 1.413 1.406 1.239 
 [mm1] 3.579 0.309 3.454 
F (000) 2068 1640 6144 
Crystal size [mm3] 0.25 0.08 0.08 0.38 0.11 0.09 0.13 0.08 0.06 
 range [°] 2.93 to 60.00 1.58 to 27.58 2.60 to 60.00 
Index ranges (h,k,l) 16,18;21,21;17,17 16,16;18,18;27,27 38,38;38,38;1
5,15 
Reflections collected 90436 86052 169554 
Independent reflections 6958 17616 5959 
Completeness to   99.6% (60.0) 99.8% (25.2) 100% (60.0) 
Data/restraints/parameter 6958/4/601 17616/868/1170 5959/37/450 
Goodness-of-fit on F2 1.058 1.020 1.068 
R indices (final) [I>2(I)] 
R1 0.0479 0.0519 0.0365 
wR2 0.1208 0.1193 0.0783 
R indices (all data) 
R1 0.0656 0.0808 0.0404 
wR2 0.1456 0.1354 0.0798 
Largest diff. peak and hole 
[eÅ3]
0.844/1.132 1.61/0.728 0.450/0.443 
a
 Data common for all structures: T = 173(2) K.
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As illustrated in Figure 4.5, each PF6
 anion exhibits numerous hydrogen bonds
to each of the two neighboring cations. The FH, FN, and PN distances, 
summarized in Table 4.7, are in typical ranges for hydrogen bonds.167 All of the NH 
linkages participate in hydrogen bonding with the anion. In the cyclopentadienyl variant, 
[(η5-C5H5)Ru(PPh3)(GBI)]
+ PF6
 (8+ PF6
CH2Cl2), the Ru-NH protons were not
involved in hydrogen bonding interactions, but the other NH groups were.75 Although it 
is unlikely of any special significance, some of the hydrogen bonding distances in 48+ 
PF6
(C5H12)1.5 are shorter than those in 8
+ PF6
CH2Cl2 (F
…H: 2.029, 2.052, 2.082,
and 2.108 Å vs. 2.195 Å; P…N: 3.781(6) Å vs. 3.802(3) Å; F…N: 2.907(7) and 2.855(7)
Å vs. 2.939(4) Å). Interestingly, the shortest F…H contact in 48+ PF6
(C5H12)1.5 is that
associated with the Ru-NH moiety (2.029 Å). 
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Table 4.6 Key bond lengths [Å], bond angles [°], and torsion angles [°] for 48+ 
PF6
(C5H12)1.5, 48
+ BArf
.H2O, and 49.
a,b
48+ PF6
(C5H12)1.5 48
+ BArf
.H2O 49 
Ru(1)-N(1) 2.097(4) 2.105(2) 2.104(3) 
Ru(1)-N(3) 2.134(4) 2.108(2) 2.107(2) 
Ru(1)-C(9) 1.860(6) 1.868(4) 1.839(4) 
C(1)-N(1) 1.284(7) 1.278(4) 1.295(4) 
C(1)-N(2) 1.374(7) 1.386(4) 1.365(4) 
C(1)-N(4) 1.337(7) 1.362(4) 1.354(4) 
C(2)-N(2) 1.354(7) 1.372(4) 1.389(4) 
C(2)-N(3) 1.320(7) 1.303(4) 1.348(4) 
C(2)-N(5) 1.352(7) 1.347(4) 1.339(4) 
C(9)-Ru(1)-N(1) 92.5(2) 93.05(12) 92.73 
C(9)-Ru(1)-N(3) 89.4(2) 89.22(12) 91.90 
N(1)-Ru(1)-N(3) 81.54(16) 80.71(9) 80.56(10) 
N(1)-C(1)-N(2) 120.7(5) 121.2(2) 121.9(3) 
N(1)-C(1)-N(4) 124.5(5) 125.4(3) 123.9(3) 
Ru(1)-N(1)-C(1) 129.5(4) 130.3(2) 126.6(2) 
Ru(1)-N(3)-C(2) 123.5(4) 124.5(2) 124.4(2) 
C(2)-N(2)-C(1) 123.9(4) 122.2(2) 120.9(3) 
N(3)-C(2)-N(2) 126.5(5) 126.6(3) 122.9(3) 
N(3)-C(2)-N(5) 112.1(5) 113.0(3) 116.6(3) 
C(9)-Ru(1)-N(3)-C(2) 118.5(5) 124.8(3) 122.9(3) 
C(9)-Ru(1)-N(1)-C(1) 123.5(5) 120.4(3) 133.5(3) 
N(1)-C(1)-N(4)-H(4B) 132.8 162.8 139.4 
Ru(1)-N(1)-C(1)-N(4) 160.9(4) 167.0(2) 157.8(2) 
Ru(1)-N(3)-C(2)-N(5) 176.9(3) 168.2(2) 179.4(2) 
N(4)-C(1)-N(2)-C(2) –159.1(5) –157.2(3) 153.1(3) 
N(5)-C(2)-N(2)-C(1) 150.2(5) 154.7(3) –138.4(3)
C(3)-N(3)-C(2)-N(2) 176.7(5) 173.7(3) –173.5(3)
C(8)-N(5)-C(2)-N(2) –178.0(5) –176.2(3) 174.8(3)
N(3)-C(2)-C(1)-N(4) –173.3(7) –165.5(3) 172.3(3)
N(1)-C(1)-C(2)-N(5) 152.5(7) 160.8(4) 143.7(3)
N(4)-C(1)-C(8)-C(3) –169.1(7) –165.6(3) 166.5(3)
N(1)-C(1)-C(8)-C(4) 140.0(2) 143.0(9) –116.2(7)
Average 160.9(15) 163.1(9) 155.9(19) 
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Table 4.6 Continued 
48+ PF6
(C5H12)1.5 48
+ BArf
.H2O 49 
Average difference 
from 180° 
19.1(15) 16.9(9) 24.1(19) 
Ru(1)-N(3)-C(2)-N(2) 3.6(8) (4) 2.6(4) 
Ru(1)-N(1)-C(1)-N(2) 17.9(8) 10.9(4) 19.2(4) 
N(1)-C(1)-N(2)-C(2) 21.9(8) 24.7(4) 29.6(4) 
N(3)-C(2)-N(2)-C(1) 29.2(9) 22.9(4) 38.3(4) 
H(5)-N(5)-C(2)-N(2) 2.0 3.7 
H(2)-N(2)-C(2)-N(5) –29.8 –25.5 13.0 
H(2)-N(2)-C(1)-N(4) 20.8 23.0 2.2 
H(4B)-N(4)-C(1)-N(2) –46.2 19.2 –43.4
H(1)-N(1)-C(1)-N(4) 14.9 6.4 –7.4
H(4A)-N(4)-C(1)-N(1) 12.8 –43.9 20.0 
C(3)-N(3)-C(2)-N(5) –2.7(6) –4.1(3) 3.3(3) 
N(4)-C(1)-C(2)-N(5) 16.0(1) 7.4(6) 21.7(5) 
N(1)-C(1)-C(2)-N(3) –4.8(5) 2.6(3) 6.9(3) 
N(1)-C(1)-C(8)-C(3) –9.8(5) –0.5(2) 13.9(2) 
Average difference  
from 0° 
16.6(13) 14.9(12) 17.0(14) 
synperiplanar DD dyads 
H(4A)-N(4)-N(1)-H(1) 25.2 –35.0 11.5 
H(2)-N(2)-N(4)-H(4B) –24.7 38.4 –38.0
H(2)-N(2)-N(5)-H(5) 24.4 19.1 
H(5)-N(5)-N(4)-H(4B) 51.2 14.9 
Average difference  
from 0°  
33.5(15) 24.1(12) 38.0(0) 
a For distances involving hydrogen bonds, see Table 4.5. b For atom numbers, see Figures 4.6-4.8.
The salt 48+ BArf
H2O could also be characterized crystallographically. X-ray
data were collected and refined as described in the experimental section and Table 4.3. 
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The resulting structure is shown in Figure 4.6. Several of the CF3 groups were 
disordered and modeled. Key metrical data are summarized in Tables 4.5, 4.6, and 4.8. 
In this case the GBI ligand is more planar than 48+ PF6
(C5H12)1.5 with torsion angles
closer to 0° or ± 180°. The average differences from 0° and 180° are 14.9(12)° and 
16.9(9)°, respectively. The carbon-nitrogen bond lengths exhibit similar patterns as in 
48+ PF6
(C5H12)1.5. The H2O molecule in the lattice exhibits hydrogen bonding with
three of the five NH units (N2-H2, N4-H4B, and N5-H5). However, in contrast to 48+ 
PF6
(C5H12)1.5, there are no hydrogen bonding interactions involving the BArf
 anion,
consistent with its poor hydrogen bond acceptor properties.60  
Table 4.7 Selected F…H, P…N, and F…N distances [Å] in 48+ PF6
–.(C5H12)1.5.
a,b
F1…H4B 2.717 P1…N4 4.156(7) 
F1…H2 2.052b P1…N5 4.258(5) 
F1…H5 3.492 P1…N1' 4.151(5) 
F1…H1' 3.665 P1…N4' 4.218(7) 
F2…H4A' 3.562 F1…N2 2.907(7)b
F2…H1' 3.595 F1…N4 3.331(8) 
F3…H4B 2.932 F1…N5 3.965(6) 
F3…H2 2.820 F2… N1' 4.365(6) 
F3…H5 3.783 F2…N4' 4.113(7) 
F4…H1' 2.029b F3…N2 3.275(8) 
F4…H4A' 3.234 F3…N4 3.073(9) 
F4…H4B' 3.958 F3…N5 4.241(7) 
F5… H1' 2.825 F4…N1' 2.959(6) 
F5…H4A' 2.108b F4…N4' 3.825(8) 
F5…H4B' 3.485 F5… N1' 3.525(6) 
F6…H2 2.621 F5…N4' 2.953(8) 
F6…H5 2.082b F6…N2 3.175(9) 
P1…N2 3.781(6)b F6…N5 2.855(7)b
a For atom numbers, see Figures 4.6-4.8. b Shortest F…H, P…N and F…N distances [Å] in 8+ PF6
–
.CH2Cl2: 2.195; 3.802(3); and 2.939(4).
75
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The three NH units on the nitrogen atoms remote from the ruthenium atom, N5-
H5, N2-H2, and N4-H4B, exhibit an approximately synperiplanar NH triad as evidenced 
by H-N-N-H torsion angles that are reasonably close to 0° (38.4°, –19.1°, 14.9°; average 
difference from 0°, 24.1(12)°). The other two NH units, N1-H1 and N4-H4A, exhibit an 
approximately synperiplanar NH dyad with a torsion angle of –35.0°. The NH units in 
48+ BArf
H2O more closely resemble a synperiplanar NH triad than they do in 48
+
PF6
–.(C5H12)1.5 (average difference from 0°, 24.1(12)° vs. 33.5(15)°). This is clear from
Figure 4.7, which shows the overlaid structures of both the cations. 
Table 4.8 Selected O…H and O…N distances [Å] in 48+ BArf
–.H2O.
a,b
O1…H2 2.046b O1…N2 2.796b
O1…H4B 2.281 O1…N4 3.043 
O1…H5 3.434 O1…N5 3.903 
a
 For atom numbers, see Figure 4.7. b Shortest F…H and F…N distances [Å] in 48+ PF6
–.(C5H12)1.5:
2.029 and 2.855(7). 
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According to the full paper associated with chapter 2,75 the Ru-P distance in the 
hexafluorophosphate salt 8+ PF6
CH2Cl2 is slightly shorter than that in 8
+
BArf
CH2Cl2 salt (2.302(3) Å vs 2.3154(10) Å). The former cation is hydrogen bonded
to the anion while no such interactions are present in the latter. Hydrogen bonding with 
the anion increases electron density on ruthenium and enhances back bonding.75 This 
leads to a slightly shorter Ru-P bond in the former salt as PF6
 is a better hydrogen bond
acceptor.60 However in contrast, the Ru-CO distance in the salt 48+ BArf
H2O
(1.868(4) Å) is similar to that in 48+ PF6
(C5H12)1.5 (1.860(6) Å). Due to the solvate in
the former, both the cations now have hydrogen bonding opportunities.  
The deprotonated GBI complex 49 was also characterized by X-ray 
crystallography. X-ray data were collected and refined as described in the experimental 
section and Table 4.3. The resulting structure is shown in Figure 4.8. Key metrical data 
are summarized Table 4.4.  
The cation is formally octahedral, with the pentaphenylcyclopentadienyl ligand 
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occupying three coordinating sites, as evident from the OC-Ru-N and N-Ru-N bond 
angles of ca. 90°. The ruthenium-nitrogen bond lengths are similar to those in 
literature.75,104,116 The GBI ligand is slightly puckered. As one approach to quantifying 
this, consider the many torsion angles with values near 0° or ±180°. The average 
differences from 0° and 180° are 17.0(14)° and 24.1(19)°, respectively. 
The carbon nitrogen bond length of the coordinated CNH (C1-N1) linkage is 
considerably shorter than that of the coordinated CNAr (C2-N3) linkage (1.295(4) vs. 
1.348(4) Å). At the same time, the non-coordinated C2-N5 linkage is shorter than the 
C2-N2, C1-N2, and C1-N4 linkages (1.339(4) vs. 1.389(4), 1.365(4), and 1.354(4) Å). 
For reference, typical carbon nitrogen double bond lengths are 1.279 Å168 (Ph(H)C=NR 
(R = Ph, 1.286(8) Å; R = Me, 1.284(10) Å))169 and single bond lengths (Csp2-N) range
from 1.355 Å (Csp2-Nsp2) to 1.416 Å (Csp2-Nsp3).
168 These data are best modeled by a
tautomer of 49 that has been deprotonated at N5 and exhibits the dominant resonance 
form shown in Scheme 4.4 (C=NH for C1-N1, C-NAr for C2-N3, and C=NAr for C2-
N5). 
Two NH units on the nitrogen atoms remote from the ruthenium atom, N2-H2 
and N4-H4B, exhibit a roughly synperiplanar NH dyad, as reflected by a H-N-N-H 
torsion angle reasonably close to 0° (38.0°). The other two NH units, N1-H1 and N4-
H4A, exhibit a more synperiplanar NH dyad, as evidenced by a torsion angle of 11.5°.  
In 49, the GBI ligand is even more puckered than it is in 48+ PF6
(C5H12)1.5.
The average differences of ligand-based torsion angles from 0° or ±180° now increases 
to 17.0(14)° and 24.1(19)° as opposed to 16.6(13)° and 19.1(15)°. This is clearly 
illustrated in Figures 4.7 and 4.9. 
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4.2.3 Hydrogen bonding and catalysis in the second coordination sphere 
4.2.3.1 Hydrogen bonding in the second coordination sphere 
As shown in chapter 2 (Figure 2.5), the addition of dimethyl malonate (10a) to 9+ 
BArf
2H2O has been probed by 
1H NMR. Due to NHO interactions between 10a and
the cation, three NH units of the ruthenium complex shifted downfield (at 1.0 equiv of 
10a; Δδ (ppm) = 0.89, 0.50, and 0.27; Δν (Hz) = 445, 250, and 135), while the Ru-NH 
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unit shifted upfield. Thus, a similar experiment with 10a and the hydrate 48+ 
BArf
4H2O was conducted.
As shown in Figure 4.10, 10a was added to 48+ BArf
4H2O. The 
1H NMR
signals of three of the four types of NH units (H5 (orange)/H2 (green)/H4 (purple)) 
shifted progressively downfield with the addition of increasing amounts of 10a (0.5 and 
1.0 equiv). At 1.0 equiv of 10a, the  values (ppm) were 1.08, 0.52, and 0.32 (Δν (Hz) 
= 540, 260, and 160), respectively. On the other hand, one NH unit (H1 (magenta)) and 
the H2O signal shifted upfield and at 1.0 equiv of 10a the  (ppm) values were .15 
and 0.16.  
Based on the  (ppm) data, the two most probable host-guest adducts would be 
LXXVa and LXXVb, as shown in Figure 4.11 (top). Out of these two, LXXVa is most 
likely the dominant form as the NH5 signal is shifted to a greater extent than the NH4 
signal. However, it should be kept in mind that there are two protons on N4, as opposed 
only one on N5. These two remain in rapid equilibrium on the NMR time scale in the 
presence of 10a, as evidenced by a single signal. Hence, adduct formation will have an 
intrinsically greater effect on the NH5 signal.  
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Comparing the relative downfield shifts in the cases of 48+ BArf
4H2O and 9
+
BArf
2H2O with 1.0 equiv of 10a, the host guest interaction with 10a appears to be
slightly stronger in the former ( (ppm) = 1.08 vs. 0.89, 0.52 vs. 0.50, and 0.32 vs. 
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0.27; Δν (Hz) = 540 vs. 445, 260 vs. 250, and 160 vs. 135). 
4.2.3.2 Catalysis in the second coordination sphere 
Once enantiopure (SRu)-48
+ BArf
 was obtained (Scheme 4.5), the stage was set
for employing this hydrogen bond donor as a catalyst. The condensation of 1-
methylindole (5a) and trans-ß-nitrostyrene (6) to give 3-substituted indoles (7a) was 
studied first, using conditions identical to those mentioned in chapters 2 (Table 2.9) and 
chapter 3 (Table 3.3). This is a benchmark reaction that can be effected with many 
hydrogen bond donor catalysts.68 The enantioselectivities were assayed by chiral HPLC 
as tabulated below. 
Thus, 1-methylindole (5a; 2.0 equiv) was treated with 6 (1.0 equiv) in the 
presence of 5-10 mol% of (SRu)-48
+ BArf
 in CD2Cl2 at room temperature under
aerobic conditions (Table 4.9, entries 1a,b). The reactions were clean and after 1-3 h, 
workups gave 1-methyl-3-(2-nitro-1-phenylethyl)-1H-indole (7a)68a in ≥95% yields. 
However, chiral HPLC analyses indicated racemic products. 
Next, a Michael addition reaction mentioned in chapter 3 was chosen for further 
screening. The addition of 2,4-pentanedione (20) to 6 was efficiently catalyzed in the 
presence of (RRuRCRC)-18c
+ PF6
− or (SRuRCRC)-18c
+ PF6
− at room temperature (see
Table 3.5, entry 1). As both the diastereomers of 18c+ PF6
− contain a NMe2 moiety, no
external base was added. After 24 h, workups gave 70-75% yields of 3-(2-nitro-1-
phenylethyl)pentane-2,4-dione (21).123 Chiral HPLC analysis indicated an extremely 
high ee (>99%).  
As shown in Table 4.9 (entries 2), the addition of 20 to 6 in CD2Cl2 using 10 
mol% of (SRu)-48
+ BArf
 in CD2Cl2 at 78 °C under aerobic conditions was
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investigated. The reaction was monitored by TLC. The formation of product 21 was only 
observed in the presence of 10 mol% of both (SRu)-48
+ BArf
 and NEt3 (entries 2a,b vs.
entry 2c). After 24 h, workup gave 21 in >99% yield. However, chiral HPLC analysis 
indicated a racemic product. 
Analogously, malononitrile (26) and 6 were reacted in the presence of 10 mol% 
of both (SRu)-48
+ BArf
– and NEt3 in CD2Cl2 at 35 °C (Table 3.5, entriy 3a). The
reaction was also monitored by TLC. After 1 h, workup gave the product 27 in 80% 
yield.21a However, chiral HPLC analysis again indicated a racemic product. 
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4.2.3.3 Enantioselective catalysis in the second coordination sphere 
Next the focus was shifted to a different kind of hydrogen bond acceptor, trans-
3-cinnamoyloxazolidin-2-one (50; Table 4.10, entry 1), based on a 2-oxazolidinone core 
(Table 4.10, box). This core is immensely popular in chemistry related to the Evans 
chiral auxiliary.170 Compound 50 recently has been utilized as a substrate in 
organocatalyzed tandem Michael addition reactions.171 Some derivatives of 50 have also 
been used in organocatalyzed Michael additions of thiols. Many hafnium based Lewis 
acids have also been found to catalyze the addition of thiols to the Michael acceptor 50 
in moderate yields (10-70%), but the enantioselectivities with the enantiopure catalyst 
have been poor (43-59% ee).172 Hence, this reaction was investigated (Table 4.10, entry 
1). 
Initially, 50 (2.0 equiv) was treated with thiophenol (28, 1.0 equiv) in the 
presence of NEt3 (1.0 equiv) and 10 mol% of (SRu)-48
+ BArf
 in toluene at 78 °C
(Table 4.10, entry 1a). After 12 h, workup gave only a 25% yield of the product, 3-(3-
phenyl-3-(phenylthio)propanoyl)oxazolidin-2-one (51).172 Gratifyingly, chiral HPLC 
analysis indicated an extremely high ee value (>99%). Although this compound has been 
prepared earlier in enantioenriched form, the absolute configuration of the enantiomer 
was not assigned.172 Compound 50 was not highly soluble under the reaction condition 
and crashed out of the solution. This might be the reason for low yield. An analogous 
reaction under more dilute conditions and using a longer reaction time gave 51 in 60% 
yield and in >99% ee (entry 1b). 
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Similarly, 3-(2-methyl-2-propenoyl)oxazolidin-2-one (52) and 28 were reacted in 
the presence of NEt3 (1.0 equiv) and 10 mol% of (SRu)-48
+ BArf
 in toluene at 78 °C
(Table 4.10, entry 2). After 24 h, workup gave a 70% yield of the product 53, for which 
the configuration of the enantiomers had been previously assigned.173 Chiral HPLC 
analysis of the product indicated a 7% ee. 
4.2.3.4 Multifunctional catalysis in the second coordination sphere 
Complex 49 contains a benzimidazolic nitrogen that has been deprotonated, as 
shown in Figure 4.8 and Table 4.6. The reprotonation of this nitrogen is vital in the 
resolution of the chiral-at-metal ruthenium complex, as shown in Scheme 4.5. This 
indicates that 49 can act as a base and raises the possibility that it could participate in 
base catalyzed reactions. Importantly, reattachment of the proton transforms the 
170 
ruthenium fragment into a hydrogen bond donor with a synperiplanar DDD triad 
(Figures 4.6-4.9 and Table 4.6). As demonstrated in chapters 2 and 3 and Tables 4.9 and 
4.10, this motif promotes reaction via second coordination sphere hydrogen bonding. To 
investigate the possibilities of 49 acting as a catalyst, Michael addition reactions between 
1,3-dicarbonyl equivalents and 6 were investigated (Table 4.11). These are benchmark 
reactions for hydrogen bond donor catalysts that incorporate bases for additional 
functionality.120  
First, diethyl malonate (10b; 2.0 equiv) was treated with 6 (1.0 equiv) in the 
presence of 10 mol% of 49 and the internal standard Ph2SiMe2 in CD2Cl2 at room 
temperature under aerobic conditions (Table 4.11, entry 1). The reaction was monitored 
by 1H NMR. A clean conversion to the addition product, ethyl-2-carboethoxy-4-nitro-3-
phenylbutyrate (19a),120a was observed. After 24 h, workup gave 19a in 75% yield.  
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To extend the scope of this strategy, 26 and 6 were reacted in the presence of 10 
mol% of 49 in CD2Cl2 (Table 4.11, entry 2). After 1 h, workup gave the product 27 in 
90% yield.21a  
4.3 Discussion 
4.3.1 Second coordination sphere promoted catalysis 
The successful syntheses of the salts 48+ X containing bulky cyclopentadienyl 
ligands were achieved in this chapter (Table 4.1-4.4 and Scheme 4.4). These were 
extended to the formation of a neutral complex 49 by treatment with K+ t-BuO 
(Scheme 4.4). Protonation of this neutral compound with an enantiopure acid, separation 
of the diastereomers, and subsequent anion metathesis afforded the resolved catalyst 
(SRu)-48
+ BArf
 (Scheme 4.5 and Figure 4.2). This differs from the chiral catalysts in
chapter 3 in the absence of a conventional carbon stereocenter. 
The facility with which 48+ X can enter into hydrogen bonding interactions is 
evidenced by the NMR data in Figure 4.10 and the crystal structures in Figures 4.5 and 
4.6. The results presented in Tables 4.9 and 4.10 clearly indicate that 48+ BArf
 acts as a
hydrogen bond donor catalyst and promotes simple organic transformations. Based on 
the evidence provided above, it is clear that the catalyst activates the substrate through 
hydrogen bonding in the second coordination sphere and hence these catalyzed reactions 
are examples of second coordination sphere promoted catalysis (SCSPC). 
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4.3.2 Transition state assemblies for Table 4.10 
In an effort to overcome the poor enantioselectivity with 6 (Table 4.9), a 
hydrogen bond acceptor based on a 2-oxazolidinone backbone, 50, was considered 
(Table 4.10). It was hypothesized that the electronically differentiated carbonyl groups 
(Figure 4.11, blue and red) would preferentially direct the binding of the catalyst to one 
regiochemical form over the other (Figure 4.11, top). Furthermore, the C=C-C=O single 
bond in 50 can adopt either a s-cis or s-trans conformation (50a/b). The two conformers 
present opposite C=C enantiofaces with respect to either side of the approximately 
planar Ph-C=C-C=O assembly. However, the s-trans conformation encounters A1,3 
strain between the vinyl (C=CHPh) and NCH2 protons and thus the s-cis conformation is 
favored by approximately 4.5 kcal/mol.174  
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As shown in Figure 4.12, the electronically differentiated C=O groups are 
suggested to promote regioselective dyad binding, and the A1,3 strain an s-cis C=C-C=O 
conformation. The enhanced radial extension of the pentaphenylcyclopentadienyl ligand 
blocks the approach of the nucleophile to the re,re C=C face, so that the nucleophile 
must approach the si,si C=C face from the bottom as in Figure 4.12. Importantly, the 
absolute configuration of the major enantiomer from the reaction of 50 and 28 has not 
been established. Thus, it may prove necessary to switch the regioselectivity with which 
28 binds to the dyad in this model.  
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With respect to the substrate 52, which features a methyl substituent α to the 
amide carbonyl group and a terminal alkene, the relevant s-cis and s-trans conformations 
are depicted in Figure 4.13. Now both are destabilished by A1,3 strain, and no clear 
C=C-C=O conformational preference is expected, either in the free ligand or a hydrogen 
bonded assembly. Accordingly, the product 53 is nearly racemic. 
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4.3.3 Multiple role of the metal 
Attaching ruthenium to GBI primarily creates a second coordination sphere 
where the substrate can bind with the synperiplanar NH DDD triad. In the case of C=C 
conjugated carbonyl and nitro substrates, this will polarize the π-system. This activates 
the substrate towards nucleophiles. The ruthenium complex can also provide the 
necessary chiral atmosphere for enantioselective product formation, as seen in Table 
4.10 (entries 1a and 1b).  
The scope of this system can be further expanded where the ligand can have 
additional functionality. Initially, 49 is a neutral compound due to the combination of the 
anionic GBIH ligand and a [(η
5-C5Ph5)Ru(CO)]
+ fragment. Compound 49 is devoid of
the DDD triad and the remaining NH protons distort from synperiplanarity as evident 
from the crystal structure (Figures 4.7-4.9). This syn arrangement is an important feature 
of the immensely popular thiourea based hydrogen bond donors.8f,13a  
When the deprotonated benzimidazolic nitrogen regains the proton by 
deprotonating a substrate, the complex turns cationic. The conjugate base has to pair 
with the substrate derived counter anion as there is no other anion to compete. In the 
process, the cationic species has regained its DDD triad and can activate either the 
conjugate base further or any other substrate by hydrogen bonding. Thus, in theory, 49 
would be a multifunctional catalyst: (1) acting as a base to activate one substrate, (2) 
serving as a hydrogen bond donor to activate the other substrate, and (3) ion pairing with 
the conjugate base of the more acidic substrate.  
The successful catalytic reactions shown in Table 4.11 clearly reflect this 
multifunctionality of 49. Scheme 4.6 illustrates the possible activation modus. When 
diethyl malonate ester (10b) is added to 49, an equilibrium will be reached between 49 
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and 48+ CH(CO2Et)2
. Complex 48+ CH(CO2Et)2
 is depicted as a cationic ruthenium
species with the conjugate base of 10b as the counter anion. The conjugate base can 
react further with any other reactant. Finally, the initial anionic addition intermediate can 
deprotonate the benzimidazolic proton of the cation in 48+ CH(CO2Et)
 and complete
the reaction. In doing so, the neutral ruthenium complex 49 is reformed. This can 
activate another substrate and carry on the catalytic cycle. This model nicely fits with the 
results (Table 4.11) as a catalytic amount (10 mol%) of 49 was enough to effect 
reactions in 75-90% yields without any external base.  
Similar concepts have recently been explored by Meggers with the iridium 
complex LXXIX (Figure 4.17).175 In the same vein, here also a neutral iridium complex 
is transformed to a cationic species during the course of the catalytic cycle. It activates 
one of the substrates by deprotonating and the other by hydrogen bonding. Finally, high 
enantioselectivities were also observed for the products. The entire process of substrate 
activation, deprotonation, and condensation happens in the second coordination sphere 
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and broadens the scope of second coordination sphere promoted catalysis. 
4.4 Conclusion 
The elaboration of the chiral cationic cyclopentadienyl ruthenium GBI 
complexes to pentaphenylcyclopentadienyl ruthenium GBI complexes enables the facile 
resolution of the enantiomers and provides a new set of catalysts to be applied in 
hydrogen bond donor promoted enantioselective organic transformations. The chelation 
of GBI preorganizes the NH moieties of the ligand into synperiplanar arrays, and their 
acidities are increased relative to cyclopentadienyl analogs.  
Unlike most transition metal catalyzed reactions, there is no direct interaction of 
the substrate with the ruthenium; rather, hydrogen bonds derived from NH groups 
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remote from the metal center are involved. These chiral-at-metal complexes contains no 
additional ligand chirality, contrary to the catalysts in chapter 3, and hence 
enantioselection is a sole function of the metal chirality. As the hydrogen bonding 
interactions, activation of the substrates, and promotion of the enantioselective 
transformations occur in the second coordination sphere, these results extend the horizon 
of second coordination sphere promoted catalysis (SCSPC). However, unless special 
features are built into the substrate, the enantioselectivities generally appear to be lower 
than with the catalyst in chapter 3. 
Finally, it has been shown that deprotonated variants, which are neutral, can 
function as bases, thereby further activating substrates in what can be viewed as 
multifunctional second coordination sphere promoted catalysis. This constitute yet 
another promising direction for future investigation. 
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4.5 Experimental Section
4.5.1 General data 
1H, 13C{1H}, and 31P{1H} NMR spectra were recorded on standard 500 MHz 
spectrometers at ambient probe temperature (24 °C) and referenced as follows (, ppm): 
1H, residual internal CHCl3 (7.26), CHD2OD (3.30), or CHDCl2 (5.32); 
13C, internal
CDCl3 (77.0), CD3OD (49.1), or CD2Cl2 (53.9); 
31P{1H}, external H3PO4 (0.0). IR
spectra were recorded using a Shimadzu IRAffinity-1 spectrophotometer with a Pike 
MIRacle ATR system (diamond/ZnSe crystal). Circular dichroism spectra were obtained 
using a Chirascan CD Spectrometer (Applied Photophysics). Melting points were 
recorded with a Stanford Research Systems (SRS) MPA100 (Opti-Melt) automated 
device. Microanalyses were conducted by Atlantic Microlab. HPLC analyses were 
conducted with a Shimadzu instrument package (pump/autosampler/detector LC-
20AD/SIL-20A/SPD-M20A; columns Chiralpak AD, Chiralpak AD-H, Chiralpak AS-H, 
Chiralcel OD, Chiralcel OD-H).  
Solvents were treated as follows: toluene, hexanes, Et2O, and CH2Cl2 were dried 
and degassed using a Glass Contour solvent purification system; CH3CN (99.5% BDH); 
pentane (99.7%, J. T. Baker), MeOH (99.8%, BDH), CDCl3, CD2Cl2, and CD3OD (3  
Cambridge Isotope Laboratories) were used as received. The 2-guanidinobenzimidazole 
(GBI; 95%, Aldrich), 1-methylindole (5a; 98%, Acros Organics), trans-β-nitrostyrene 
(6; 99%, Alfa Aesar), (S)-1,1'-binaphthyl-2,2'-diyl hydrogen phosphate or (P)-1,1'-
binaphthyl-2,2'-diyl hydrogen phosphate ((P)-12; 98%, Alfa Aesar), 2,4-pentanedione 
(20; 99%, Aldrich), malononitrile (26; 98%, TCI), thiophenol (28; 97%, Aldrich), NEt3 
(99%, Alfa Aesar), Ag+ PF6
 (99%, Alfa Aesar), Me3NO
.2H2O (98%, TCI), Ru3(CO)12
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(99%, Aldrich), CH3COOH (≥99.7%, Aldrich), K
+ t-BuO (97%, Alfa Aesar), PhLi (2.0
M in Bu2O, Aldrich), HBr (45% w/v in CH3COOH, Alfa Aesar), silica gel (SiliFlash 
F60, Silicycle), neutral alumia (Brockmann I, 50-200 μm, Acros Organics), and celite 
were used as received. 
Compounds trans-3-cinnamoyloxazolidin-2-one (50) and 3-(2-methyl-2-
propenoyl)oxazolidin-2-one (52) were prepared following literature procedures.176,177 
Reactions in Schlenk flasks were carried under nitrogen atmospheres. Other reactions 
and workups were carried out under air.  
4.5.2 Syntheses and catalysis 
1,2,3,4,5-pentaphenylcyclopenta-2,4-dien-1-ol (44).165 A Schlenk flask was 
charged with tetraphenylcyclopentadienone (45, 2.50 g, 6.56 mmol)166 and Et2O (50
mL) with stirring. The mixture was cooled to 0 °C and PhLi (2.0 M in Bu2O; 5.00 mL, 
10.0 mmol) was added dropwise with vigorous stirring. The ice bath was removed and 
the grey-yellow suspension was stirred. After 2 h, the mixture was cooled to 0 °C and 
HCl (1.0 M in H2O) was added slowly, followed by H2O (5 mL). A pale brown 
precipitate formed. Then CH2Cl2 (30 mL) was added, giving an organic/aqueous 
liquid/liquid biphasic system. The organic layer was separated, washed with H2O (3 × 5 
mL), and dried (Na2SO4). The solvent was removed by oil pump vacuum (rt, then 40 
°C) to give 44 as a pale yellow solid (2.43 g, 5.25 mmol, 80%). 
NMR (, CDCl3):
165 1H (500 MHz) 7.57 (d, 2H, 3JHH = 7.1 Hz), 7.27 (t, 1H,
3JHH = 7.8 Hz), 7.19-7.10 (m, 7H), 7.08-6.97 (m, 14H), 2.46 (s, 1H); 
13C{1H} (125 
MHz) 147.9, 142.5 (2  s, i-CPhCCOH and i-CPhC=CCOH), 140.1 (s, i-CPhCOH), 
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135.0, 133.8 (2  s, C=CCOH and C=CCOH), 129.9, 129.5, 127.9, 127.7, 127.0, 127.1 
(6  s, o- and m-CPhCCOH, o- and m-CPhC=CCOH, and o- and m-CPhCOH), 128.4 (s, 
p-CPhCCOH or p-CPhC=CCOH), 126.9 (s, p-CPhCOH), 125.0 (s, p-CPhC=CCOH or p-
CPhCCOH), 90.2 (s, COH). 
 
5-Bromo-1,2,3,4,5-pentaphenyl-1,3-cyclopentadiene (43).165 A round bottom 
flask was charged with 44 (1.50 g, 3.20 mmol) and CH3COOH (12 mL) with stirring. 
The mixture was refluxed and cooled to room temperature, giving an orange solution. 
Then HBr (0.60 mL) was added. The resulting suspension was refluxed. After 30 min, 
the oil bath was allowed to cool to room temperature. After 4 h, the orange precipitate 
was isolated by filtration, washed with H2O (3 × 10 mL), and dried by oil pump vacuum 
(60 °C, 12 h) to give crude 43. The residue was then chromatographed on a silica gel 
column (3 × 15 cm, 80:20 v/v hexanes/CH2Cl2) to give 43 as orange yellow solid (1.27 
g, 2.43 mmol, 76%), which was light sensitive and stored in the dark. 
 
NMR (, CDCl3):
165 1H (500 MHz) 7.58-7.52 (m, 3H), 7.30-7.26 (m, 5H), 7.18-
6.89 (m, 17H); 13C{1H} (125 MHz) 148.2, 141.8 (2  s, i-CPhCCBr and i-CPhC=CCBr), 
135.8 (s, i-CPhCBr), 134.6, 134.1 (2  s, C=CCBr and C=CCBr), 130.4, 130.0 (2  s, o- 
and m-CPhCCBr), 128.3 (s, p-CPhCCBr), 127.8 (s, p-CPhCBr or p-CPhC=CCBr), 127.7 
(s, o/m-CPhC=CCBr), 127.4 (s, p-CPhC=CCBr or p-CPhCBr), 127.4 (s, m/o-
CPhC=CCBr), 127.1, 127.0 (2  s, o- and m-CPhCBr), 76.6 (s, CBr).  
 
(η5-C5Ph5)Ru(CO)2Br (42).
163 A Schlenk flask was charged with 43 (0.247 g, 
0.470 mmol), Ru3(CO)12 (0.100 g, 0.156 mmol), and toluene (6 mL) with stirring. The 
mixture was refluxed. After 4 h, the oil bath was removed. After 4 h, the solvent was 
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removed by rotary evaporation and the residue was chromatographed on a silica gel 
column (3 × 20 cm, 80:20 → 20:80 v/v hexanes/CH2Cl2). The solvent was removed 
from the product containing fractions by oil pump vacuum to give 42 as a greenish 
yellow solid (0.240 g, 0.352 mmol, 75%). 
 
NMR (, CD2Cl2):
178 1H (500 MHz) 7.23 (tt, 5H, 3JHH = 7.2 Hz, 
4JHH = 1.5 Hz, 
p-CPhH), 7.11 (tt, 10H, 
3JHH = 8.1 Hz, 
4JHH = 2.2 Hz, o-CPhH), 7.07-7.05 (m, 10H, m-
CPhH); 
13C{1H} (125 MHz) 197.2 (s, CO), 132.7 (s, o-CPh), 130.0 (s, i-CPh), 128.7 (s, 
p-CPh), 128.10 (s, m-CPh), 107.1 (s, C5Ph5). 
 
[(η5-C5Ph5)Ru(CO)(GBI)]
+ PF6
 (48+ PF6
). A Schlenk flask was charged 
with 42 (0.200 g, 0.293 mmol), CH3CN (10 mL), and (after 2 min) Me3NO
.2H2O (0.032 
g, 0.29 mmol) with stirring. Within 5 min, the suspension became an orange solution. 
Then GBI (0.051 g, 0.29 mmol) was added. After 15 min, Ag+ PF6
 (0.074 g, 0.29 
mmol) was added. After 16 h, the solvent was removed by rotary evaporation. Then 
CH2Cl2 (10 mL) was added. The suspension was passed through celite, which was 
washed with CH2Cl2 (3  10 mL). The solvent was removed from the combined filtrates 
by rotary evaporation. The residue was chromatographed on a silica gel column (3  25 
cm, 100:2 v/v CH2Cl2/MeOH). The solvent was removed from the product containing 
fractions by rotary evaporation. The residue was washed with 50:50 v/v CH2Cl2/hexane 
(3  30 mL) and dried by oil pump vacuum to give 48+ PF6
 as a bright green solid 
(0.199 g, 0.204 mmol, 70%), dec. pt. 156 °C (capillary). Anal. Calcd for 
C44H34F6N5OPRuC6H14: C 61.22, H 4.93, N 7.14. Found C 61.29, H 4.67, N 7.93.
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NMR (, CD2Cl2):
179 1H (500 MHz) 7.35 (d, 1H, 3JHH = 8.0 Hz, CH7/8), 7.20-
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7.14 (m, 7H, p-CPhH, CH5/6, and CH8/7), 7.02 (t, 10H, 
3JHH = 7.2 Hz, m-CPhH),
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6.95-6.90 (m, 11H, o-CPhH and CH6/5), 5.48 (br s, 2H, H2NC=NH ), 4.77 (s, 1H, 
RuNH), 1.27 (m, C6H14), 0.98-0.82 (m, C6H14);
181 13C{1H} (125 MHz) 205.3 (s, CO), 
154.3 (s, C1), 146.0 (s, C2), 141.1 (s, C3), 141.5 (s, C4), 132.3 (s, o-CPh), 131.9 (s, i-
CPh), 128.1 (s, m-CPh and p-CPh),
182 124.1 (s, C5), 122.3 (s, C6), 118.9 (s, C7), 111.8 
(s, C8), 100.6 (s, C5Ph5), 30.2, 24.1, 14.3 (3  s, C6H14). 
 
IR (cm1, powder film): 3367 (m), 3057 (m), 2960 (w), 2924 (w), 1948 (s, CO), 
1674 (s), 1558 (m), 1500 (s), 1462 (w), 1444 (m), 1398 (m), 1259 (w), 1076 (m), 1028 
(s), 1014 (m), 840 (s), 800 (s), 738 (s), 698 (s) 
 
[(η5-C5Ph5)Ru(CO)(GBI)]
+ BArf
 (48+ BArf
).26 A Schlenk flask was charged 
with 42 (0.0200 g, 0.0293 mmol), CH3CN (1 mL), and (after 1 min) Me3NO
.2H2O 
(0.0032 g, 0.029 mmol) with stirring. Within 5 min, the suspension became an orange 
solution. Then GBI (0.0051 g, 0.029 mmol) was added. After 15 min, Ag+ PF6
 (0.0074 
g, 0.029 mmol) was added. After 16 h, the solvent was removed by rotary evaporation. 
Then CH2Cl2 (1 mL) was added. The suspension was passed through celite, which was 
washed with CH2Cl2 (3  1 mL). The solvent was removed from the combined filtrates 
by rotary evaporation. The residue was chromatographed on a alumina column (3  15 
cm, 95:5 → 75/25 v/v CH2Cl2/MeOH). The solvent was removed from the product 
containing fractions by oil pump vacuum to give 48+ X where X– is principally derived 
from the alumina (<5% PF6
–).104  
A round bottom flask was charged with 48+ X (0.025 g, ca. 0.033 mmol if the 
mass is considered to represent the cation), CH2Cl2 (2 mL), H2O (1 mL), and Na
+ BArf
 
(0.029 g, 0.033 mmol)26,65 with stirring. After 30 min, the organic layer was separated, 
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washed with H2O (3  3 mL), and dried (Na2SO4). The evaporation of the solvent by 
rotary evaporation led to partial decomposition of the compound. Therefore, the solvent 
was removed by purging N2 through the solution. Then 30:70 v/v CH2Cl2/hexane (4 
mL) was added and the mixture was passed through a short plug of celite. The solvent 
was removed by purging N2 through the filtrate. Hexanes (2 mL) was added to give a 
suspension. The solvent was removed by purging N2 through the mixture. This 
hexane/purge cycle was repeated to give 48+ BArf
4H2O (0.040 g, 0.023 mmol, 69%) 
as a dirty green solid, dec. pt. 105 °C (capillary). The sample appeared to partially 
decompose under oil pump vacuum. Hence, it was dried in air for one week. Anal. Calcd 
for C76H46BF24N5ORu(H2O)2: C 55.57, H 3.21, N 4.21. Found C 55.76, H 3.37, N 
3.95. Calcd for C76H46BF24N5ORu(H2O)4 (per the integration of the H2O peak in the 
undried sample used for 1H NMR): C 54.40, H 3.38, N 4.12. 
 
NMR (, CD2Cl2):
179 1H (500 MHz) 9.47 (br s, 1H, NH), 8.36 (br s, 1H, NH), 
7.72 (s, 8H, o-B(C6H3(CF3)2)4), 7.56 (s, 4H, p-B(C6H3(CF3)2)4), 7.37 (d, 1H, 
3JHH = 
7.8 Hz, CH7/8), 7.27-7.25 (m, 2H, CH5/6 and CH8/7), 7.19 (t, 5H, 3JHH = 7.6 Hz, p-
CPhH), 7.04 (t, 10H, 
3JHH = 8.7 Hz, m-CPhH),
180 7.02-6.95 (m, 1H, CH6/5), 6.92 (t, 
10H, 3JHH = 7.6 Hz, o-CPhH), 5.13 (s, 1H, RuNH), 5.05 (br s, 2H, H2NC=NH), 1.80 (br 
s, 8H, H2O); 
13C{1H} (125 MHz) 204.5 (s, CO), 162.5 (q, 1JCB = 50.7 Hz, i-
C6H3(CF3)2), 152.9 (s, C1), 144.0 (s, C2), 140.9 (s, C3), 135.2 (s, o-C6H3(CF3)2), 
132.4 (s, C4), 132.3 (s, o-CPh), 131.5 (s, i-CPh), 129.2 (q, 
2JCF = 29.1 Hz, m-
C6H3(CF3)2), 128.4 (s, p-CPh),
180 128.2 (s, m-CPh),
180 125.3 (s, C5), 124.9 (q, 1JCF = 
271.7 Hz, C6H3(CF3)2), 124.1 (s, C6), 119.6 (s, C7), 117.9 (s, p-C6H3(CF3)2), 111.5 (s, 
C8), 100.4 (s, C5Ph5). 
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IR (cm1, powder film): 3689 (w), 3649 (w), 3450 (w), 3401 (w), 1977 (m, CO), 
1681 (m), 1608 (w), 1564 (m), 1354 (s), 1274 (s), 1163 (s), 1114 (s), 1091 (m), 1029 
(w), 927 (w), 889 (w), 839 (w), 742 (s), 700 (s), 680 (s), 669 (s). 
 
(η5-C5Ph5)Ru(CO)(GBIH) (49).
26 A round bottom flask was charged with 48+ 
PF6
 (0.462 g, 0.459 mmol), K+ t-BuO (0.360 g, 3.21 mmol), CH2Cl2 (100 mL), and 
H2O (30 mL) with stirring. A yellow suspension began to form within a few minutes. 
After 2 h, MeOH (10 mL) was added to the organic/aqueous liquid/liquid biphase 
system. The organic layer was separated, washed with H2O (3  4 mL), and dried 
(Na2SO4). The solvent was removed by rotary evaporation. The residue was washed 
with CH2Cl2 (3  10 mL) and dried by oil pump vacuum to give 49 as a bright yellow 
powder (0.250 g, 0.334 mmol, 73%), dec. pt. 160 °C (capillary). Anal. Calcd for 
C44H35N5ORu: C 70.57, H 4.44, N 9.35. Found C 71.00, H 4.65, N 9.01. 
 
NMR (, CD2Cl2/CD3OD):
179,183 1H (500 MHz) 7.16 (d, 1H, 3JHH = 7.7 Hz, 
CH8),180 7.09 (t, 5H, 3JHH = 7.3 Hz, p-CPhH), 7.03 (d, 1H, 
3JHH = 7.9 Hz, CH7),
180 
6.99-6.88 (m, 21H, m-CPhH, o-CPhH, and CH6), 6.72 (t, 1H, 
3JHH = 7.7 Hz, CH5);
180 
13C{1H} (125 MHz) 207.8 (s, CO), 159.0 (s, C1), 154.4 (s, C2), 143.9 (s, C3), 137.9 (s, 
C4), 133.0 (s, i-CPh), 132.6 (s, o-CPh), 127.7 (s, m-CPh),
180 127.4 (s, p-CPh),
180 120.7 
(s, C5), 119.9 (s, C6), 117.3 (s, C7), 111.7 (s, C8), 101.4 (s, C5Ph5). 
IR (cm1, powder film): 3479 (w), 3369 (w), 3059 (w), 2956 (w), 2922 (w), 2852 
(w), 1934 (s, CO), 1668 (m), 1622 (w), 1602 (w), 1566 (m), 1502 (w), 1444 (w), 1375 
(s), 1261 (w), 1240 (s), 1074 (m), 1028 (w), 920 (w), 864 (w), 844 (w), 800 (w), 783 
(w), 740 (s), 700 (s). 
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(RRu/SRu)-48
+ (P)-Phos.26 A round bottom flask was charged with CD2Cl2 (2 
mL), 49 (0.075 g, 0.10 mmol), and 12 (0.035 g, 0.10 mmol) with stirring. Within 2 min, 
a clear solution was obtained. After 10 min, the solution was filtered through a short 
plug of celite. The filtrate was added dropwise to hexanes (5 mL) with stirring. A pale 
green precipitate formed. The solvent was removed by oil pump vacuum to give 
(RRu/SRu)-48
+ (P)-Phos as a pale green solid (0.10 g, 0.092 mmol, 92%) as a 
50±2:50±2 mixture of Ru,Axial configurational diastereomers, as assayed by 1H NMR 
using the NH protons at 4.45 and 4.92 ppm. 
 
NMR (, CD2Cl2; signals for diastereomers are separated by "/"):
179,184 1H (500 
MHz) 13.67/13.16 (br s, 1H, NH), 12.30/10.81 (br s, 1H, NH), 8.12 (br s, 2H, H(P)-
Phos), 7.95 (d, 2H, 
3JHH = 7.3 Hz, H(P)-Phos), 7.59 (br s, 2H, H(P)-Phos), 7.36-7.23, 7.19-
7.13, 7.08-6.98, 6.97-6.90, 6.84-6.82 (5  m, 6H, 3H, 8H, 13H, and 5H, remaining H(P)-
Phos, CPhH, and CH5-8), 6.12/5.56 (br s, 1H, NH), 4.92/4.45 (br s, 1H, NH); 
13C{1H} 
(125 MHz) 205.55 (s, CO), 155.02/154.71 (s, C1), 149.05/148.98 (s, C(P)-Phos), 
147.08/146.75 (s, C2), 141.46/141.42 (s, C3), 132.78/132.72 (s, C4), 132.28/132.17 (s, 
o-CPh), 132.11/132.03 (s, i-CPh), 131.59, 130.90, 129.31, 128.70, 128.50 (5  s, C(P)-
Phos) 127.97/127.76 (s, m-CPh), 127.90/127.67 (s, p-CPh), 127.31, 126.35, 125.35 (3  s, 
C(P)-Phos), 123.36/122.98 (s, C5), 122.68 (s, C(P)-Phos), 122.14/121.88 (s, C6), 121.63 
(s, C(P)-Phos), 118.36/117.84 (s, C7), 111.92/111.73 (s, C8), 100.64/100.32 (s, C5Ph5); 
31P{1H} (CD2Cl2, 202 MHz) 6.2 (s, P(P)-Phos). 
 
(SRu)-48
+ (P)-Phos. A round bottom flask was charged with (RRu/SRu)-48
+ 
(P)-Phos (0.100 g, 0.100 mmol) and 90:10 v/v toluene/hexane (5 mL) with stirring. 
After 2 min, the solution was kept at –35 °C for 24 h. This gave a yellow solid 
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suspended in a dirty green supernatant. The solid was isolated by filtration, washed with 
70:30 v/v toluene/hexane (3  2 mL), and dried by rotary evaporation. The solvent was 
removed from the combined filtrates by rotary evaporation. Then 90:10 v/v 
toluene/hexane (3 mL) was added. The sample was kept at –35 °C for 24 h. Again a 
yellow solid suspended in a dirty green supernatant formed. The yellow solid was 
isolated by filtration and washed with 70:30 v/v toluene/hexane (3  1 mL). The two 
crops of solid were combined and dried by oil pump vacuum to give (SRu)-48
+ (P)-
PhosCH3C6H5 (0.042 g, 0.035 mmol, 35% or 70% of theory, >98:<02 SRu/RRu as 
assayed by 1H NMR using the NH protons at 4.48 and 4.92 ppm; the 13C NMR signals 
for the cation are consistent with a high diastereomer ratio) as a bright yellow powder, 
dec. pt. 105 °C (capillary). Anal. Calcd for C71H54N5O5PRuC6H5CH3: C 71.71, H 
4.58, N 5.89. Found C 72.06, H 4.78, N 5.66. The configuration was assigned by 
analogy to that of (SRu)-48
+ BArf
, which was assigned by CD spectroscopy (Figure 
4.3(a)).  
 
NMR (, CD2Cl2):
179,184 1H (500 MHz) 13.77 (br s, 1H, NH), 12.33 (br s, 1H, 
NH), 8.01 (d, 2H, 3JHH = 8.9 Hz, H(P)-Phos), 7.95 (d, 2H, 
3JHH = 8.9 Hz, H(P)-Phos), 
7.52 (d, 2H, 3JHH = 8.2 Hz, H(P)-Phos), 7.44 (t, 2H, 
3JHH = 8.2 Hz, H(P)-Phos), 7.38 (d, 
2H, 3JHH = 8.2 Hz, H(P)-Phos), 7.33 (d, 1H, 
3JHH = 7.7 Hz, CH7/8), 7.29-7.23 (m, 4H, 
H(P)-Phos, CH8/7, and CH5/6), 7.18-7.10 (m, 10H, p-CPhH and CH3C6H5), 7.04-6.99 (t, 
10H, 3JHH = 7.8 Hz, m-CPhH), 6.97-6.91 (d, 10H, 
3JHH = 7.6 Hz, o-CPhH), 6.88 (t, 1H, 
3JHH = 7.7 Hz, CH6/5), 5.70 (s, 2H, NH2), 4.48 (s, 1H, RuNH), 2.34 (s, 3H, CH3C6H5); 
13C{1H} (CD2Cl2, 125 MHz) 205.5 (s, CO), 155.1 (s, C1), 149.3 (s, C(P)-Phos), 147.2 
(s, C2), 141.5 (s, C3), 138.6 (s, i-C6H5CH3), 132.8 (s, C4), 132.3 (s, o-CPh), 132.1 (s, i-
CPh), 131.3 (s, o-C6H5CH3), 131.6, 130.7, 129.3, 128.7, 128.5 (5  s, C(P)-Phos and m-
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C6H5CH3) 128.0 (s, m-CPh),
180 127.9 (s, p-CPh),
180 127.2, 126.5 (2  s, C(P)-Phos), 
125.7 (s, p-C6H5CH3), 125.3 (s, C(P)-Phos), 123.3 (s, C5), 122.5 (s, C(P)-Phos), 122.1 (s, 
C6), 121.9 (s, C(P)-Phos), 118.4 (s, C7), 111.9 (s, C8), 100.7 (s, C5Ph5) 21.6 (s, 
C6H5CH3); 
31P{1H} (CD2Cl2, 202 MHz) 6.2 (s, P(P)-Phos). 
The solvent was removed from the combined filtrates by oil pump vacuum to 
give (RRu/SRu)-48
+ (P)-Phos (0.064 g, 0.060 mmol, 60%, 80:20 RRu/SRu as assayed by 
1H NMR vs. the NH protons at 4.45 and 4.92 ppm) as a pale green solid. 
 
(SRu)-48
+ BArf
. A round bottom flask was charged with (SRu)-48
+ (P)-Phos 
(0.050 g, 0.050 mmol), Na+ BArf
 (0.044 g, 0.050 mmol), CH2Cl2 (3 mL), and H2O (2 
mL) with stirring. After 5 min, the organic layer turned dirty green. After 30 min, it was 
separated, washed with H2O (3  3 mL), and dried (Na2SO4). The evaporation of the 
solvent by rotary evaporation led to partial decomposition of the compound. Therefore, 
the solvent was removed by purging N2 through the solution. Then 30:70 v/v 
CH2Cl2/hexane (4 mL) was added and the mixture was passed through a short plug of 
celite. The solvent was removed by purging N2 through the filtrate. Hexanes (2 mL) was 
added to give a suspension. The solvent was removed by purging N2 through the 
mixture. This hexane/purge cycle was repeated to give (SRu)-48
+ BArf
2H2O as a dirty 
green solid (0.064 g, 0.040 mmol, 80%), dec. pt. 105 °C (capillary). The sample 
appeared to partially decompose under oil pump vacuum. Hence, it was dried in air for 
one week. Anal. Calcd for C76H46BF24N5ORuH2O: C 55.96, H 2.97, N 4.29. Found C 
56.38, H 3.29, N 4.50. Calcd for C76H46BF24N5ORu(H2O)2 (per the integration of the 
H2O peak in the undried sample used for 
1H NMR): C 55.57, H 3.21, N 4.21. The 
configuration was tentatively assigned by the CD spectra (Figure 4.3; see additional 
details in text). 
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NMR (, CD2Cl2):
26,179 1H (500 MHz) 9.45 (br s, 1H, NH), 8.33 (br s, 1H, 
NH), 7.72 (s, 8H, o-B(C6H3(CF3)2)4), 7.56 (s, 4H, p-B(C6H3(CF3)2)4), 7.37 (d, 1H, 
3JHH = 7.8 Hz, CH7/8), 7.27-7.25 (m, 2H, CH5/6 and CH8/7), 7.19 (t, 5H, 
3JHH = 7.6 
Hz, p-CPhH), 7.04 (t, 10H, 
3JHH = 8.7 Hz, m-CPhH), 7.02-6.95 (m, 1H, CH6/5), 6.92 (d, 
10H, 3JHH = 7.6 Hz, o-CPhH ), 5.13 (s, 1H, RuNH), 5.06 (br s, 2H, NH2), 1.73 (br s, 
4H, H2O); 
13C{1H} (125 MHz) 204.5 (s, CO), 162.55 (q, 1JCB = 50.7 Hz, i-
C6H3(CF3)2), 152.9 (s, C1), 144.0 (s, C2), 140.9 (s, C3), 135.2 (s, o-C6H3(CF3)2), 
132.4 (s, C4), 132.3 (s, o-CPh), 131.5 (s, i-CPh), 129.2 (q, 
2JCF = 30.9 Hz, m-
C6H3(CF3)2), 128.4 (s, p-CPh),
180 128.2 (s, m-CPh),
180 125.3 (s, C5), 124.9 (q, 1JCF = 
271.7 Hz, C6H3(CF3)2), 124.1 (s, C6), 119.6 (s, C7), 117.9 (s, p-C6H3(CF3)2), 111.5 (s, 
C8), 100.4 (s, C5Ph5). 
 
CD (nm, 1.2 × 10–3 M in CH3CN ([θ], deg·L·mol
–1cm–1 and Δε, L·mol–1cm–
1)): 310 (+13336 and +4.04), 330 (sh, +828 and +2.50), 345 (sh, +4288 and +1.30), 360 
(sh, +8262 and +0.25), 370 (299 and 0.09), 400 (sh, +2396 and +0.73), 425 (+3714 
and +1.12), 435 (sh, +3498 and +1.07). 
 
Friedel-Crafts alkylations catalyzed by (SRu)-48
+ BArf
 (Table 4.9, entry 1). 
1-methyl-3-(2-nitro-1-phenylethyl)-1H-indole (7a).68 An NMR tube was 
charged with (SRu)-48
+ BArf
 (entry 1a, 0.0034 g, 0.0020 mmol, 10 mol%), 5a (0.0052 
g, 0.040 mmol), 6 (0.0030 g, 0.020 mmol), an internal standard (Ph2SiMe2, 0.0021 g, 
0.010 mmol) and CD2Cl2 (0.5 mL). The tube was capped. Product formation was 
monitored vs. the standard by 1H NMR. After specified time, the solvent was removed 
by rotary evaporation. The residue was taken up in hexane/ethyl acetate (30:70 v/v) and 
passed through a short silica gel column, which was washed with additional hexane/ethyl 
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acetate (50:50 v/v, 5 mL). The solvent was removed from the combined filtrates by 
rotary evaporation, and a second silica gel chromatography step was carried out (1  10 
cm, 90:10 v/v hexane/ethyl acetate). The solvent was removed from the product 
containing fractions by oil pump vacuum to give 7a (0.0056 g, 0.020 mmol, >99%) as a 
colorless oil.  
 
NMR (δ, CDCl3): 
1H (500 MHz) 7.47 (d, 1H, J = 7.6 Hz), 7.38-7.23 (m, 7H), 
7.10 (m, 1H), 6.88 (s, 1H), 5.21 (t, 1H, J = 8.0 Hz), 5.06 (dd, 1H, J = 12.4, 8.0 Hz), 4.95 
(dd, 1H, J = 12.4, 8.0 Hz,), 3.75 (s, 3H); Literature chemical shift values (CDCl3) agree 
within 0.01 ppm.68a  
 
The enantiomeric excess was determined by HPLC with a Chiralpak AS-H 
column, hexane/2-PrOH (90:10 v/v), 1.0 mL/min, λ = 210 nm; tR = 14.6 min, 18.6 
min.185  
 
Michael addition reactions catalyzed by (SRu)-48
+ BArf
 (Table 4.9).  
3-(2-nitro-1-phenylethyl)pentane-2,4-dione (21, entry 2c). A J. Young NMR 
tube was charged with 20 (0.0020 g, 0.020 mmol), 6 (0.0030 g, 0.020 mmol), and 
CD2Cl2 (0.5 mL) and cooled to –78 °C. Then (SRu)-48
+ BArf
 (0.0034 g, 0.0020 mmol, 
10 mol%) and NEt3 (0.0002 g, delivered by syringe, mass corresponds to weight of 
NMR tube before/after; 0.002 mmol, 10 mol%) were added and the tube was capped. 
Product formation was monitored by TLC. After 24 h, the solvent was removed by 
rotary evaporation. The residue was taken up in hexane/ethyl acetate (30:70 v/v) and 
passed through a short silica gel column, which was washed with additional hexane/ethyl 
acetate (50:50 v/v, 5 mL). The solvent was removed from the combined filtrates by 
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rotary evaporation, and a second silica gel chromatography step was carried out (1  10 
cm, 80:20 v/v hexane/ethyl acetate). The solvent was removed from the product 
containing fractions by oil pump vacuum to give 21 (0.0025 g, 0.020 mmol, >99%) as a 
colorless oil.  
 
NMR (δ, CDCl3):
123a,147 1H (500 MHz) 7.34-7.25 (m, 3H), 7.19-7.16 (m, 2H), 
4.64-4.61 (m, 2H), 4.36 (d, 1H, J = 10.7 Hz), 4.27-4.20 (m, 1H), 2.28 (s, 3H), 1.93 (s, 
3H); 13C{1H} (125 MHz) 201.6, 200.9, 135.9, 129.3, 128.5, 127.9, 78.2, 70.7, 42.9, 
30.5, 29.7. 
 
The enantiomeric excess was determined by HPLC with a Chiralpak AS-H 
column, hexane/2-PrOH (85:15 v/v), 1.0 mL/min, λ = 215 nm; tR = 14.9 min, 22.6 
min.123b  
 
2-(2-nitro-1-phenylethyl)propanedinitrile (27, entry 3c). A J. Young NMR 
tube was charged with 26 (0.0013 g, 0.020 mmol), 6 (0.0029 g, 0.020 mmol), and 
CD2Cl2 (0.5 mL) and cooled to –35 °C. Then (SRu)-48
+ BArf
 (0.0034 g, 0.0020 mmol, 
10 mol%) and NEt3 (0.0002 g, delivered by syringe, mass corresponds to weight of 
NMR tube before/after; 0.002 mmol, 10 mol%) were added and the tube was capped. 
Product formation was monitored by TLC. After 1 h, the solvent was removed by rotary 
evaporation. The residue was taken up in hexane/ethyl acetate (30:70 v/v) and passed 
through a short silica gel column, which was washed with additional hexane/ethyl 
acetate (50:50 v/v, 5 mL). The solvent was removed from the combined filtrates by 
rotary evaporation, and a second silica gel chromatography step was carried out (1  10 
cm, 60:40 v/v hexane/ethyl acetate). The solvent was removed from the product 
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containing fractions by oil pump vacuum to give 27 (0.0034 g, 0.016 mmol, 80%) as a 
pale yellow oil.  
 
NMR (δ, CDCl3):
21a,147 1H (500 MHz) 7.54-7.41 (m, 3H), 7.41-7.29 (m, 2H), 
4.99 (dd, 1H, J = 14.3, 8.2 Hz), 4.91 (dd, 1H, J = 14.3, 6.1 Hz), 4.43 (d, 1H, J = 5.8 Hz), 
4.15-4.03 (m, 1H); 13C{1H} (125 MHz) 131.8, 130.4, 129.4, 127.7, 110.5, 110.4, 74.9, 
43.5, 27.5. 
 
The enantiomeric excess was determined by HPLC with a Chiralcel OD column, 
hexane/2-PrOH (50:50 v/v), 0.50 mL/min, λ = 215 nm; tR = 19.5 min, 54.7 min.
21a,186  
 
Additions of 28 to 50 or 52 catalyzed by (SRu)-48
+ BArf
 (Table 4.10). A J. 
Young NMR tube was charged with the Michael acceptor (50 or 52, 0.040 mmol), 28 
(0.0022 g, 0.020 mmol), and CD2Cl2 (0.3 mL) and cooled to –78 °C. Then (SRu)-48
+ 
BArf
 (0.0034 g, 0.0020 mmol, 10 mol%) and NEt3 (0.0022 g, delivered by syringe, 
mass corresponds to weight of NMR tube before/after; 0.020 mmol) were added and the 
tube was capped. Product formation was monitored by TLC. After the specified time, the 
solvent was removed by rotary evaporation. The residue was taken up in hexane/ethyl 
acetate (30:70 v/v) and passed through a short silica gel column, which was washed with 
additional hexane/ethyl acetate (50:50 v/v, 5 mL). The solvent was removed from the 
combined filtrates by rotary evaporation, and a second silica gel chromatography step 
was carried out (1  10 cm, CH2Cl2). The solvent was removed from the product 
containing fractions by rotary evaporation (yields, Table 4.10).  
 
3-[1-oxo-3-phenyl-3-(phenylthio)propyl]oxazolidin-2-one (51, entry 1). NMR 
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(δ, CDCl3):
147,172 1H (500 MHz) 7.35-7.37 (m, 2H), 7.25-7.29 (m, 2H), 7.18 (t, 1H, J = 
7.3 Hz), 4.30-4.40 (m, 2H), 4.02-4.07 (m, 1H), 3.87-3.98 (m, 2H), 3.30 (dd, 1H, J = 
13.4, 8.0 Hz), 3.01 (dd, 1H, J = 13.4, 5.7 Hz), 1.28 (d, 3H, J = 8.5 Hz); 13C{1H} (125 
MHz) 175.5, 153.1, 135.9, 130.3, 129.0, 126.6, 62.0, 42.8, 38.3, 37.4, 17.4. 
 
The enantiomeric excess was determined by HPLC with a Chiralpak AS-H 
column, hexane/2-PrOH (90:10 v/v), 1.0 mL/min, λ = 210 nm; tR = 32.5 min (major), 
34.4 min (minor).187 
 
3-[(2-methyl-1-oxo-3-(phenylthio)propyl]oxazolidin-2-one (53, entry 2). 
NMR (δ, CDCl3):
147,173 1H (500 MHz) 7.35-7.37 (m, 2H), 7.25-7.29 (m, 2H), 7.18 (t, 
1H, J = 7.3 Hz), 4.30-4.40 (m, 2H), 4.02-4.07 (m, 1H), 3.87-3.98 (m, 2H), 3.30 (dd, 1H, 
J = 13.4, 8.0 Hz), 3.01 (dd, 1H, J = 13.4, 5.7 Hz), 1.28 (d, 3H, J = 8.5 Hz); 13C{1H} 
(125 MHz) 175.5, 153.1, 135.9, 130.3, 129.0, 126.6, 62.0, 42.8, 38.3, 37.4, 17.4. 
 
The enantiomeric excess was determined by HPLC with a Chiralcel OD column, 
hexane/2-PrOH (70:30 v/v), 1.0 mL/min, λ = 254 nm; tR = 22.7 min (major, S), 25.5 min 
(minor, R).151,173  
 
Addition of Michael donors to 6 catalyzed by 49 (Table 4.11).  
Ethyl-2-carboethoxy-4-nitro-3-phenylbutyrate (19a, entry 1). A J. Young 
NMR tube was charged with 10b (0.0320 g, 0.200 mmol), Ph2SiMe2 (~0.0500 mmol; 
internal standard), 6 (0.0150 g, 0.100 mmol), and CD2Cl2 (0.5 mL). Then 49 (0.0075 g, 
0.010 mmol, 10 mol%) was added and the tube was capped. Product formation was 
monitored vs. the standard by 1H NMR. After 24 h, the solvent was removed by rotary 
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evaporation. The residue was taken up in hexane/ethyl acetate (30:70 v/v) and passed 
through a short silica gel column, which was washed with additional hexane/ethyl 
acetate (50:50 v/v, 5 mL). The solvent was removed from the combined filtrates by 
rotary evaporation, and a second silica gel chromatography step was carried out (1  10 
cm, 80:20 v/v hexane/ethyl acetate). The solvent was removed from the product 
containing fractions by oil pump vacuum to give 19a (0.0306 g, 0.0750 mmol, 75%) as a 
colorless oil.  
 
NMR (δ, CDCl3):
120a,147 1H (500 MHz) 7.32-7.23 (m, 5H), 4.92 (dd, 1H, J = 
13.2, 4.7 Hz), 4.86 (dd, 1H, J = 13.2, 9.5 Hz), 4.26-4.17 (m, 3H), 4.00 (q, 2H, J = 7.1 
Hz), 3.82 (d, 1H, J = 9.3 Hz), 1.25 (t, 3H, J = 7.1 Hz), 1.03 (t, 3H, J = 7.1 Hz); 13C{1H} 
(125 MHz) 167.4, 166.7, 136.2, 128.8, 128.3, 127.9, 77.6, 62.1, 61.8, 55.0, 42.9, 13.9, 
13.6. 
 
2-(2-nitro-1-phenylethyl)propanedinitrile (27, entry 2). A J. Young NMR tube 
was charged with 26 (0.0660 g, 0.100 mmol), Ph2SiMe2 (~0.050 mmol; internal 
standard), 6 (0.0149 g, 0.100 mmol,), and CD2Cl2 (0.5 mL). Then 49 (0.0075 g, 0.010 
mmol, 10 mol%) was added and the tube was capped. Product formation was monitored 
vs. the standard by 1H NMR. After 1 h, the solvent was removed by rotary evaporation. 
The residue was taken up in hexane/ethyl acetate (30:70 v/v) and passed through a short 
silica gel column, which was washed with additional hexane/ethyl acetate (50:50 v/v, 5 
mL). The solvent was removed from the combined filtrates by rotary evaporation, and a 
second silica gel chromatography step was carried out (1  10 cm, 60:40 v/v 
hexane/ethyl acetate). The solvent was removed from the product containing fractions by 
oil pump vacuum to give 27 (0.0161 g, 0.0750 mmol, 80%) as a pale yellow oil.  
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NMR (δ, CDCl3):
21a,147 1H (500 MHz) 7.54-7.41 (m, 3H), 7.41-7.29 (m, 2H), 
4.99 (dd, 1H, J = 14.3, 8.2 Hz), 4.91 (dd, 1H, J = 14.3, 6.1 Hz), 4.43 (d, 1H, J = 5.8 Hz), 
4.15-4.03 (m, 1H); 13C{1H} (125 MHz) 131.8, 130.4, 129.4, 127.7, 110.5, 110.4, 74.9, 
43.5, 27.5. 
 
Crystallography A. A CH2Cl2/pentane solution of 48
+ PF6
– was kept in an 
NMR tube. After 24 h, yellow blocks of 48+ PF6
(C5H12)1.5 with well defined faces 
had formed.  
Data were collected as outlined in Table 4.5. The integrated intensity information 
for each reflection was obtained by reduction of the data frames with the program 
APEX2.92 Cell parameters were obtained from 180 frames using a 0.5° scan. Data were 
corrected for Lorentz and polarization factors, and using SADABS,93 absorption and 
crystal decay effects. The structure was solved by direct methods using SHELXTL 
(SHELXS).94 Hydrogen atoms were placed in idealized positions and were refined using 
a riding model. All non-hydrogen atoms were refined with anisotropic thermal 
parameters. The parameters were refined by weighted least squares refinement on F2 to 
convergence.94  
 
B. A CH2Cl2/hexane solution of 48
+ BArf
–∙4H2O was kept in an NMR tube. 
After 1 week, colorless blocks of 48+ BArf
.H2O with well defined faces had formed.  
Data were collected as outlined in Table 4.5. The integrated intensity information 
for each reflection was obtained by reduction of the data frames with the program 
APEX2.92 Cell parameters were obtained from 60 frames using a 0.5° scan. Data were 
corrected for Lorentz and polarization factors, and using SADABS,93 absorption and 
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crystal decay effects. The structure was solved by direct methods using SHELXTL 
(SHELXS).94 Several of the CF3 groups were disordered and were modeled. Residual 
electron density peaks close to the fluorine atoms of the CF3 groups indicated further 
disorder, but modeling efforts were not successful. Additional residual electron densities 
were observed, and tentatively assigned to a disordered and/or partially occupied hexane. 
This electron density contribution was extracted with the program 
PLATON/SQUEEZE.188 Hydrogen atoms were placed in idealized positions and were 
refined using a riding model. All non-hydrogen atoms were refined with anisotropic 
thermal parameters. The parameters were refined by weighted least squares refinement 
on F2 to convergence.94  
 
C. A CHCl3/MeOH solution (10:1 v/v) of 49 was kept in an NMR tube. After 1 
week, colorless needles of 49 with well defined faces had formed.  
Data were collected as outlined in Table 4.5. The integrated intensity information 
for each reflection was obtained by reduction of the data frames with the program 
APEX2.92 Cell parameters were obtained from 180 frames using a 0.5° scan. Data were 
corrected for Lorentz and polarization factors, and using SADABS,93 absorption and 
crystal decay effects. The structure was solved by direct methods using SHELXTL 
(SHELXS).94 The phenyl ring C39 to C33 was disordered between two positions and 
was modeled with a 53:47 occupancy ratio. Larger thermal ellipsoids on C21 to C26 
suggested disorder, but modeling efforts were not successful. Additional residual 
electron densities were observed, and tentatively assigned to disordered and/or partially 
occupied H2O or MeOH molecule sites. Thus, the electron density contribution was 
extracted with the program PLATON/SQUEEZE.188 Hydrogen atoms were placed in 
idealized positions and were refined using a riding model. All non-hydrogen atoms were 
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refined with anisotropic thermal parameters. The parameters were refined by weighted 
least squares refinement on F2 to convergence.94 
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5. SUMMARY AND CONCLUSION 
 
5.1 Conclusion from this study 
 
This dissertation for the first time describes the development of new chiral-at-
metal ruthenium based organometallic hydrogen bond donors derived from 2-
guanidinobenzimidazole (GBI) and their application in enantioselective catalysis. Unlike 
most transition metal catalyzed reactions, there is no direct interaction of the substrate 
with the ruthenium; rather, association involves hydrogen bonding derived from NH 
groups which are remote from the metal center (Figure 5.1). The hydrogen bonding 
interactions and the activation of the substrates occurs solely in the second coordination 
sphere, and thereby promote the reactions (Figure 5.1). Thus, these systems successfully 
justify the term second coordination sphere promoted catalysis. 
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GBI is a chelating ligand with NH protons that can act as potent hydrogen bond 
donors (D). Chelating to ruthenium preorganizes the NH protons in a synperiplanar 
conformation. Comparisons of catalytic efficacies of GBI and its derivatives (chapters 1-
4) lead to the conclusion that preorganization is vital in turning GBI into an active 
catalyst. However, increasing the NH proton acidities by protonation, methylation, or 
chelation cannot be completely ignored.  
Furthermore, chiral substituted GBI ligands (GBI-R) afford ruthenium 
complexes as mixtures of Ru,C configurational diastereomers ([(η5-C5H5)Ru(CO)(GBI-
R)]+ PF6
– (18a-d+ PF6
–)). Using an enantiopure ligand bearing an additional basic 
NMe2 moiety, the diastereomers could be easily separated ((RRuRCRC)-18c
+ PF6
− and 
(SRuRCRC)-18c
+ PF6
−). These efficiently catalyze Friedel-Crafts alkylations of indoles, 
Michael addition reactions of 1,3-dicarbonyl equivalents to nitroalkenes, and additions 
of cyclic-β-keto esters to dialkyl azodicarboxylates. In all of these reactions, products are 
obtained in high yields even in the absence of any external base, showing that the 
bifunctional capability of the ligand is retained. Most of the reactions are also highly 
enantioselective (90-99% ee). When compared, the free ligand performs poorly in 
catalytic efficacies and enantioselectivities, establishing the importance of the metal in 
tuning the properties of the attached ligand, influencing any interactions happening in 
the second coordination sphere, and thereby enhancing the catalytic abilities. The 
configuration of the product is usually controlled by the carbon as opposed to the 
ruthenium stereocenter.  
Similarly, enantiopure chiral-at-metal ruthenium GBI complex ([(η5-
C5Ph5)Ru(CO)GBI]
+ BArf
– ((SRu)-48
+ BArf
−) bearing a bulky electron withdrawing 
pentaphenylcyclopentadienyl ligand could also be synthesized. The metal complex is 
also an efficient catalyst for Friedel-Crafts alkylations and Michael addition reactions 
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under aerobic conditions. Importantly, the addition of thiophenol (28) to trans-3-
cinnamoyloxazolidin-2-one (50) is highly enantioselective (>99%). Here, the ruthenium 
atom is the only stereocenter in the molecule, contrary to complexes mentioned 
previously. This indicates that the metal stereocenter alone can influence the second 
coordination sphere interaction to such an extent that enantioselectivities as high as 
>99% can be achieved.  
Isolation of these aforementioned enantiopure ruthenium complexes followed by 
their successful application in catalysis establishes the viability of using these 
enantiopure transition metal complexes containing ligand based NH hydrogen bond 
donors to catalyze enantioselective organic transformations in high yields and 
enantioselectivities. Furthermore, the neutral complex (η5-C5Ph5)Ru(CO)(GBIH) (49), 
which features a deprotonated GBI ligand, is capable of acting as a multifunctional 
catalyst and promotes Michael addition reactions in the absence of any external base. 
This new system provides a promising direction for future developments of a 
multifunctional catalyst system. In these reactions, 49 acts as a base to activate one 
substrate, hydrogen bonds to the other, and ion pairs with the conjugate base of the first 
substrate. Each of these represents a second coordination sphere interaction, and expands 
the horizon of SCSPC.  
 
5.2 Beyond this study 
 
The above studies should inspire chemist to explore numerous other metal 
complexes that could be potential hydrogen bond donor catalysts and participate in 
SCSPC. Furthermore, these overlooked hydrogen bond donors could easily be fine-tuned 
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for a plethora of additional functionalities and thereby promoting numerous other 
enantioselective organic transformations.  
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APPENDIX A 
This appendix contains NMR spectra and the checkCIF reports related to chapter 
2, titled Modification and Application of 2-guanidinobenzimidazole for Second 
Coordination Sphere Promoted Catalysis. 
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Figure a1 NMR spectra of 1+ BArf
 (CD2Cl2; * = solvent or H2O): (a) 
1H (500 MHz);
(b) 13C{1H} (125 MHz). 
229 
Figure a2 NMR spectra of 2+ BArf
 (CD2Cl2; * = solvent or impurities): (a) 
1H (500
MHz); (b) 13C{1H} (125 MHz). 
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Figure a3 NMR spectra of 3+ BArf
 (CD2Cl2; * = solvent or H2O): (a) 
1H (500 MHz); 
(b) 13C{1H} (125 MHz). 
  
231 
Figure a4 NMR spectra of 4+ BArf
 (CD2Cl2; * = solvent or impurities): (a) 
1H (500
MHz); (b) 13C{1H} (125 MHz). 
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Figure a5 NMR spectra of 9+ (P)-Phos (CD2Cl2; * = solvent or impurities): (a) 
1H 
(500 MHz); (b) 13C{1H} (125 MHz). 
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CheckCIF report for 3+ BArf
H2O  
 
The following ALERTS were generated. Each ALERT has the format 
test-name_ALERT_alert-type_alert-level.  
 
Alert level A  
THETM01_ALERT_3_A The value of sine(theta_max)/wavelength is less than 0.550  
Calculated sin(theta_max)/wavelength = 0.5040  
 
Crystallographer's Response: Data was collected on a Bruker GADDS instrument 
with Cu-source and MWPC (multiwire proportional counter) detector. Under these 
experimental conditions the maximum angle that can be collected is 120 degrees 
two-theta. The quality of the crystal used was poor and no reflections were found 
above 102 degree 2-theta.  
 
PLAT089_ALERT_3_A Poor Data / Parameter Ratio (Zmax < 18) ........ 3.72  
 
Crystallographer's Response: Data was collected on a Bruker GADDS instrument 
with Cu-source and MWPC (multiwire proportional counter) detector. Under these 
experimental conditions the maximum angle that can be collected is 120 degrees 
two-theta. The quality of the crystal used was poor and no reflections were found 
above 102 degree 2-theta.  
 
Alert level B  
PLAT019_ALERT_1_B _diffrn_measured_fraction_theta_full/_max < 1.0 0.598 Report  
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Crystallographer's Response: Data was collected on a Bruker GADDS instrument 
with Cu-source and MWPC (multiwire proportional counter) detector which has 
geometrical restrictions.  
 
PLAT340_ALERT_3_B Low Bond Precision on C-C Bonds ............... 0.0180 Ang.  
 
Crystallographer's Response: The quality of the crystal used was poor and no 
reflections were found above 102 degree 2-theta.  
 
PLAT420_ALERT_2_B D-H Without Acceptor  O1W - H1WA ...  
 
Crystallographer's Response: Hydrogen atoms on the water could not be located 
and was placed to satisfy the stoichiometry. No hydrogen bonding was considered 
for the geometric location due to disorder of the neighboring nitrogen and fluorine 
atoms.  
 
Alert level C  
CRYSC01_ALERT_1_C The word below has not been recognised as a standard 
identifier. gray  
CRYSC01_ALERT_1_C No recognised colour has been given for crystal colour. 
DIFMX01_ALERT_2_C The maximum difference density is > 0.1*ZMAX*0.75  
_refine_diff_density_max given = 0.736  
Test value = 0.675  
DIFMX02_ALERT_1_C The maximum difference density is > 0.1*ZMAX*0.75  
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The relevant atom site should be identified.  
REFNR01_ALERT_3_C Ratio of reflections to parameters is < 8 for a non-
centrosymmetric structure, where ZMAX < 18 sine(theta)/lambda 0.5040 Proportion of 
unique data used 1.0000 Ratio reflections to parameters 7.0159  
PLAT097_ALERT_2_C Large Reported Max. (Positive) 
Residual Density 0.74 eA–3  
PLAT213_ALERT_2_C Atom F1 has ADP max/min Ratio ..... 3.5 prolat  
And 2 other PLAT213 Alerts More ...  
PLAT220_ALERT_2_C Large Non-Solvent C Ueq(max)/Ueq(min) Range 3.1 Ratio  
PLAT234_ALERT_4_C Large Hirshfeld Difference F4A -- C8N .. 0.21 Ang.  
And 13 other PLAT234 Alerts More ...  
PLAT243_ALERT_4_C High 'Solvent' Ueq as Compared to Neighbors of N1 Check  
PLAT250_ALERT_2_C Large U3/U1 Ratio for Average U(i,j) Tensor .... 2.7 Note  
PLAT417_ALERT_2_C Short Inter D-H..H-D H2B .. H1WB .. 2.10 Ang.  
PLAT417_ALERT_2_C Short Inter D-H..H-D H1WB .. H3AB .. 2.11 Ang.  
PLAT713_ALERT_1_C TORSION Unknown or Inconsistent Label .......... N2_A  
N2_A C1_A N1 C1A_B  
 
Alert level G  
PLAT002_ALERT_2_G Number of Distance or Angle Restraints on AtSite 57 
PLAT003_ALERT_2_G Number of Uiso or Uij Restrained non-H Atoms ... 3 
PLAT007_ALERT_5_G Number of Unrefined Donor-H Atoms .............. 14 
PLAT042_ALERT_1_G Calc. and Reported MoietyFormula Strings Differ 
PLAT072_ALERT_2_G SHELXL First Parameter in WGHT Unusually Large. 0.12 
PLAT083_ALERT_2_G SHELXL Second Parameter in WGHT Unusually Large. 16.99 
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Why ?  
PLAT171_ALERT_4_G The CIF-Embedded .res File Contains EADP Records 13  
PLAT176_ALERT_4_G The CIF-Embedded .res File Contains SADI Records 16  
PLAT178_ALERT_4_G The CIF-Embedded .res File Contains SIMU Records 1  
PLAT230_ALERT_2_G Hirshfeld Test Diff for F6A -- C8N .. 7.9 su  
And 5 other PLAT230 Alerts More ...  
PLAT242_ALERT_2_G Low Ueq as Compared to Neighbors for ..... C7N  
And 3 other PLAT242 Alerts More ...  
PLAT301_ALERT_3_G Main Residue Disorder ............ Percentage = 39 
PLAT302_ALERT_4_G Anion/Solvent Disorder ............ Percentage = 60  
PLAT434_ALERT_2_G Short Inter HL..HL Contact F2 .. F17 .2.78 Ang.  
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels .......... 10  
PLAT790_ALERT_4_G Centre of Gravity not Within Unit Cell: Resd. # 3 H2 O  
PLAT811_ALERT_5_G No ADDSYM Analysis: Too Many Excluded Atoms ....  
PLAT860_ALERT_3_G Number of Least-Squares Restraints ............. 206  
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CheckCIF report for 4+ BArf
H2O(CH2Cl2)0.5 
 
The following ALERTS were generated. Each ALERT has the format  
test-name_ALERT_alert-type_alert-level.  
 
Alert level A  
PLAT213_ALERT_2_A Atom F9C has ADP max/min Ratio ..... 8.2 prolat  
 
Crystallographer's Response: Several terminal CF3 groups were present in the 
structure. Some of the F atoms showed elongated thermal ellipsoids indicating 
disorder. Our efforts to model this disorder, while increasing the number of 
parameters, restraints and constraints, did not improve the reliability factors. The 
model also indicated extended disorder as the thermal ellipsoids were still elongated. 
For the final refinement, a model with no disorder, but with elongated ellipsoids 
were used.  
 
Alert level B  
DIFMX01_ALERT_2_B The maximum difference density is > 0.1*ZMAX*1.00 
_refine_diff_density_max given = 1.951 Test value = 1.700  
 
Crystallographer's Response: Several terminal CF3 groups were present in the 
structure. Some of the F atoms showed elongated thermal ellipsoids indicating 
disorder. Our efforts to model this disorder, while increasing the number of 
parameters, restraints and constraints, did not improve the reliability factors. The 
model also indicated extended disorder as the thermal ellipsoids were still elongated. 
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For the final refinement, a model with no disorder, but with elongated ellipsoids 
were used.  
THETM01_ALERT_3_B The value of sine(theta_max)/wavelength is less than 0.575 
Calculated sin(theta_max)/wavelength = 0.5661  
 
Crystallographer's Response: Data was collected on a Bruker GADDS instrument 
with Cu-source and MWPC (multiwire proportional counter) detector. Under these 
experimental conditions the maximum angle that can be collected is 120 degrees two-
theta.  
 
PLAT019_ALERT_1_B _diffrn_measured_fraction_theta_full/_max < 1.0 0.839 Report  
 
Crystallographer's Response: Data was collected on a Bruker GADDS instrument 
with Cu-source and MWPC (multiwire proportional counter) detector which has 
geometrical restrictions.  
 
PLAT097_ALERT_2_B Large Reported Max. (Positive) Residual Density 1.95 eA–3  
 
Crystallographer's Response: Several terminal CF3 groups were present in the 
structure. Some of the F atoms showed elongated thermal ellipsoids indicating 
disorder. Our efforts to model this disorder, while increasing the number of 
parameters, restraints and constraints, did not improve the reliability factors. The 
model also indicated extended disorder as the thermal ellipsoids were still elongated. 
For the final refinement, a model with no disorder, but with elongated ellipsoids 
were used.  
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PLAT213_ALERT_2_B Atom F16 has ADP max/min Ratio ..... 4.1 prolat  
 
Crystallographer's Response: Several terminal CF3 groups were present in the 
structure. Some of the F atoms showed elongated thermal ellipsoids indicating 
disorder. Our efforts to model this disorder, while increasing the number of 
parameters, restraints and constraints, did not improve the reliability factors. The 
model also indicated extended disorder as the thermal ellipsoids were still elongated. 
For the final refinement, a model with no disorder, but with elongated ellipsoids 
were used.  
 
PLAT213_ALERT_2_B Atom F18 has ADP max/min Ratio ..... 4.4 prolat  
PLAT420_ALERT_2_B D-H Without Acceptor O1 - H1C ...  
 
Crystallographer's Response: We could not locate the hydrogen atoms on the water 
molecules. Hydrogen atoms were placed only to satisfy the stoichiometry.  
 
Alert level C  
DIFMX02_ALERT_1_C The maximum difference density is > 0.1*ZMAX*0.75 The 
relevant atom site should be identified.  
REFNR01_ALERT_3_C Ratio of reflections to parameters is < 10 for a centrosymmetric 
structure sine(theta)/lambda 0.5661 Proportion of unique data used 1.0000 Ratio reflections 
to parameters 9.8229  
RFACR01_ALERT_3_C The value of the weighted R factor is > 0.25 Weighted R 
factor given 0.278  
PLAT084_ALERT_3_C High wR2 Value (i.e. > 0.25) ................... 0.28 Report  
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PLAT213_ALERT_2_C Atom F13 has ADP max/min Ratio ..... 3.2 prolat  
 
Crystallographer's Response: Several terminal CF3 groups were present in the 
structure. Some of the F atoms showed elongated thermal ellipsoids indicating 
disorder. Our efforts to model this disorder, while increasing the number of 
parameters, restraints and constraints, did not improve the reliability factors. The 
model also indicated extended disorder as the thermal ellipsoids were still elongated. 
For the final refinement, a model with no disorder, but with elongated ellipsoids 
were used.  
 
And 3 other PLAT213 Alerts More ...  
PLAT220_ALERT_2_C Large Non-Solvent F Ueq(max)/Ueq(min) Range 4.0 Ratio 
PLAT220_ALERT_2_C Large Non-Solvent F Ueq(max)/Ueq(min) Range 5.3 Ratio  
PLAT230_ALERT_2_C Hirshfeld Test Diff for F8C -- C32D .. 6.0 su  
PLAT234_ALERT_4_C Large Hirshfeld Difference F23 -- C32B .. 0.17 Ang.  
PLAT234_ALERT_4_C Large Hirshfeld Difference F7C -- C32D .. 0.18 Ang.  
PLAT244_ALERT_4_C Low 'Solvent' Ueq as Compared to Neighbors of C1T  
PLAT334_ALERT_2_C Small Average Benzene C-C Dist. C2 -C7 1.36 Ang.  
PLAT340_ALERT_3_C Low Bond Precision on C-C Bonds .............. 0.0082 Ang.  
PLAT420_ALERT_2_C D-H Without Acceptor N3 - H3 ...  
 
Crystallographer's Response: We could not locate the hydrogen atoms on the water 
molecules. Hydrogen atoms were placed only to satisfy the stoichiometry.  
 
And 2 other PLAT420 Alerts More ...  
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PLAT480_ALERT_4_C Long H...A H-Bond Reported H1B .. F13C .. 2.59 Ang.  
 
Alert level G  
PLAT007_ALERT_5_G Number of Unrefined Donor-H Atoms .............. 12  
PLAT042_ALERT_1_G Calc. and Reported MoietyFormula Strings Differ  
PLAT045_ALERT_1_G Calculated and Reported Z Differ by ............ 0.50 Ratio  
PLAT072_ALERT_2_G SHELXL First Parameter in WGHT Unusually Large. 0.16 
Report  
PLAT083_ALERT_2_G SHELXL Second Parameter in WGHT Unusually Large. 9.17 
Why ?  
PLAT154_ALERT_1_G The su's on the Cell Angles are Equal .......... 0.00300 Degree  
PLAT242_ALERT_2_G Low Ueq as Compared to Neighbors for ..... C7B  
And 15 other PLAT242 Alerts More ...  
PLAT434_ALERT_2_G Short Inter HL..HL Contact F15C .. F20 .2.82 Ang.  
PLAT434_ALERT_2_G Short Inter HL..HL Contact F24 .. F24 .2.80 Ang.  
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........2 
PLAT790_ALERT_4_G Centre of Gravity not Within Unit Cell: Resd. # 4 
C7 H8 N3 
PLAT790_ALERT_4_G Centre of Gravity not Within Unit Cell: Resd. # 6 
H2 O 
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CheckCIF report for [1-H]2+ 2BrH2O 
 
The following ALERTS were generated. Each ALERT has the format  
test-name_ALERT_alert-type_alert-level.  
 
Alert level B  
Crystal system given = monoclinic  
THETM01_ALERT_3_B The value of sine(theta_max)/wavelength is less than 0.575  
Calculated sin(theta_max)/wavelength = 0.5668  
 
Crystallographer's Response: Data was collected on a Bruker GADDS instrument 
with Cu-source and  
MWPC (multiwire proportional counter) detector. Under these experimental 
conditions the maximum angle that can be collected is 120 degrees two-theta.  
 
PLAT019_ALERT_1_B Check _diffrn_measured_fraction_theta_full/_max 0.845  
 
Crystallographer's Response: Data was collected on a Bruker GADDS instrument 
with Cu-source and  
MWPC (multiwire proportional counter) detector which has geometrical restrictions  
 
Alert level C  
PLAT480_ALERT_4_C Long H...A H-Bond Reported H4B .. BR2 .. 3.08 Ang.  
PLAT911_ALERT_3_C Missing # FCF Refl Between THmin & STh/L= 0.567 24  
PLAT913_ALERT_3_C Missing # of Very Strong Reflections in FCF .... 4 
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PLAT976_ALERT_2_C Negative Residual Density at 0.91A from N5 –0.42 eA3  
 
Alert level G  
PLAT007_ALERT_5_G Number of Unrefined Donor-H Atoms .............. 9 Why ?  
PLAT042_ALERT_1_G Calc. and Reported MoietyFormula Strings Differ  
PLAT909_ALERT_3_G Percentage of Observed Data at Theta(Max) still 82 %  
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APPENDIX B 
 
This appendix contains NMR spectra, details of calculated circular dichroism 
(CD) spectra of (RRuRCRC)-18c
+ PF6
− and (SRuRCRC)-18c
+ PF6
−, chiral HPLC traces, 
and the checkCIF reports related to chapter 3, titled Epimeric Chiral-at-Metal 
Ruthenium Complexes: Separation and Applications. 
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Figure b1 NMR spectra of (RCRC)-16c (CDCl3; * = solvent or impurities): (a) 
1H (500 
MHz); (b) 13C{1H} (125 MHz).  
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Figure b2 NMR spectra of (RCRC)-16d (CD3OD; * = solvent or impurities): (a) 
1H (500 
MHz); (b) 13C{1H} (125 MHz).  
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Figure b3 NMR spectra of (RRuRCRC/SRuRCRC)-18c
+ PF6
– (CD3CN; * = solvent or 
impurities): (a) 1H (500 MHz); (b) 13C{1H} (125 MHz).  
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Figure b4 NMR spectra of (RRuRCRC)-18c
+ X– (CD3CN; * = solvent or impurities): (a) 
1H (500 MHz); (b) 13C{1H} (125 MHz).  
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Figure b5 NMR spectra of (SRuRCRC)-18c
+ X– (CD3CN; * = solvent or impurities): (a) 
1H (500 MHz); (b) 13C{1H} (125 MHz).  
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Figure b6 NMR spectra of (RRuRCRC)-18c
+ PF6
– (CD3CN; * = solvent or impurities): 
(a) 1H (500 MHz); (b) 13C{1H} (125 MHz). 
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Figure b7 NMR spectra of (SRuRCRC)-18c
+ PF6
– (CD3CN; * = solvent or impurities): 
(a) 1H (500 MHz); (b) 13C{1H} (125 MHz).  
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Figure b8 NMR spectra (CD3CN; * = internal standard, 1-bromo-3,5-bis(trifluoro-
methyl)benzene (–63.56 ppm)): (a) 19F{1H} (470 MHz), (RRuRCRC)-18c
+ PF6
–; (b) 
19F{1H} (470 MHz), (SRuRCRC)-18c
+ PF6
–.  
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Figure b9 NMR spectra of (RRuRCRC)-18c
+ TRISPHAT– (CDCl3; * = solvent or 
impurities): (a) 1H (500 MHz), (b) 13C{1H} (125 MHz).  
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Figure b10 NMR spectra of (RRuRCRC/SRuRCRC)-18d
+ PF6
– (CD2Cl2; * = solvent or 
impurities): (a) 1H (500 MHz); (b) 13C{1H} (125 MHz).  
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Table b1 Summary of crystallographic data.  
 
(RRuRCRC)-18c
+ (Δ)-
TRISPHAT–·CHCl3 
(RRuRCRC/SRuRCRC)-18c
+ 
TRISPHAT–·(Et2O)2
a
 
molecular formula C41H30Cl15N6O7PRu C48H49Cl12N6O9PRu 
formula weight 1382.50 1411.37 
temperature (K) 150(2) 110(2) 
wavelength (Å) 0.77490 1.54178 
crystal system Monoclinic Monoclinic 
space group P21 P21 
unit cell dimensions:   
a [Å] 10.286(2) 15.3215(5) 
b [Å] 20.552(4) 13.8122(4) 
c [Å] 13.183(4) 27.4488(8) 
α [°] 90 90 
β [°] 111.967(2) 103.025(2) 
γ [°] 90 90 
V [Å3] 2584.6(10) 5659.4(3) 
Z 2 4 
calc [Mgm
3] 1.776 1.656 
 [mm1] 1.165 8.226 
F (000) 1376 2856 
crystal size [mm3] 0.03 0.03 0.015 0.08 0.04 0.03 
 range [°] 1.82 to 27.50 1.65 to 59.99 
index ranges (h,k,l) 12,12;24,24;15,15 17,17;15,14;30,30 
reflections collected 24796 73140 
independent reflections 9102 15448 
completeness to  99.5% (27.50°) 79.8% (67.68°) 
data/restraints/parameters 9102/1/652 15448/7/1403 
goodness-of-fit on F2 1.014 1.056 
R indices (final) [I>2 (I)]   
R1 0.0367 0.0303 
wR2 0.0847 0.0697 
R indices (all data)   
R1 0.0380 0.0361 
wR2 0.0854 0.0720 
absolute structure parameter 0.03(2) 0.006(4) 
Largest diff. peak and hole [eÅ3] 0.451/0.376 0.657/0.849 
a a 1:1 mixture of two diastereomers of 18c+ and two enantiomers of TRISPHAT–, with two Et2O 
molecules per ruthenium. 
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Calculation of the circular dichroism (CD) excitations of (RRuRCRC)-18c
+ PF6
− and 
(SRuRCRC)-18c
+ PF6
– 
 
All calculations were performed using the Gaussian 09 (G09) suite of 
programs.189 Full geometry optimizations in the gas phase were performed on the 
cations of the diastereoisomers, (RRuRCRC)-18c
+ PF6
− and (SRuRCRC)-18c
+ PF6
−, using 
Density Functional Theory (DFT) with the Stuttgart/Dresden (SDD) basis set and small-
core quasi-relativistic Effective Core Potential (ECP)190 for ruthenium and the triple- 
quality Pople basis set on carbon, nitrogen, and hydrogen, including a diffuse and 
polarization function on carbon and nitrogen (6-311+G(d)).191 The B3LYP functional 
(Becke-3 hybrid exchange192 and Lee-Yang-Parr correlation193), as implemented in 
G09, was used for the geometry optimization. Frequency calculations on the B3LYP 
optimized geometry were performed to confirm that the stationary points were minima 
(i.e. all real frequencies). Time-Dependent Density Functional Theory (TD-DFT)194 
calculations in implicit CH3CN (PCM)
195 at the B3LYP gas phase optimized geometries 
were performed to calculate the CD excitations and rotatory strengths196 of (RRuRCRC)-
18c+ PF6
− and (SRuRCRC)-18c
+ PF6
− using both the B3LYP and BHandHLYP197 
functionals with the SDD basis set and ECP on ruthenium and triple- quality Pople 
basis set including a diffuse and polarization function on carbon, nitrogen, and hydrogen 
(6-311+G(d)).191  
 
CD spectra were simulated using the Gaussian function shown in Equation 1 
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  ]       Equation 1 
 
 257 
 
where  is the band width at height 1/e (= 0.20 eV), ∆Ei and Ri are the excitation 
energy (eV) and rotatory strength R (1040 cgs) in dipole length (Rlen) for excitation i, A 
is the number of excitations calculations (A = 33), and Δε is the molar extinction 
coefficient (M–1cm–1).  
The purpose of checking the results with two basis sets was to increase 
confidence in the conclusions, should they be the same for both methods. The results for 
all of the above calculations are given in Figures b11 and b12. 
 
 
 
Figure b11 Calculated CD excitations and rotatory strengths using the B3LYP 
functional: (a) Simulated CD spectrum of (RRuRCRC)-18c
+ PF6
−; (b) Simulated CD 
spectrum of (SRuRCRC)-18c
+ PF6
−; (c) Plot of calculated CD excitations for (RRuRCRC)-
18c+ PF6
− versus wavelength; (d) Plot of calculated CD excitations for (SRuRCRC)-18c
+ 
PF6
− versus wavelength. 
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Figure b12 Calculated CD excitations and rotatory strengths using the BHandHLYP 
functional: (a) Simulated CD spectrum of (RRuRCRC)-18c
+ PF6
−; (b) Simulated CD 
spectrum of (SRuRCRC)-18c
+ PF6
−; (c) Plot of calculated CD excitations for (RRuRCRC)-
18c+ PF6
− versus wavelength; (d) Plot of calculated CD excitations for (SRuRCRC)-18c
+ 
PF6
− versus wavelength. 
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HPLC traces 
Friedel-Crafts alkylation of 5a or 5b with 6 catalyzed by (SRuRCRC)-18c
+ PF6
– 
(Table 3.3) 
 
 
 
Figure b13 HPLC trace of 7a (Table 3.3, entry 1): catalyzed by (SRuRCRC)-18c
+ PF6
–. 
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Figure b14 HPLC trace of 7b (Table 3.3, entry 2): catalyzed by (SRuRCRC)-18c
+ PF6
–. 
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Addition of dialkyl malonates to nitroalkenes (Table3.4) 
(a) 
 
 
(b) 
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(c) 
 
 
(d) 
 
 
Figure b15 HPLC traces of 19a (Table 3.4, entry 1): (a) racemic sample; (b) catalyzed 
by (SRuRCRC)-18c
+ PF6
–; (c) catalyzed by (RRuRCRC)-18c
+ PF6
–; (d) catalyzed by 
(RCRC)-16c. 
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(a) 
 
 
(b) 
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(c) 
 
 
(d) 
 
 
Figure b16 HPLC traces of 19b (Table 3.4, entry 2): (a) racemic sample; (b) catalyzed 
by (SRuRCRC)-18c
+ PF6
–; (c) catalyzed by (RRuRCRC)-18c
+ PF6
–; (d) catalyzed by 
(RCRC)-16c. 
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(a) 
 
 
(b) 
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(c) 
 
 
(d) 
 
 
Figure b17 HPLC traces of 19c (Table 3.4, entry 3): (a) racemic sample; (b) catalyzed 
by (SRuRCRC)-18c
+ PF6
–; (c) catalyzed by (RRuRCRC)-18c
+ PF6
–; (d) catalyzed by 
(RCRC)-16c. 
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(a) 
 
 
(b) 
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(c) 
 
 
(d) 
 
 
Figure b18 HPLC traces of 19d (Table 3.4, entry 4): (a) racemic sample; (b) catalyzed 
by (SRuRCRC)-18c
+ PF6
–; (c) catalyzed by (RRuRCRC)-18c
+ PF6
–; (d) catalyzed by 
(RCRC)-16c. 
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(a) 
 
 
(b) 
 
 
 
 270 
 
(c) 
 
 
(d) 
 
 
Figure b19 HPLC traces of 19e (Table 3.4, entry 5): (a) racemic sample; (b) catalyzed 
by (SRuRCRC)-18c
+ PF6
–; (c) catalyzed by (RRuRCRC)-18c
+ PF6
–; (d) catalyzed by 
(RCRC)-16c. 
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(a) 
 
 
(b) 
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(c) 
 
 
Figure b20 HPLC traces of 19f (Table 3.4, entry 6): (a) catalyzed by (SRuRCRC)-18c
+ 
PF6
–; (b) catalyzed by (RRuRCRC)-18c
+ PF6
–; (c) catalyzed by (RCRC)-16c. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 273 
 
(a) 
 
 
(b) 
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(c) 
 
 
Figure b21 HPLC traces of 19g (Table 3.4, entry 7): (a) racemic sample; (b) catalyzed 
by (SRuRCRC)-18c
+ PF6
–; (c) catalyzed by (RRuRCRC)-18c
+ PF6
–. 
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(a) 
 
 
(b) 
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(c) 
 
 
Figure b22 HPLC traces of 19h (Table 3.4, entry 8): (a) racemic sample; (b) catalyzed 
by (SRuRCRC)-18c
+ PF6
–; (c) catalyzed by (RRuRCRC)-18c
+ PF6
–. 
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Additions of Michael donors to 6 (Table 3.5). 
(a) 
 
 
(b) 
 
Figure b23 HPLC traces of 21 (Table 3.5, entry 1): (a) catalyzed by (SRuRCRC)-18c
+ 
PF6
–; (b) catalyzed by (RRuRCRC)-18c
+ PF6
–. 
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Figure b24 HPLC trace of 23 (Table 3.5, entry 2): catalyzed by (SRuRCRC)-18c
+ PF6
–. 
 
  
 279 
 
(a) 
 
 
 
(b) 
 
 
 
Figure b25 HPLC traces of 25 (Table 3.5, entry 3): (a) catalyzed by (SRuRCRC)-18c
+ 
PF6
–; (b) catalyzed by (RRuRCRC)-18c
+ PF6
–. 
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(a) 
 
 
(b) 
 
 
 
 
 
 
 
(c) 
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Figure b26 HPLC traces of 27 (Table 3.5, entry 4): (a) racemic sample; (b) catalyzed by 
(RRuRCRC)-18c
+ PF6
– (entry 4b) ; (c) catalyzed by (SRuRCRC)-18c
+ PF6
– (entry 4d). 
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Additions of 22 to dialkyl azodicarboxylates (Table 3.6). 
(a) 
 
 
(b) 
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(c) 
 
 
Figure b27 HPLC traces of 37 (Table 3.6, entry 1): (a) racemic sample; (b) catalyzed by 
(SRuRCRC)-18c
+ PF6
– (entry 1a) ; (c) catalyzed by (RRuRCRC)-18c
+ PF6
– (entry 1b). 
  
 284 
 
(a) 
 
(b) 
 
Figure b28 HPLC traces of 39 (Table 3.6, entry 2): (a) catalyzed by (SRuRCRC)-18c
+ 
PF6
– (entry 2a); (b) catalyzed by (RRuRCRC)-18c
+ PF6
– (entry 2c). 
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APPENDIX C 
 
This appendix contains the NMR spectra (1D and 2D), chiral HPLC traces, and 
the checkCIF reports related to chapter 4, titled Enantiopure Chiral-at-Metal Ruthenium 
Complexes: Syntheses, Resolution, and Applications in Second Coordination Sphere 
Promoted Catalysis. 
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Figure c1 NMR spectra of 48+ PF6
 (CD2Cl2; * = solvent or impurities): (a) 
1H (500 
MHz); (b) 13C{1H} (125 MHz). 
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Figure c2 NMR spectra of 48+ PF6
 (CD2Cl2, 500 MHz): (a) 
1H-1H COSY; (b) Partial 
1H-1H COSY for the aromatic region. 
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Figure c3 NMR spectra of 48+ PF6
 (CD2Cl2, 500 MHz): (a) 
13C DEPT-90; (b) Partial 
13C DEPT-90 for the aromatic region. 
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Figure c4 NMR spectra of 48+ PF6
 (CD2Cl2, 500 MHz): (a) 
1H-13C HSQC; (b) Partial 
1H-13C HSQC for the aromatic region. 
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Figure c5 NMR spectra of 48+ PF6
 (CD2Cl2, 500 MHz): (a) 
1H-13C HMBC; (b) Partial 
1H-13C HMBC for the aromatic region. 
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Figure c6 NMR spectra of 48+ BArf
 (CD2Cl2; * = solvent or impurities): (a) 
1H (500 
MHz); (b) 13C{1H} (125 MHz). 
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Figure c7 NMR spectra of 48+ BArf
 (CD2Cl2, 500 MHz): (a) 
1H-1H COSY; (b) Partial 
1H-1H COSY for the aromatic region. 
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Figure c8 NMR spectra of 48+ BArf
 (CD2Cl2, 500 MHz): (a) 
13C DEPT-90; (b) Partial 
13C DEPT-90 for the aromatic region. 
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Figure c9 NMR spectra of 48+ BArf
 (CD2Cl2, 500 MHz): (a) 
1H-13C HSQC; (b) 
Partial 1H-13C HSQC for the aromatic region. 
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Figure c10 NMR spectra of 48+ BArf
 (CD2Cl2, 500 MHz): (a) 
1H-13C HMBC; (b) 
Partial 1H-13C HMBC for the aromatic region. 
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Figure c11 NMR spectra of 49 (1:1 v/v CD2Cl2/CD3OD; * = solvent or impurities): (a) 
1H (500 MHz); (b) 13C{1H} (125 MHz). 
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Figure c12 NMR spectra of 49 (1:1 v/v CD2Cl2/CD3OD, 500 MHz): (a) 
1H-1H COSY; 
(b) Partial 1H-1H COSY for the aromatic region. 
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Figure c13 NMR spectra of 49 (1:1 v/v CD2Cl2/CD3OD, 500 MHz): (a) 
13C DEPT-90; 
(b) Partial 13C DEPT-90 for the aromatic region. 
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Figure c14 NMR spectra of 49 (1:1 v/v CD2Cl2/CD3OD, 500 MHz): (a) 
1H-13C HSQC; 
(b) Partial 1H-13C HSQC for the aromatic region. 
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Figure c15 NMR spectra of 49 (1:1 v/v CD2Cl2/CD3OD, 500 MHz): (a) 
1H-13C 
HMBC; (b) Partial 1H-13C HMBC for the aromatic region. 
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Figure c16 NMR spectra of (RRu/SRu)-48
+ (P)-Phos (CD2Cl2; * = solvent or 
impurities): (a) 1H (500 MHz); (b) 13C{1H} (125 MHz). 
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Figure c17 NMR spectra of (SRu)-48
+ (P)-Phos (CD2Cl2; * = solvent or impurities): 
(a) 1H (500 MHz); (b) 13C{1H} (125 MHz).  
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Additions of 28 to 50 or 52 catalyzed by (SRu)-48
+ BArf
 (Table 4.10). 
(a) 
 
(b) 
 
Figure c32. HPLC traces of 51 (Table 4.10, entry 1): (a) racemic sample; (b) catalyzed 
by (SRu)-48
+ BArf
–.  
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Figure c33. HPLC trace of 53 (Table 4.10, entry 1): catalyzed by (SRu)-48
+ BArf
–. 
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CheckCIF report for 48+ PF6
(C5H12)1.5 
 
The following ALERTS were generated. Each ALERT has the format  
test-name_ALERT_alert-type_alert-level.  
 
Alert level B  
THETM01_ALERT_3_B The value of sine(theta_max)/wavelength is less than 0.575  
Calculated sin(theta_max)/wavelength = 0.5617  
PLAT023_ALERT_3_  Resolution (too) Low [sin(theta)/Lambda < 0.6]…60.00 Degree  
 
Alert level C  
PLAT048_ALERT_1_C MoietyFormula Not Given ........................ a 
PLAT125_ALERT_4_C No '_symmetry_space_group_name_Hall' Given ..... 
PLAT243_ALERT_4_C High 'Solvent' Ueq as Compared to Neighbors of C60 
PLAT250_ALERT_2_C Large U3/U1 Ratio for Average U(i,j) Tensor .... Low…3.6 
PLAT342_ALERT_3_C Bond Precision on C-C Bonds ...............0.0085 Ang. 
PLAT420_ALERT_2_C D-H Without Acceptor N4 – H4B 
 
Alert level G  
PLAT002_ALERT_2_G Number of Distance or Angle Restraints on AtSite 4 
PLAT005_ALERT_5_G No _iucr_refine_instructions_details in the CIF  
PLAT007_ALERT_5_G Number of Unrefined Donor-H Atoms .............. 5 
PLAT045_ALERT_1_G Calculated and Reported Z Differ by ............0.50 Ratio  
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PLAT244_ALERT_4_G Low 'Solvent' Ueq as Compared to Neighbors of P1 
PLAT300_ALERT_4_G Atom Site Occupancy of *C61 is Constrained at 0.500  
PLAT300_ALERT_4_G Atom Site Occupancy of *C61A is Constrained at 0.500 
PLAT300_ALERT_4_G Atom Site Occupancy of *C62 is Constrained at 0.500  
PLAT302_ALERT_4_G Anion/Solvent Disorder ............ Percentage = 10  
PLAT304_ALERT_4_G Non-Integer Number of Atoms ( 8.50) in Resd. # 4  
PLAT432_ALERT_2_G Short Inter X...Y Contact C60 .. C62 .. 2.48 Ang.  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 12  
N1 -RU1 -C9 -O1  –135.00 11.00  1.555  1.555  1.555  1.555  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 13  
N3 -RU1 -C9 -O1  144.00 11.00  1.555  1.555  1.555  1.555  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 14  
C12 -RU1 -C9 -O1  13.00 11.00  1.555  1.555  1.555  1.555  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 15  
C13 -RU1 -C9 -O1  –25.00 11.00  1.555  1.555  1.555  1.555  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 16   
C11 -RU1 -C9 -O1  42.00 11.00  1.555  1.555  1.555  1.555  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 17   
C10 -RU1 -C9 -O1  24.00 11.00  1.555  1.555  1.555  1.555  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 18   
C14 -RU1 -C9 -O1  –39.00 11.00  1.555  1.555  1.555  1.555  
PLAT779_ALERT_4_G Suspect or Irrelevant (Bond) Angle in CIF .... # 264   
C62 -C61 -C62  3.564  1.555  1.555  17.00 Deg.  
PLAT779_ALERT_4_G Suspect or Irrelevant (Bond) Angle in CIF .... # 273  
 307 
 
C62 -C61 -H62B  3.564  1.555  1.555  43.40 Deg.  
PLAT779_ALERT_4_G Suspect or Irrelevant (Bond) Angle in CIF .... # 274   
C62 -C61 -H62B  1.555  1.555  1.555  36.00 Deg.  
PLAT779_ALERT_4_G Suspect or Irrelevant (Bond) Angle in CIF .... # 283   
C62 -C62 -C61A  3.564  1.555  1.555  31.00 Deg.  
PLAT790_ALERT_4_G Centre of Gravity not Within Unit Cell: Resd. # 2 
F6P 
PLAT790_ALERT_4_G Centre of Gravity not Within Unit Cell: Resd. # 3 
C5 H12 
PLAT790_ALERT_4_G Centre of Gravity not Within Unit Cell: Resd. # 4 
C2.50 H6 
PLAT809_ALERT_1_G Can not Parse the SHELXL Weighting Scheme String 
PLAT860_ALERT_3_G Number of Least-Squares Restraints ............. 4   
PLAT899_ALERT_4_G SHELXL97 is Deprecated and Succeeded by SHELXL 2014   
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CheckCIF report for 48+ BArf
.H2O 
 
The following ALERTS were generated. Each ALERT has the format  
test-name_ALERT_alert-type_alert-level.  
 
Alert level B  
PLAT417_ALERT_2_B Short Inter D-H..H-D …H2 H1   .. 2.06 Ang.  
 
Alert level C  
PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density .... 2.22  
PLAT213_ALERT_2_C Atom F4C has ADP max/min Ratio ..... 3.1 prolat 
PLAT213_ALERT_2_C Atom F22D has ADP max/min Ratio ..... 3.2 prolat 
PLAT220_ALERT_2_C Large Non-Solvent C Ueq(max)/Ueq(min) Range 3.9 Ratio  
PLAT241_ALERT_2_C High Ueq as Compared to Neighbors for ..... C31   
PLAT250_ALERT_2_C Large U3/U1 Ratio for Average U(i,j) Tensor .... 2.5   
PLAT420_ALERT_2_C D-H Without Acceptor N4 - H4B  
PLAT480_ALERT_4_C Long H...A H- ond Reported H1 . F9C …2.57 Ang.  
PLAT480_ALERT_4_C Long H...A H-Bond Reported H2 .. F21C .. 2.61 Ang.  
PLAT480_ALERT_4_C Long H...A H-Bond Reported H5 .. F16C .. 2.58 Ang.  
PLAT480_ALERT_4_C Long H...A H-Bond Reported H5 .. F21D .. 2.57 Ang.  
PLAT480_ALERT_4_C Long H...A H-Bond Reported H1SB .. F3C .. 2.56 Ang.  
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Alert level G 
PLAT002_ALERT_2_G Number of Distance or Angle Restraints on AtSite 44 
PLAT003_ALERT_2_G Number of Uiso or Uij Restrained non-H Atoms ... 40 
PLAT007_ALERT_5_G Number of Unrefined Donor-H Atoms .............. 7  
PLAT042_ALERT_1_G Calc. and Reported MoietyFormula Strings Differ The 
PLAT154_ALERT_1_G su's on the Cell Angles are Equal ..........The…0.00200 Degree 
PLAT176_ALERT_4_G CIF-Embedded .res File Contains SADI Records The 12 
PLAT178_ALERT_4_G CIF-Embedded .res File Contains SIMU Records 5 
PLAT242_ALERT_2_G Low Ueq as Compared to Neighbors for ..... C7C  
PLAT242_ALERT_2_G Low Ueq as Compared to Neighbors for ..... C8C  
PLAT242_ALERT_2_G Low Ueq as Compared to Neighbors for ..... C15C  
PLAT300_ALERT_4_G Atom Site Occupancy of >F10C is Constrained at 0.505  
PLAT300_ALERT_4_G Atom Site Occupancy of >F11C is Constrained at 0.505  
PLAT300_ALERT_4_G Atom Site Occupancy of >F12C is Constrained at 0.505  
PLAT300_ALERT_4_G Atom Site Occupancy of >F13D is Constrained at 0.540  
PLAT300_ALERT_4_G Atom Site Occupancy of >F14D is Constrained at 0.540  
PLAT300_ALERT_4_G Atom Site Occupancy of >F15D is Constrained at 0.540  
PLAT300_ALERT_4_G Atom Site Occupancy of >F16D is Constrained at 0.600  
PLAT300_ALERT_4_G Atom Site Occupancy of >F17D is Constrained at 0.600  
PLAT300_ALERT_4_G Atom Site Occupancy of >F18D is Constrained at 0.600  
PLAT300_ALERT_4_G Atom Site Occupancy of >F19C is Constrained at 0.707  
PLAT300_ALERT_4_G Atom Site Occupancy of >F20C is Constrained at 0.707  
PLAT300_ALERT_4_G Atom Site Occupancy of >F21C is Constrained at 0.707  
PLAT300_ALERT_4_G Atom Site Occupancy of >F22D is Constrained at 0.511  
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PLAT300_ALERT_4_G Atom Site Occupancy of >F23D is Constrained at 0.511  
PLAT300_ALERT_4_G Atom Site Occupancy of >F24D is Constrained at 0.511  
PLAT300_ALERT_4_G Atom Site Occupancy of <F10D is Constrained at 0.495  
PLAT300_ALERT_4_G Atom Site Occupancy of <F11D is Constrained at 0.495  
PLAT300_ALERT_4_G Atom Site Occupancy of <F12D is Constrained at 0.495  
PLAT300_ALERT_4_G Atom Site Occupancy of <F13C is Constrained at 0.460  
PLAT300_ALERT_4_G Atom Site Occupancy of <F14C is Constrained at 0.460  
PLAT300_ALERT_4_G Atom Site Occupancy of <F15C is Constrained at 0.460  
PLAT300_ALERT_4_G Atom Site Occupancy of <F16C is Constrained at 0.400  
PLAT300_ALERT_4_G Atom Site Occupancy of <F17C is Constrained at 0.400  
PLAT300_ALERT_4_G Atom Site Occupancy of <F18C is Constrained at 0.400  
PLAT300_ALERT_4_G Atom Site Occupancy of <F19D is Constrained at 0.293  
PLAT300_ALERT_4_G Atom Site Occupancy of <F20D is Constrained at 0.293  
PLAT300_ALERT_4_G Atom Site Occupancy of <F21D is Constrained at 0.293  
PLAT300_ALERT_4_G Atom Site Occupancy of <F22C is Constrained at 0.489  
PLAT300_ALERT_4_G Atom Site Occupancy of <F23C is Constrained at 0.489  
PLAT300_ALERT_4_G Atom Site Occupancy of <F24C is Constrained at 0.489  
PLAT300_ALERT_4_G Atom Site Occupancy of >C16C is Constrained at 0.505  
PLAT300_ALERT_4_G Atom Site Occupancy of >C23D is Constrained at 0.540  
PLAT300_ALERT_4_G Atom Site Occupancy of >C24D is Constrained at 0.600  
PLAT300_ALERT_4_G Atom Site Occupancy of >C31C is Constrained at 0.707  
PLAT300_ALERT_4_G Atom Site Occupancy of >C32D is Constrained at 0.511  
PLAT300_ALERT_4_G Atom Site Occupancy of <C16D is Constrained at 0.495  
PLAT300_ALERT_4_G Atom Site Occupancy of <C23C is Constrained at 0.460  
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PLAT300_ALERT_4_G Atom Site Occupancy of <C24C is Constrained at 0.400  
PLAT300_ALERT_4_G Atom Site Occupancy of <C31D is Constrained at 0.293  
PLAT300_ALERT_4_G Atom Site Occupancy of <C32C is Constrained at 0.489   
PLAT301_ALERT_3_G Main Residue Disorder ............ Percentage = 19   
PLAT434_ALERT_2_G Short Inter HL..HL Contact F1C .. F10D .. 2.81 Ang.  
PLAT434_ALERT_2_G Short Inter HL..HL Contact F2C .. F10C . 2.79 Ang.  
PLAT434_ALERT_2_G Short Inter HL..HL Contact F8C .. F18D  2.79 Ang.  
PLAT606_ALERT_4_G VERY LARGE Solvent Accessible VOID(S) in Structure  
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels .......... 2 
PLAT860_ALERT_3_G Number of Least-Squares Restraints ............. 868  
PLAT869_ALERT_4_G ALERTS Related to the use of SQUEEZE Suppressed  
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CheckCIF report for 49 
 
The following ALERTS were generated. Each ALERT has the format  
test-name_ALERT_alert-type_alert-level.  
 
Alert level B  
THETM01_ALERT_3_B The value of sine(theta_max)/wavelength is less than 0.575  
Calculated sin(theta_max)/wavelength = 0.5617  
 
Alert level C  
PLAT220_ALERT_2_C Large Non-Solvent C Ueq(max)/Ueq(min) Range  4.7 Ratio  
PLAT222_ALERT_3_C Large Non-Solvent H Uiso(max)/Uiso(min) ... 4.3 Ratio  
PLAT241_ALERT_2_C High Ueq as Compared to Neighbors for ..... C24   
PLAT411_ALERT_2_C Short Inter H...H Contact H24 .. H43 .. 2.12 Ang.  
PLAT420_ALERT_2_C D-H Without Acceptor N3 -H3 ..  
PLAT420_ALERT_2_C D-H Without Acceptor N5 - H5B ..  
 
Alert level G  
PLAT002_ALERT_2_G Number of Distance or Angle Restraints on AtSite 19 
PLAT005_ALERT_5_G No _iucr_refine_instructions_details in the CIF 
PLAT007_ALERT_5_G Number of Unrefined Donor-H Atoms ..............4 
PLAT083_ALERT_2_G SHELXL Second Parameter in WGHT Unusually 
Large…81.46 
PLAT152_ALERT_1_G The Supplied and Calc. Volume s.u. Differ by ...2 Units 
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PLAT230_ALERT_2_G Hirshfeld Test Diff for O1 -- C9 .. 5.5 su  
PLAT230_ALERT_2_G Hirshfeld Test Diff for C14 -- C39 .. 7.5 su  
PLAT230_ALERT_2_G Hirshfeld Test Diff for C14 -- C39A .. 5.5 su  
PLAT232_ALERT_2_G Hirshfeld Test Diff (M-X) Ru1 -- C9 .. 5.8 su  
PLAT300_ALERT_4_G Atom Site Occupancy of >C39 is Constrained at 0.528 
PLAT300_ALERT_4_G Atom Site Occupancy of >C40 is Constrained at 0.528 
PLAT300_ALERT_4_G Atom Site Occupancy of >C41 is Constrained at 0.528 
PLAT300_ALERT_4_G Atom Site Occupancy of >C42 is Constrained at 0.528 
PLAT300_ALERT_4_G Atom Site Occupancy of >C43 is Constrained at 0.528 
PLAT300_ALERT_4_G Atom Site Occupancy of >C44 is Constrained at 0.528 
PLAT300_ALERT_4_G Atom Site Occupancy of <C39A is Constrained at 0.472 
PLAT300_ALERT_4_G Atom Site Occupancy of <C40A is Constrained at 0.472 
PLAT300_ALERT_4_G Atom Site Occupancy of <C41A is Constrained at 0.472 
PLAT300_ALERT_4_G Atom Site Occupancy of <C42A is Constrained at 0.472 
PLAT300_ALERT_4_G Atom Site Occupancy of <C43A is Constrained at 0.472 
PLAT300_ALERT_4_G Atom Site Occupancy of <C44A is Constrained at 0.472 
PLAT301_ALERT_3_G Main Residue Disorder ............ Percentage = 12  
PLAT606_ALERT_4_G VERY LARGE Solvent Accessible VOID(S) in Structure  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 51  
N3 -RU1 -C9 -O1  133.00 4.00  1.555  1.555  1.555  1.555  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 52  
N1 -RU1 -C9 -O1  -147.00 4.00  1.555  1.555  1.555  1.555  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 53  
C12 -RU1 -C9 -O1  -13.00 4.00  1.555  1.555  1.555  1.555  
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PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 54  
C13 -RU1 -C9 -O1  24.00 4.00  1.555  1.555  1.555  1.555  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 55  
C11 -RU1 -C9 -O1  -42.00 4.00  1.555  1.555  1.555  1.555  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 56  
C10 -RU1 -C9 -O1  -27.00 4.00  1.555  1.555  1.555  1.555  
PLAT710_ALERT_4_G Delete 1-2-3 or 2-3-4 Linear Torsion Angle ... # 57  
C14 -RU1 -C9 -O1  34.00 4.00  1.555  1.555  1.555  1.555  
PLAT779_ALERT_4_G Suspect or Irrelevant (Bond) Angle in CIF .... # 96  
C39 -C14 -C39A  1.555  1.555  1.555  10.90 Deg.  
PLAT860_ALERT_3_G Number of Least-Squares Restraints ............. 37  
PLAT869_ALERT_4_G ALERTS Related to the use of SQUEEZE Suppressed  
PLAT899_ALERT_4_G SHELXL97 is Deprecated and Succeeded by SHELXL 2014  
 
 
